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ABSTRACT

Harmeyer, Kayla M. Ph.D., Purdue University, December 2014. JMJC DomainContaining Histone Demethylase 2 (Jhd2): Bridging the Gap between H3K4
Trimethylation and H3 Acetylation. Major Professor: Scott Briggs.

Gene expression has been shown to be regulated through epigenetic modifications
to the N-terminal tail of histones. Among these modifications is methylation of lysine
residues. The enzyme Jhd2 is a histone demethylase that functions to remove H3K4
methylation in S. cerevisiae. Jhd2 is a homologue of the human JARID1 family of
histone demethylases, which has four members: JARID1A, B, C and D. JARID1B is of
particular interest because it has been shown to be up regulated in 90 percent of primary
breast cancers. Furthermore, JARID1A has been shown to be up regulated in gastric
cancer. Therefore studying how these H3K4 histone demethylases function will give
great insight into how JARID1 family members are missregulated during tumorigenesis
and how they can be targeted by inhibitors.
Studies have shown cross-talk between H3K4 methylation and H3K14 acetylation,
two marks generally associated with active transcription. Our study shows H3K14
acetylation mediates this cross-talk with H3K4 trimethylation by modulating the
interaction between the H3K4 demethylase Jhd2 and the H3 N-terminal tail and by
affecting Jhd2’s association with chromatin. By mutating H3K14, H3K4 trimethylation
can be modulated in a Jhd2 dependent manner. Additionally, deletion of a histone

xxvi
acetyltransferase GCN5 results in a decrease in not only H3 acetylation but also in global
and gene specific H3K4 trimethylation. This decrease in H3K4 trimethylation is
dependent on Jhd2. We further demonstrate that deletion of GCN5 causes an increase in
Jhd2 binding to chromatin. We also show the opposite phenotype, lower levels of Jhd2 at
chromatin, when histone deacetylases are deleted. This indicates that the turnover of
H3K14 acetylation affects H3K4 trimethylation through Jhd2. We were able to
demonstrate that this mechanism may be conserved through humans and Drosophila
melanogaster and that deletion of JHD2 partially rescues a gcn5∆ 6-AU sensitivity
phenotype, elucidating to a role for this cross-talk mechanism in transcriptional
elongation. Furthermore, we show that deletion of the histone deacetylase RPD3 results
in an increase of H3K4 trimethylation, most significantly at the 3’ regions of the genes
analyzed. Though this increase in H3K4 trimethylation is observed, deletion of RPD3
does not alter the localization of either Set1, the sole H3K4 methyltransferase, or Jhd2
across the gene. This suggests a new mechanism in which histone acetylation affects the
H3K4 trimethylation enrichment at actively transcribed genes. Altogether, these studies
mechanistically describe how H3K14 acetylation modulates H3K4 trimethylation through
the histone demethylase Jhd2 as well as present a new mechanism in which histone
acetylation may play a role in the enrichment of H3K4 trimethylation throughout the
open reading frame of actively transcribed genes.
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CHAPTER 1. INTRODUCTION

1.1
1.1.1

Chromatin structure

The nucleosome
Eukaryotic cells have evolved to contain a complex of DNA and proteins that

allows for the approximate two meters of DNA (in the human genome) to be packaged
into the nucleus (1-5). This complex of DNA and proteins is called chromatin. The basic
repeating unit of chromatin is the nucleosome, which is comprised of 146 base pairs (bp)
of DNA wrapped around an octamer of histone proteins, two copies of each H3, H4, H2A,
and H2B (1-5). Through years of work, structural and biochemical analyses have
brought significant insight to the structural characteristics of the nucleosome. Structural
analysis has determined that the octamer of histone proteins form a disc shape that allows
the 146 bp of DNA to wrap around in 1.65 turns in a left-handed superhelix (2;3;6). The
nucleosome also has distinct interactions between the four core histones. In solution there
are distinct heterodimer formation between H2A and H2B and H3 only dimerizes with
H4 (3). H3-H4 dimers have been shown to form a (H3-H4)2 tetramer when refolded in
vitro (3). Therefore, the current model of nucleosome assembly is through a step-wise
manner, in which either the tetramer or two heterodimers of H3-H4 are first deposited

2
onto the DNA which is then followed for the incorporation of two H2A-H2B
heterodimers (3). The histones themselves have two distinct regions, the histone fold
region, which is highly ordered, and the histone tail, which is mostly unstructured and
extends out of the nucleosomal core particle (2;3;7). Each of these distinct regions has
roles in nucleosome structure and stability. The histone fold regions are necessary for the
interaction between the histones and between the histones and DNA (2;3). Though the
histone tails are unstructured, studies have found that they interact with the DNA
wrapped around the nucleosome, the linker DNA (DNA connecting two nucleosomes),
and with neighboring nucleosomes, indicating the histone tails may play a role in higher
order chromatin structure which will be discussed in the next section (2;7-10).
Furthermore, the H2B and H3 tails have been suggested to play an important role in
nucleosome stability by affecting the interaction between the DNA and the histones (7).
Another very important characteristic of these histone tails is the ability for them to be
extensively post-translationally modified, which will be discussed in the following
sections.

1.1.2

Higher ordered chromatin structure
The mammalian genome is packaged by hundreds of thousands of nucleosomes

(3). This packaging results in a higher ordered chromatin structure that directly affects
DNA processes through controlling the accessibility of the genetic code (3;11;12).
Therefore, understanding how chromatin is packaged in the nucleus during interphase
and how nucleosome positioning can be modulated is of great importance in the
understanding of DNA mediated processes. The first level of chromatin organization is
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called “beads-on-a-string” (12-14). Interestingly, even though the histones do not make
any base-specific interactions with the DNA, the placement of the nucleosome along the
DNA at this first level of organization is not only dependent on the nature of the histones
themselves but on the DNA sequence (3;12). This is believed to be due to specific
sequences of DNA having a better ability to bend around the histones (12).
Further formation of higher ordered structure with neighboring nucleosomes form
chromatin fibers (12). However, the exact nature of these chromatin fibers is currently
under debate. The classic model is that the 10 nm chromatin fiber folds into a 30 nm fiber
(12;14). The structure of this 30 nm fiber has been under constant discussion; however,
due to advancements in technology, the current debate is if these 30 nm fibers actually
exist in vivo (12;14). Much work on characterizing the nature of the 30 nm fiber has been
done through in vitro analysis; however, in vivo analysis using cryo-EM, small angle Xray scattering (SAXS), chromosome-conformation-capture (3C), and electron
spectroscopic imaging (ESI) indicated that though 10 nm fibers could be observed, no 30
nm fibers were detected (15-20). Interestingly, the irregular folding of 10 nm fibers
instead of the highly ordered 30 nm fibers suggests that higher order of chromatin could
be more dynamic (14).
Though there is controversy over the nature of this higher ordered structure, the
compact nature of chromatin inside the eukaryotic nucleus has been classified into two
groups depending on the degree of compactness and transcriptional activity. These
classes are termed heterochromatin and euchromatin. Heterochromatin is highly
condensed and transcriptionally silent (21;22). Euchromatin on the other hand is
transcriptionally active and less compact (22). Though the compactness and number of
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nucleosomes are less in euchromatin, both positioning and post-translational
modifications of the nucleosomes at specific gene loci are fundamentally important in
controlling gene expression (11;23)

1.2
1.2.1

Modulating chromatin

ATP-dependent chromatin remodeling
Though euchromatin is relatively less compact, the nucleosomes that are present

create an obstacle for the transcriptional machinery and for transcription factors to access
the DNA (24;25). Therefore, it is necessary to position the nucleosome across the DNA at
specific locations and to be able to move or evict the nucleosomes when necessary to
facilitate proper levels of transcription as well as proper execution of other DNA template
process such as DNA replication and repair (26). For this process the eukaryotic cell has
enzymes that function to disrupt the nucleosome structure through hydrolysis of ATP
(11;25;26). This class of enzymes is called ATP-dependent chromatin remodelers
(11;25;26). These remodelers have many roles that they play to modulate the chromatin
structure. For example, after the DNA has been replicated, specific remodelers are
necessary to ensure that the nucleosomes are correctly spaced along the genome (26).
Furthermore, because nucleosomes can shield specific DNA sequences from the
transcription factors that recognize them, chromatin remodelers are necessary to
dynamically alter the nucleosome position to mediate proper gene activation or
repression by those transcription factors (11;25;26). For example, under certain
conditions transcription factors are needed to activate their target genes, and therefore, it
is necessary to alter the nucleosome positioning through ATP-dependent remodeling
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factors so that the DNA sequence becomes exposed for the transcription factor to bind
and elicit the proper transcriptional response (11;25).
To perform the variety of chromatin remodeling processes needed, the cell has
four distinct classes of ATP-dependent chromatin remodelers (25-27). Every enzyme in
these classes shares a similar ATPase domain (25;26). These classes are characterized by
the other domains found in the protein sequence that specialize their function to a unique
biological process (25). The first class of ATP-dependent remodelers to be discovered
was the SWI/SNF family (25). This complex was originally discovered through two
different screens in Saccharomyces cerevisiae that were testing the effects different genes
had on the mating-type switch or for growth of sucrose (25;27;28). Further work was
done to describe how the SWI/SNF complex was able to utilize ATP to increase the
accessibility of nucleosomal DNA to the DNA binding protein Gal4 (25;29). This family
of chromatin remodelers is evolutionarily conserved and has been characterized to slide
and remove nucleosomes at specific loci (25-27).
The second class is the ISW1 family that was initially discovered in Drosophila
melanogaster (25;26;30;31). The complexes found in this family consist of two to four
protein subunits and are generally associated with regulating the spacing between the
nucleosomes (25;26). For this reason many members of this family have been associated
with chromatin assembly and gene repression (25;26;31). However, one member, the
NURF complex, has been associated with active transcription by randomizing the spacing
of nucleosomes leading to an environment more acceptable to gene expression (25;26;31).
The CHD family of chromatin remodelers is characterized as containing
chromodomains upstream of the ATPase domain (25;26). Chromodomains have been
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shown to interact with methylated lysine residues (32;33). This family of remodelers also
has diverse functions. They have been shown to promote transcription through their
ability to slide or remove nucleosomes (25;26). However, a member of this family called
the Mi-2/NuRD complex associates with a histone deacetylases and a H3K4 demethylase,
which are enzymes generally associated with transcriptional repression (25;26;34;35).
The last class of chromatin remodelers is the INO80 family (25;26). Originally
discovered in S. cerevisiae, this family is characterized as being in large complexes
consisting of more than ten protein subunits (25;26;36). Similar to the other classes of
chromatin remodelers, the INO80 family performs diverse processes including
transcription regulation and responding to DNA damage (25;26).
As indicated by the multiple cellular processes that these ATP-dependent
chromatin remodelers modulate and that these functions must be performed at specific
loci, proper localization and nucleosomal recognition is fundamental in the ability of
these enzymes to carry out their function. One very common theme with all of these
remodelers is their ability to interact with specific histone post-translational modifications
(PTMs) (25;26). Therefore, histone PTMs play a very important function in DNA
template process and chromatin organization. The remaining portion of this introduction
will be to further discuss these histone PTMs and what roles they play in the
transcriptional process from general changes in the chromatin landscape to the
recruitment of chromatin associated-factors, such as chromatin remodelers and other
histone modifiers.
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1.2.2

Histone post-translational modifications
Eukaryotic cells use nucleosomes to package DNA in the nucleus, but these

nucleosomes can also be altered chemically to affect this packaging and compaction. In
the 1960’s scientists discovered that histones can be post-translationally modified by
methyl and acetyl groups (37-41). Since this initial discovery, what functional roles that
these modifications play has been a major question in the chromatin biology field (37-41).
From that initial discovery, the number of modifications found on histones has grown to
over 100 distinct sites of modifications, mostly found on the histone tails but also in the
histone fold domain (11;40). These include lysine and arginine methylation, lysine
acetylation, serine and threonine phosphorylation, ubiquitination, and sumoylation, as
well as others less well-known modifications such as crotonylation (11;39;40). Through
the development of high-throughput deep sequencing and the use of DNA microarrays
individually in conjunction with chromatin immunoprecipition (ChIP), ChIP-seq and
ChIP-chip, respectively, the locations of these modifications are being mapped along the
genomes of many organisms (11;40;42-45). However, what the biological roles that these
post-translational modifications play are still being investigated. There are two major
functions that have been assigned to these histone PTMs. They can alter the chemical or
charged composition of the histones themselves to directly affect the chromatin structure
or they can act as docking sites for chromatin associated proteins (11;39). These two
functions are not mutually exclusive, and what role each modification plays on
transcription is completely dependent on the type of modification and the residue that is
being modified. Four major types of histone PTMs will be discussed.
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1.2.2.1 Histone Phosphorylation
Though protein phosphorylation has been thoroughly studied throughout the
proteome, the biological roles of histone phosphorylation are still not fully characterized
(46). Due to the chemical nature of the phosphate group being negative, the addition of
phosphate groups results in a charge repulsion between the histone and DNA (40). This
would allow the nucleosome to form a more open confirmation (40). Studies have
demonstrated that the phosphorylation of histone H3 threonine 118 results in an increase
in chromatin remodeling and interferes with nucleosome wrapping (40;47). Furthermore,
in vitro analysis has shown that phosphorylation of H3T118 causes the nucleosomal
DNA to be more accessible to the DNA digestion with DNase I (40;47).
Though these physical characteristics of histone phosphorylation are known, there
is still work being done to fully understand the biological roles that histone
phosphorylation play. The reason why there is much interested in uncovering the roles of
phosphorylation on specific histone residues is due to the opposing roles that it has been
shown to have. Phosphorylation of H3 serine 10 has been shown to play a role in
chromosome condensation and segregation during mitosis (48;48). Other sites on histone
H3 have also been shown to be phosphorylated during mitosis, including serine 28 and
threonine 11 (48;48). The phosphorylation event on H3S10 has been shown to be
important for proper execution of mitosis, as a point mutation at this site in S. pombe
resulted in many mitotic defects (48;49). Histone phosphorylation of a histone variant,
H2A.X, has also been shown to be important to the cellular response to DNA damage
(50). When a double-stranded break of DNA occurs, an early step in the cellular response
is the phosphorylation of H2A.X at serine 139 (50;51). The phosphorylation of H2A.X
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recruits MDC1 (mediator of DNA damage checkpoint protein 1) (50). The recruitment of
MDC1 causes a cellular response that result in the activation of checkpoint proteins and
DNA repair enzymes (50).
Other work has been done implicated histone phosphorylation in gene activation
as a result from signaling kinases. Work done in mammalian cells that have undergone
treatment with epidermal growth factor (EGF) showed that H3 serine 10 becomes
phosphorylated at actively transcribed genes and that the rate of this phosphorylation
event correlated with the activation of the induced genes (48;48;52-54). How
phosphorylation of H3 serine 10 could play such dramatically different roles, from
mitotic chromosome aggregation to gene specific transcriptional activation to DNA
damage response, is still not fully understood and thus the nature and function of histone
phosphorylation is an ongoing study.
1.2.2.2 Histone Ubiquitination
Ubiquitin is a 78 amino acid (8.5 kDa) protein that is added onto another protein
via a lysine residue (55-57). Ubiquitination is a dynamic process in which a sequence of
activating, conjugating, and ligating enzymes function to add on the ubiquitin protein
(57). The class of enzymes shown to catalyze the removal of ubiquitin is called
deubiquitinases (55;57). The addition of ubiquitin affects the nature of the protein it is
added to, and a majority of this is based on the number of ubiquitin proteins added. A
protein that is polyubiquitinated is usually targeted for degradation by the 26S
proteasome (57). Monoubiquitination of a protein usually causes a functional change
(55;57). Both histones H2A and H2B are monoubiquitinated. Monoubiquitination of H2A
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has been associated with transcriptional repression (57-59). The establishment of this
mark is thought to occur through a sequential targeting and catalytic activity of two
polycomb group protein complexes, PRC1 and PRC2 (57-60). The model of H2A
monoubiquitination is that PRC2 deposits H3K27 trimethylation (57-59). Trimethylation
of H3K27 is recognized by PRC1, which catalyzes the addition of ubiquitin onto H2A
(57-60). In mammalian cells another enzyme has been shown to establish H2A
monoubiquitination. This ubiquitin ligase is called 2A-HUB/hRUL138 and associates
with the N-CoR/HDAC1/3 repressive complex (57;61). Establishment of H2A
monoubiquitination by this complex has been shown to prevent the recruitment of FACT
to genes and therefore inhibits transcriptional elongation (57;61).
Though histone H2A monoubiquitinated is associated with transcriptional
repression, much more extensive characterization has been done on the
monoubiquitination of H2B at lysine 123 (in yeast, lysine 120 in mammalian cells) and
its relationship with transcription (55;57). The addition of the ubiquitin group has been
shown to stabilize the nucleosome; however, one study suggested that ubiquitin only
modestly affects nucleosome stability (55;56;62-64). Based on the relatively large size of
ubiquitin, it has been shown to disrupt the higher ordered structure of chromatin, which
results in a more open confirmation (55;56;65). This correlates with H2B
monoubiquitination being associated with active transcription by playing a role in both
transcriptional initiation and elongation (57). H2B monoubiquitination has been
suggested to promote elongation and has been shown to be important for reassembly of
the nucleosome following the elongating RNA Polymerase II (RNAPII) (55;57;66).
Consistent with this model, the yeast enzymes that establish H2B monoubiquitination,
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Rad6 and Bre1, have been shown to associate with RNAPII (57). Furthermore, H2B
monoubiquitination is necessary for the establishment of two other modifications
associated with active transcription, H3K4 and H3K79 methylation (67-73). The
association between these marks will be further discussed in section 1.4.2. Furthermore,
aberrant H2B monoubiquitination levels have been shown to affect multiple cellular
processes including cell cycle progression, apoptosis, differentiation, and tumorigenesis
(55;56;74-79).
Though H2B monoubiquitination is associated with active transcription, it has
also been associated with gene repression (56;62). This is consistent with the
characterization that H2B monoubiquitination can stabilize the nucleosome (56;62;63;66).
However, how H2B monoubiquitination plays differing roles during gene repression and
activation is not completely understood. One model is that where H2B
monoubiquitination is found at a specific gene determines if this mark acts in a repressive
or activating manner (56;66). H2B monoubiquitination found at the transcriptional start
site may be more associated with a repressive role; whereas, H2B monoubiquitination
found along the open reading frame of the gene may be associated with a more activating
role (56;66). However, how monoubiquitination leads to repressive or activating
conditions has yet to be determined (56).
1.2.2.3 Histone Acetylation
Being the first histone PTM to be discovered, histone acetylation has been
thoroughly investigated (38;40;41). Though histone acetylation was initially discovered
in the 1960’s, the first enzymes shown to have the catalytic activity to add acetyl groups
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to histones were not identified until the 1990’s (38;40;41;80-82). These enzymes were
termed histone acetyltransferases or HATs, and many are found in multisubunit
complexes (80;83;84). These HATs were shown to add the acetyl group from acetyl-CoA
to the -amino group of lysine residues (84;85). Histone acetylation is generally
associated with active transcription (84;85). Histone acetylation affects transcription due
to its ability to change the charge of lysine residues in the nucleosomes, especially the
histone tail (40;86;87). The addition of an acetyl group onto a lysine residues results in
the neutralization of the positive charge (40;87). This neutralization loosens the contact
between the negatively charged DNA and acidic residues on neighboring nucleosomes
thus affecting the higher ordered folding of chromatin (2;13;40;87;88).
Besides altering the charge of the histone, acetylated lysine residues also serve as
docking sites for specific proteins (40;86;87). There is a single domain known to
specifically interact with acetylated lysine residues and that is the bromodomain, though
a PHD finger has been found to interact with H3K14 acetylation (89-92). PHD fingers
will be more thoroughly discussed in the following section. The bromodomain has an
arginine residue that hydrogen bonds to the acetyl-lysine residues (90;91;93). This
residue is located in a hydrophobic cavity that helps recognize the acetyl-lysine residue
(91;93). Many of the proteins that contain bromodomains are associated with modulating
chromatin, including chromatin remodelers and transcription factors (40;92). Because
they play an important role to mediate protein-nucleosomal interactions, there is current
work being done to target bromodomains of histone modifiers to inhibit their ability to
recognize and bind acetylated lysine residues (94).
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Histone acetylation is a highly dynamic process (87). Through in vivo analysis,
acetyl groups have been shown to have half-lives of only minutes (87;95). The enzymes
that remove these acetyl groups are called histone deacetylases or HDACs (80;83). There
are four classes of HDACs (80;83). The members of class I, II, and IV are zinc-dependent
(80;83). Class I is characterized by it sequence homology to the yeast HDAC Rpd3 and
can deacetylate all four core histones (80). Furthermore in humans this class of HDACs
are ubiquitously expressed (80). Class II share sequence homology to the yeast enzyme
Hda1 and can deacetylate histone H2B and H3 (80). Unlike the class I HDACs, the class
II HDACs have been shown to expressed tissue-specifically (80). Like HATs, class I and
II HDACs are found in complexes (83;84). The enzymes in class III are related to the
yeast Sir2 HDACs, which are involved in gene silencing and heterochromatin formation
and are NAD-dependent (80;83;84;96;97).
Acetylation along an actively transcribed gene is found enriched at the promoter
and transcriptional start site (42;80). Low levels of histone acetylation are found along
the open reading frame (ORF) (42;80). This is thought to repress the activation of cryptic
promoters located in the ORFs (80;98). Due to the close correlation between histone
acetylation and active transcription, altered histone acetylation across the genome is
associated with diseases, such as cancer (83;85). This abnormal establishment of histone
acetylation in cancer has been shown to result from mutations and translocations
affecting the function of HATs or from the mistargeting of HDACs resulting in
inappropriate gene repression (84;85). One extensively studied case of this is in acute
promyelocytic leukemia (APL) (84;99-101). In APL there is a translocation involving the
retinoic acid receptor-α, which results in inappropriate recruitment of HDACs to retinoic-
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acid response elements (RAREs) (84;99-101). This causes myloid cells to not
differentiate and develop properly (84;99-101). Furthermore, HDACs have become a
good target for cancer treatment because inhibitors of HDACs have been demonstrated to
have low toxicity and a wide therapeutic range (84). In fact, the Food and Drug
Administration (FDA) has approved a HDAC inhibitor for the treatment of cutaneous Tcell lymphoma (CTCL) (83;102).
1.2.2.4 Histone Methylation
Like histone acetylation, histone methylation was one of the first histone PTMs
discovered (38;103) . However, unlike acetylation, methylation has shown to be a diverse
modification which can be associated with either transcriptional activation or repression
depending on the residue modified and degree of methylation (86;104-107). Three
histone amino acids have been found to be methylated - lysine, arginine, and glutamine
(103;108-111). Of those amino acids lysine methylation has been most studied, followed
by arginine and glutamine. (40;105;108) Also differing from acetylation, the addition of
methyl groups does not change the charge of the lysine or arginine residues (105).
Therefore, methylation is primarily thought of as producing a docking site which
mediates the interaction between chromatin modifiers, chromatin remodelers, and
transcription factors with the nucleosome (105;106;108;112).
Histone glutamine methylation has been found on histone H2A in the nucleolus
specifically enriched at the 35S rDNA locus (110). In yeast, Nop1 was found to be the
enzyme that catalyzes the addition of this mark (110). Interestingly, Nop1 is a
characterized rRNA methyltransferase that is a subunit of RNA polymerase I (RNAPI)
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(110). The localization of glutamine (H2A Q105 in yeast and H2A Q104 in human cells)
methylation at this locus has been shown to prevent recruitment of FACT and result in a
more open form of chromatin (110). One model that was proposed is that glutamine
methylation prevents FACT from recognizing the histones and reincorporating back into
chromatin following transcription by RNAPII (110). However, this model does not fully
explain why glutamine methylation is still found at chromatin at locus (110). Therefore,
H2A glutamine methylation needs further characterization to completely understand the
role in plays in 35S rDNA transcription.
Arginine methylation is associated with transcriptional activation and repression
depending on the arginine residue that is modified (86;104). There are five major site of
arginine methylation on histone H3 and H4 – H3R2, H3R8, H3R17, H3R26, and H4R3
(108). The enzymes that catalyze the addition of the methyl groups are called protein
arginine methyltransferases (PRMTs) (104;108). There are nine members of this family
and they utilize S-adenosylmethionine (SAM) as a cofactor and transfer the methyl group
from SAM to arginine’s guanidine nitrogen (104). There are three forms of arginine
methylation, monomethyl arginines, asymmetric dimethyl arginine, and symmetric
dimethyl arginine (104). Arginine methylation can be removed. The histone deiminase
PADI4 (Peridylarginine deiminase 4) reacts with the methyl arginine and converts it to
citrulline (86;104;108;113;114). However, because this changes the complete nature of
the residue and targets both methylated and unmodified arginine residues, PADI4 is not a
true demethylase (108;113). Recent studies suggest the Jumonji domain-containing
protein, JMJD6 can demethylase both H3R2 and H4R3 dimethylation (104;115).
However, further investigation of JMJD6 will need to be done to confirm that it acts as a
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bona fide arginine demethylase (104;116). Furthermore, Jumonji domain-containing
proteins will be further discussed as histone lysine demethylases (116).
The histone modification that will be the focus of the rest of this thesis is histone
lysine methylation. Like histone arginine methylation, multiple lysine residues can be
methylated. The major sites of lysine methylation are histone H3 lysines 4, 9, 27, 26, and
79 and histone H4 lysine 20 (105;108;117). However, in S. cerevisiae the major sits of
methylation are only H3K4, K36 and K79, though recently methylation of lysines 5, 8,
and 12 of H4 by the enzyme Set5 has been identified (118;119). Depending on the
residue that is modified, lysine methylation can be associated with transcriptional
activation or repression. H3K4, K36, and K79 methylation are associated with
transcriptional activation (86;105). Methylation on H3K9, H3K27 and H4K20 is
associated with transcription repression (86;105;111). Lysine residues can also have
different degrees of methylation. One, two, or three methyl groups can be covalently
linked to the -amino group of lysine resulting in either mono-, di-, or trimethylation,
respectively (105;112;117).
The class of enzymes that add the methyl groups is histone lysine
methyltransferases (KMTs) (112;117). Like PRMTs, KMTs use SAM as a cofactor
(112;117). One class of KMTs consists of enzymes that have a conserved SET
(Suppressor of Variegation (Su(var)), Enhancer-of-Zeste (E(z)), and Trithorax (Trx))
domain (108;117;120;121). Another class of KMTs does not contain a SET domain and
consist of the H3K79 methyltransferase Dot1 (S. cerevisiae) or DOT1L (human)
(108;112;122-124). Interestingly, the catalytic domain of the Dot1 class shares sequence
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similarity to arginine methyltransferase (106). However, Dot1 has not been demonstrated
to target arginine residues (106;124).
Though acetylation, phosphorylation, and ubiquitination were known to be
reversible, historically lysine methylation was believed to be a stable PTM (108;109).
With no known enzymes that targeted lysine residues for demethylation, lysine
methylation was thought to be only lost with the incorporation of de novo nucleosomes
(107). However, this changed in the early 2000’s when the first histone lysine
demethylase was discovered (125;126). This enzyme is now known to be in the class of
LSD1 (Lysine Specific Demethylase 1) histone demethylases (86;126;127). Two
enzymes in this class are LSD1 and LSD2 (127). This class of enzymes uses flavin
adenine dinucleotide (FAD) in an amine oxidation reaction (125;127). Due to the
catalytic mechanism, the LSD1 class of enzymes can only demethylase mono- and
dimethylated lysine residues (127). LSD2 targets H3K4 mono- and dimethylation (127129). LSD1 can target H3K4 mono- and dimethylation and H3K9 mono- and
dimethylation (86;126;127;130). Interestingly, because LSD1 has different substrates
(H3K4 and H3K 9 methylation) LSD1 can act as a transcriptional repressor or activator
(86;130). In vivo LSD1 acts in a complex and depending on the complex that LSD1
associates with dictates which lysine residue it targets for demethylation and what role it
plays in respect to transcription (86;127;131;132).
The second class of histone lysine demethylases was discovered a couple years
after the LSD1 class (133). This class of enzymes was discovered due to the hypothesis
that a similar oxygenase reaction performed by the bacterial AlkB family of oxygenases,
which were found to demethylate DNA, could be done to demethylate methylated lysine
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residues (133). This led to the characterization that JHDM1, a Jumonji (Jmj) C domain
containing protein, could demethylate H3K36 methylation (127;133). Since then over
twenty of the thirty JmjC domain containing proteins in humans and three of the five in
yeast have been shown to have demethylase activity (127;132;133). Due to the
dioxygenase reaction of the JmjC domain, the JmjC domain containing demethylases are
capable of removing all forms of lysine methylation including trimethylation
(127;132;133). This catalytic mechanism involves the cofactors iron and -ketoglutarate
as well as oxygen to form oxoferryl, a highly reactive species (127;132;133). This allows
the methyl group to by hydroxylated, which is followed by the hydroxymethyl group
spontaneously forming formaldehyde resulting in the demethylation of the lysine residue
(132;133). Most of the members of this class of demethylases are highly specific for a
particular lysine residue and have been found to target all methylated lysine sites, except
H3K79 (106;127). Interestingly, there are no known demethylases that target this site
(106).
As previously mentioned, the addition of methyl groups onto the lysine residue
does not affect its positive charge. Therefore, methylated lysine residues are thought to
act as docking sites for chromatin associated proteins (105;106). Similar to the
bromodomain, which interacts with acetylated lysine residues, there are specific protein
domains that have been found to directly interact with methylated lysine residues. These
domains include chromodomains, WD40 repeats, Tudor domains, and PHD fingers
(32;33;108;134-137). PHD fingers are interesting because they not only bind specific
lysine residues, but they can bind in a highly specific manner to the degree or type of
modification that lysine holds (135-137). For example, the JmjC domain containing
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histone demethylase JARID1B, which targets H3K4 methylation, has three PHD fingers
(35;138). The first PHD finger has been shown to interact with unmodified H3K4;
whereas, the third PHD finger preferentially binds to a trimethylated H3K4 peptide
(35;139). Furthermore, the tandem PHD fingers in the human DPF3b (D4, zinc and
double PHD fingers, family 3 protein) interacts not only with unmodified H3K4 but it
also has been shown to interact with H3K14 acetylation (the second and the first PHD
finger, respectively) (89;135;136). These are just two examples of the specificity and
versatility of PHD fingers and how modified or unmodified lysine residues act as docking
sites for chromatin associated proteins.

1.3

Histone H3 lysine 4 methylation

H3K4 methylation is generally associated with gene activation (42;140;141).
Genome wide studies have found that there is a distinct enrichment pattern of the states
of H3K4 methylation across the open reading frame. H3K4 trimethylation is found
enriched at the transcription start site and 5’-ORF of actively transcribed genes, and in
mammalian cells H3K4 trimethylation is also enriched at active promoters
(42;87;142;143). H3K4 dimethylation is predominately at in the middle of the ORF, and
H3K4 monomethylation has been found to be enriched at the 3’-ORF of actively
transcribed genes (42;142). This pattern of methylation is conserved from yeast to human
(142-144). Furthermore, H3K4 monomethylation has also been observed to be enriched
at enhancers in both mammalian cells and in Drosophila (142;145).
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1.3.1

H3K4 methyltransferases
The first H3K4 histone methyltransferase to be discovered was found in yeast

cells (121). Because the SET domain containing proteins CLR4 (S. pombe) and
SUV39H1 (mouse and humans) had been shown to be H3K9 methyltransferases, it was
hypothesized that one of the seven SET domain-containing proteins in yeast would be a
methyltransferase responsible for targeting H3K4 (120;121;146). After analyzing yeast
strains with individual gene deletions for the genes that encode each of the seven SET
domain-containing proteins, Set1 was indicated as the methyltransferase which targeted
this mark (121). With this, and further studies, Set1 was found to be the sole H3K4
methyltransferase, as deletion of the SET1 gene, as well as point mutations in the
catalytic SET domain, resulted in a complete loss of H3K4 mono-, di-, and trimethylation
(117;121;147-149). In yeast Set1 functions in an eight membered complex termed Set1C
or COMPASS (Complex of Proteins Associated with Set1) (148;150;151). The eight
members include Set1, Swd1, Swd2, Swd3, Bre2, Sdc1, Shg1, and Spp1 (147;149).
Interestingly, even though Set1 is the catalytic subunit, other members of the complex
have been shown to be necessary for proper global levels of H3K4 methylation as well as
play a role in Set1 protein stability (147;149;151-153). Deletion of either BRE2 or SDC1
causes a loss in global H3K4 trimethylation as well as a decrease in mono- and
dimethylation (147;152-154). Deletion of either SWD1 or SWD3 results in a significant
decrease in Set1 protein levels and a loss of all forms of H3K4 trimethylation
(147;152;153). Deletion of the subunit Spp1 causes a modest decrease in Set1 protein
levels and only a slight decrease in global H3K4 trimethylation levels (147;152;153).
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Finally, there has been no phenotype associated with the loss of Shg1 (147;153). Set1 has
only one known non-histone target, Dam1, which is a kinetochore protein (155;156).
Many members of this complex are conserved through humans including Set1
(157-160). There are six human SET domain containing proteins that are homologues to
the yeast Set1 (140;141). They are SET1A, SET1B, and MLL1-4 (117;141). Each of
these homologues has been shown to be H3K4 methyltransferases and have been found
in complexes similar to yeast Set1 (141;158;161;162). Though there are other proteins
that are unique to the individual complexes, Ash2L (yBre2), RbRP5 (ySwd1), WDR5
(ySwd3), and DPY30 (ySdc1) are found in them all (140;163). The six human H3K4
methyltransferases do not appear to have completely overlapping roles (117;141). In
Drosophila and mammalian cells, the methyltransferases responsible for the bulk H3K4
di- and trimethylation are dSet1 and SET1A/B, respectively, and are part of multisubunit
complexes most similar to the yeast Set1 complex (117;164-166). MLL1 and MLL2 have
been shown to be important in the expression of the developmental HOX genes, and
deletion of either MLL1 or MLL2 results in embryonic lethality
(117;141;157;158;161;167;168). MLL3 and MLL4 have been shown to be responsible
for the establishment of monomethylation, especially at enhancer regions (117;145).
There are multiple models of how the yeast Set1 complex and its human
homologues get to chromatin to facilitate H3K4 methylation. Yeast Set1 has been shown
to associate with the serine-5 phosphorylated form of RNAPII’s carboxy-terminal domain
(CTD) (169-172). Like Set1 and H3K4 trimethylation enrichment, the ser-5
phosphorylation CTD form of RNAPII is associated with the transcriptional start site and
5’ regions of actively transcribed genes (169-172). However, if the interaction between
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the ser-5 phosphorylated form of RNAPII and the Set1C is direct or if this interaction is
necessary for Set1 recruitment is unknown. The human MLL proteins have been shown
to interact with long non-coding RNAs (ncRNAs) and this interaction is thought to be
another mechanism in which the H3K4 methyltransferase complex is recruited to specific
loci (117). Two ncRNAs, the human HOTTIP ncRNA and the mouse Mistral ncRNA,
have been shown to be important to recruit MLL1 to HOXA and mouse Mll1 to the
Hoxa6 and Hoxa7 gene clusters, respectively (117;173;174). HOTTIP is transcribed from
HOXA locus at the 5’ end (173). This ncRNA was shown to directly interact with WDR5
and is thought to bring WDR5 with MLL1 to activate HOXA genes (173). Knock-down
of HOTTIP resulted in decreased localization of WDR5 and MLL1 at the HOXA cluster
(173). Furthermore, H3K4 methyltransferases have been shown to interact with
transcription factors. MLL2 has also been shown to interact with estrogen receptor alpha,
and this interaction is thought to recruit MLL2 to the estrogen receptor target genes (175).
As previously mentioned, MLL1 and MLL2 deletions have been shown to have
an embryonic lethal phenotype, and aberrant H3K4 methylation has been linked to
diseases like cancer (117;140). Deletion of the yeast Set1 protein does result in a slight
slow growth defect (121), and there are other phenotypes associated with the loss of
SET1 and H3K4 methylation in yeast. Before Set1 was characterized as a H3K4
methyltransferase, it was shown to modulate silencing of telomeric genes and matingtype loci (176;177). It was further shown to play a role in rDNA silencing (121;178).
This correlation between the active methyl mark and silencing is thought to be due to the
spreading of Sir2 HDAC proteins from the silenced regions of the yeast genome in a
set1 strain (179-181). Global analysis of a set1 strain only showed modest transcript
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changes (around 2-fold) for the genes which transcripts were altered (181;182). Only
recently has there been a phenotype of Set1 linking changes in gene expression to a
metabolic pathway. Set1 has been shown to be important for wild-type (WT) transcript
and protein levels of genes involved in the yeast ergosterol pathway (183). Ergosterol is
the yeast equivalent to human cholesterol. Furthermore, deletion of either SET1 or the
members of the Set1 complex that affect H3K4 methylation, showed varying degrees of
sensitivity to the antifungal drug Brefeldin A (BFA) as a result of H3K4 methylation’s
role in the ergosterol pathway (184). Further studies will need to be done to understand
what other biologically relevant roles Set1 and H3K4 methylation plays in the yeast cell.

1.3.2

H3K4 demethylases
H3K4 methylation is a reversible modification. S. cerevisiae does not have a

homologue to the LSD1 class of histone demethylases, which is a H3K4 demethylase that
what discussed in a previous section (118;126). The yeast genome does encode five
proteins that contain a JmjC domain (118). Of these five proteins, Jhd2 was discovered to
have histone demethylase activity toward H3K4, in vitro (185). However, deletion of
JHD2 only had slight effect on H3K4 methylation, in vivo (67;118;185;186). Further
analysis using a tet-degron system to eliminate the cellular levels of Set1 showed that
H3K4 di- and trimethylation were greatly reduced in a Jhd2-dependent manner (186).
Also, overexpression of Jhd2 led to a global decrease of H3K4 trimethylation levels
(67;118;187). Taken together, these data suggest that Jhd2 is the only known histone
demethylase in yeast to target H3K4 methylation (118). Along with the catalytic JmjC
domain, Jhd2 also encodes a JmjN domain and a PHD finger (67;118;185-187). Based on
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the structural analysis of the JmjC and JmjN domain containing demethylase, JMJD2A,
the JmjC and the JmjN domains are thought to interact directly with each other, which is
important for demethylase activity (187;188). Though a crystal structure for Jhd2 has not
been solved, the conserved residues that are hypothesized to form this domain-domain
interaction in Jhd2’s JmjN domain have been shown to be important for Jhd2 protein
stability (187). Furthermore, deletion of and point mutations within the PHD finger has
been shown to reduce Jhd2’s ability to demethylate H3K4 trimethylation in an
overexpression analysis (67;187).
Since characterizing that Jhd2 was the H3K4 histone demethylase, no interacting
partners have been characterized, and protein analysis of Jhd2 suggests that Jhd2 acts as a
monomer (185). However, work from our lab has shown that Jhd2 protein levels are
tightly regulated (67). Deletion of the E3 ubiquitin ligase, NOT4, results in a decrease in
H3K4 trimethylation levels (67;189). However, the mechanism for how Not4 affects
H3K4 methylation was not known. Further analysis of the connection between Not4 and
H3K4 methylation showed that Not4 actually polyubiquitinated Jhd2 in vivo (67). This
polyubiquitination resulted in Jhd2 to be targeted for degradation by the 26S proteasome
(67). Therefore, the decrease in H3K4 trimethylation that was observed in a NOT4
deletion strain was due to increased Jhd2 protein levels (67). Furthermore, this
mechanism of protein turnover appears to be conserved with at least one of Jhd2’s human
homologues, JARID1C (67).
Many studies have focused on linking Jhd2’s demethylase activity to a biological
function. One of the first papers demonstrating Jhd2 as being a histone demethylase
tested many conditions to determine if loss of JHD2 had a phenotype (185). However, the
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loss of the demethylase did not result in any growth changes for the conditions they
tested (185). However, overexpression of Jhd2 resulted in a loss of telomeric silencing,
albeit modestly, and more recently it was shown that Jhd2 plays a role in mitotic
condensation of rDNA (185;190). Another study linked Jhd2 to both the activation and
repression of the inducible GAL1 gene (191). This study showed that loss of JHD2
resulted in increased levels of H3K4 trimethylation levels during GAL1 activation and a
delayed decrease in H3K4 trimethylation levels during GAL1 repression (191). Though
changes in H3K4 methylation were observed, if Jhd2 affected transcript levels of GAL1
during activation or repression was not indicated (191). Other studies have shown that
Jhd2 is necessary for healthy meiotic progeny and that deletion of JHD2 results in
decreased levels of reactive oxygen species in the cell (192;193). Though these
phenotypes have been reported for Jhd2, there is much unknown about Jhd2’s function as
a H3K4 demethylase, specifically if it plays a role in modulating transcriptional.
The JmjC-domain containing H3K4 demethylase Jhd2 is conserved. Much work
has been done to study its Drosophila and human homologues. The Drosophila
homologue “little imaginal disc” or LID is classified as a trithorax group protein (194197). This classification is interesting because the trithorax grouping indicates that LID
would act as a transcriptional activator, which is contradictory to its function to remove
the active transcription mark H3K4 methylation (195;198). However, further analysis
revealed that LID did promote the expression of the HOX gene Ubx, and flies with
homozygous mutant alleles of LID resulted in a multitude of phenotypes including
embryonic lethality or lethality at the late larval or pupal stages (195;199). Interestingly,
this lethality phenotype was found to be independent of LID’s demethylase activity (108).
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LID’s demethylase activity has been shown to be important for NOTCH signaling (200).
Unlike Jhd2, LID has been shown to interact with the histone deacetylase RPD3 and
histone chaperones ASF1 and NAP1 (200). The complexes that are formed consisting of
these members, as well as other proteins, are important for silencing gene targets of the
NOTCH pathway (200). Another study indicates that LID may form another complex
with the histone deacetylase RPD3, and in this complex LID may act to inhibit RPD3’s
deacetylase function independent on LID’s demethylase activity (198;200). However,
further studies will need to be performed to clarify the roles that LID plays in the LIDRPD3 complexes found in Drosophila.
Jhd2 has four homologues in humans. These homologues belong to the JARID1
family of demethylases. This family consists of JARID1A/KDM5A/RBP2,
JARID1B/KDM5B/PLU-1, JARID1C/KDM5C/SMCX, and JARID1D/KDM5D/SMCY
(201). For clarity, these family members will be referred to with the JARID1 family name.
Like Jhd2 and LID, the JARID1 family has been shown to be H3K4 demethylases
(138;201-204). JARID1A was originally found as a protein that interacted with the
retinoblastoma protein (205). It was then indicated that JARID1A plays an important role
in development, as knock-down of the C. elegans JARID1A homologue, rbr-2, resulted
in developmental defects in vulva formation (204). JARD1A has been shown to function
within two histone deacetylase complexes, the SIN3B-containing histone deacetylase
complex and the Mi-2/NuRD complex (206;207). JARID1A and the Mi-2/NuRD
complex were shown to regulate overlapping developmental genes, and it was suggested
that JARID1A and the Mi-2/NuRD complex function in the same pathway to regulate
these genes (206). Interestingly, JARID1A has also been shown to regulate genes
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involved in the circadian clock; however, this function was shown to be independent of
JARID1A’s demethylase activity (208).
JARID1B was discovered as a gene that was overexpressed in breast cancer cells
(209;210). JARDI1B expression is tightly regulated and this demethylase is only found to
be expressed in certain stages of development and in a few tissues like the testes and
mammary glands going through differentiation (209;210). The developmental phenotypes
of Jarid1b(-/-) mice have been inconsistent (211-213). Two studies have reported that
deletion of JARID1B was embryonic lethal (212;213). Another study indicated that the
Jarid1b(-/-) mice were viable, but portrayed a multitude of phenotypes including
premature death, deceased body weight, and delayed mammary gland development (211).
JARID1B has also been shown to play an important role in cell fate decision in that its
expression has been shown to prevent cell differentiation through decreasing the
expression of genes that modulate cell fate decisions (214). Like JARID1A, JARID1B
has been found to interact with the NuRD histone deacetylase complex as well as with
the histone demethylase LSD1 (35;215).
JARID1C gene is located on the X chromosome, and JARID1D is located on the
Y chromosome (201). JARID1C has been shown to be expressed in all human tissues, but
in zebrafish higher levels of expression were found in the fetal brain tissue (202).
JARID1C has been further shown to be important in mouse dendritic development (202).
Not much work has been done to characterize JARID1D. Though one study suggests
JARID1D has a male specific function by promoting DNA condensation through
recruitment of a meiosis-regulatory protein, NEC8 (216).
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1.3.3

Histone H3K4 modifiers and disease
Aberrant H3K4 methylation due to altered H3K4 methyltransferase or

demethylase function has been linked to a variety of diseases, most prevalently cancer
(201;217-219). Of the human H3K4 methyltransferases, mixed lineage leukemia (MLL1)
has been associated with acute myeloid leukemia (AML) and acute lymphoid leukemia
(ALL) (217-219). In infants, almost 70% of ALL is associated with the disruption of
MLL1’s function (217-220). MLL1 has been shown to be involved in chromosome
translocation events in these cancers (217-220). In these translocation events, MLL1
methyltransferase activity is lost due to the C-terminal half of the gene, which contains
the SET domain, being replaced (218;220). MLL1 has multiple chimeric partners (217220). However, MLL1 forms fusions with six distinct proteins for over 85% of clinical
MLL cases (221). Many of these MLL1-fusion partners are involved in transcriptional
elongation (221). Through analysis of the composition of the multiple complexes it was
found that many of the translocation partners associate with the ENL elongation factor,
which is also a MLL1 translocation partner, P-TEFb, the positive transcription elongation
factor, and DOT1L, the H3K79 methyltransferase (221;222). One hypothesis is that
MLL1 translocations are thought to result in the improper recruitment of elongation
complexes causing inappropriate elongation and, as a consequence, gene expression
(222).
Though the MLL1 involved in the translocation loses its histone
methyltransferase activity, the cell does have the other chromosomal copy of MLL1
(223). Interestingly, it has been found that the SET domain of this other copy is important
for leukemic pathogenesis (220;223). Therefore, targeting the functional MLL1 complex
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has been one means of treatment of these cancers with MLL1 fusion proteins (220). A
recent study describes one such inhibitor, MM401, which disrupts the interaction
between MLL1 and WDR5 (the human homologue of yeast Swd3) (220). This inhibitor
was demonstrated to specifically target the MLL1 complex and prevents proliferation of
MLL cells (220).
MLL3 has been suggested as a tumor suppressor. Down regulation or mutations
of MLL3 have been shown in multiple cancers, including gastric cancer, colorectal
cancers, acute myeloid leukemia (AML) and esophageal squamous cell carcinoma
(ESCC) (224;225). Tumors were found in ureter cells in MLL3 homozygous knock-out
mice (226). The tumorigenic cells from this study were found to have high levels of
phosphorylated H2A.X , which indicates DNA damage (226). MLL3 or its paralogue
MLL4 were found to interact in a coactivator complex with p53 (226). This coactivator
role of MLL3/4 was shown to be important for the expression of p53 target genes
involved in the DNA damage response, as knock-down of both MLL3 and MLL4 results
in the loss of the inducible expression of p53 target genes when exposed to a DNA
damaging agent (226). Furthermore, a multigenerational pedigree study found four
people with a mutation in the MLL3 gene that caused premature termination (224). Two
of these people were diagnosed with MLL, one with rectal cancer, and one with colon
cancer (224). This further demonstrates that H3K4 methyltransferases, like MLL1 and
MLL3, play an important role in mediating gene transcription, and altering the function
of these enzymes can lead to tumorigenesis.
The JARID1 family has been implicated in many diseases (201). Both JARID1A
and JARID1B are overexpressed in a variety of cancers (201). JARID1A has been shown
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to be overexpressed in gastric and lung cancer and has been shown to lead to cell growth
and inhibiting differentiation (201;227;228). In mouse cancer models loss of JARID1A
decreases tumorigenesis (229). Furthermore, a translocation event leading to a fusion
protein consisting of NUP98 and the third PHD finger of JARID1A has been linked to
acute myeloid leukemia (230). It is believed that the addition of JARID1A’s third PHD
finger causes mislocalization of NUP98 along the genome (230).
JARID1B was first discovered as a protein that was expressed in many breast
cancer cell lines and in primary tissue samples (209;210). As mentioned, JARID1B
expression is tightly regulated, and in most normal adult tissue cells JARID1B is not
expressed (209;210). JARID1B expression has been associated with a large number of
cancers (201). In fact, JARID1B was characterized to be expressed in 90% of invasive
ductal carcinomas (201;210). Further work showed that JARID1B functioned in breast
cancer cells to repress tumor suppressor genes, such as BRCA, CAV1, and HOXA5 (138).
Knock-down of JARID1B with shRNA showed decrease cell proliferation and tumor
growth (138). Furthermore, expression of JARID1B was shown in other cancers in
addition to breast cancer, including prostate, bladder, and lung (201;231;232). JARID1B
expression was also found in melanoma cells; however, its expression was associated
with cells that divided slowly and was therefore initially thought to be a tumor suppressor
(233). However, these slow growing cells expressing JARID1B were further shown to be
melanoma cells that were a subpopulation that resisted multidrug treatment (234).
Therefore, JARID1B’s role in melanoma cells may not be associated with cancer
establishment but may be involved in tumor progression and metastasis and drug
resistance (234).
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JARID1C has been shown to be associated with cervical and kidney cancers
(201;235;236). However, JARID1C has mostly been connected to X-linked mental
retardation (202;237). Of all mentally retarded males, X-linked mental retardation
accounts for 15-25% (238-241). Of those patients, JARID1C has been found to be
mutated at a frequency of about 2-3% (237;238). Thirteen point mutations have been
found within JARID1C in patients with X-linked mental retardation (202;241). Most of
these mutations are near domains important to JARID1C’s function, such as the PHD
finger and the JmjC catalytic domain, and most of these are missense mutations (202).
These mutations cause a decrease in JARID1C’s demethylase activity that varies from a
30% to 70% (202). X-linked mental retardation is associated with many phenotypes
including a clumsy gait, ataxia, moderate short stature, and a constant happy facial
expression with a protruding tongue (241-243). Though no direct link has been found
between JARID1D and a disease state, a study looking at deletions of the Y-chromosome
in prostate cancer showed that deletion of a JARID1D was associated with 52% of the
cases studied (201).
Due to their involvement in many diseases the JARID1 family of histone
demethylases are a becoming a desirable target for drug design, particularly JARID1B
which as mentioned is expressed in many different types of cancers but has limited
expression in normal adult tissue (244). Therefore, understanding how these enzymes
function, how their demethylase activity is regulated, and how they interact with the
nucleosome is important for development of specific inhibitors. Because Jhd2 is the only
H3K4 demethylase found in yeast and its function is conserved to the human JARID1B
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class of enzymes, we can use Jhd2 and yeast genetics to gain valuable information about
these key characteristics of H3K4 histone demethylases.

1.4

H3K4 methylation, cross-talk, and the histone code

Histone post-translational modifications play important roles as docking sites
through domains that have been previously discussed to recognize specific modifications,
such as bromodomains, chromodomains, and PHD fingers (141). To add another layer of
specificity to the proteins that recognize the nucleosome, many of these docking proteins
have more than one domain that recognizes different PTMs (245). This allows for these
docking site to “read” these modifications (245). This is what is now commonly referred
to as the histone code (245-248). H3K4 methylation has been shown to be involved in the
histone code and has been shown to work together or cross-talk with other modifications
(141). This cross-talk involves one histone PTM effecting the establishment or removal
of another modification. The first indication that PTM cross-talk was occurring was
between phosphorylation of H3S10 and histone acetylation (249). Specifically it was
found that phosphorylation at H3S10 promoted H3K14 acetylation by multiple histone
acetyltransferases, including Gcn5, in vitro and in vivo (249;250). Since then many more
modifications have been shown to cross-talk, including H3K4 methylation. Here we will
discuss specifically how proteins interact with H3K4 methylation to elicit a
transcriptional or other biological response, how H3K4 methylation affects establishment
of other modifications, and what modifications affect the establishment and removal of
H3K4 methylation.
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1.4.1

Reading H3K4 methylation to promote transcription remodeling, DNA
recombination, and histone PTMs
As previously mentioned H3K4 methylation acts as a docking site for other

proteins to bind and elicit a particular cellular response, and H3K4 methylation is most
commonly associated with active transcription. This is due to the recruitment of enzymes
like chromatin remodelers and other enzymes that establish PTMs associated with active
transcription, like chromatin remodelers. The human CHD1 protein is a chromatin
remodeler that is associated with active transcription and functions to maintain a more
open chromatin state (251-253). This chromatin remodeler has two chromodomains (254).
Analysis of these chromodomains show that they interact specifically with H3K4 di- and
trimethylated peptide and not with the unmodified peptide (254). Interestingly, this
interaction with H3K4 methylation was not found with the yeast homologue, Chd1 (254).
The chromatin remodeler Isw1 has also been shown to interact specifically with H3K4
di- and trimethylated peptides. Set1 and histone methylation were shown to be necessary
for Isw1 to localize at specific genes (255;256). Additionally, the human NURF complex,
which contains the ATP-dependent chromatin remodeler ISW1, contains a PHD finger
which preferentially binds trimethylated H3 N-terminal tails (257). This binding
preference recruits the NURF complex to Hox genes, and this is important for proper
gene expression of the Hox genes during development (257).
H3K4 trimethylation has also been associated with V(D)J (variable, diversity, and
joining) recombination of B-cell and T-cell antigen genes (258;259). V(D)J
recombination is catalyzed by the RAG1 and RAG2 complex (258;259). This complex
produces double stranded breaks that result in the formation of a functional antigen gene
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through nonhomologous recombination (258;259). This is necessary to produce the large
variety of antigen receptors (258). RAG2 has a PHD finger that has been shown to bind
to H3K4 trimethylation and this interaction has been shown to promote its activity
(258;260-262). Furthermore, the binding of RAG2’s PHD finger to H3K4 trimethylation
can be further enhanced by H3R2 symmetric dimethylation (H3R2me2s) (263). H3K4
trimethylation and H3R2me2s have been shown to colocalize at antigen receptors (263).
Furthermore, these two modifications have also been shown to colocalize at active gene
promoter (263). Interestingly, deletion of yeast SET1 or SPP1 results in loss of
H3R2me2s, suggesting H3K4 trimethylation is also important for the establishment of
this mark (263).
Other proteins that have been shown to interact with H3K4 methylation are
histone acetyltransferase complexes in yeast. SAGA is a multisubunit complex
containing the Gcn5 histone acetyltransferase (264-266). This complex is conserved from
yeast to humans and acts as a co-activator (264-266). Among the members of the SAGA
complex is the protein Sgf29 that contains tandem Tudor domains (267). This protein has
been shown to interact directly with H3K4 di- and trimethylation to target the SAGA
complex to specific target sites to establish proper H3K9 acetylation levels (267).
Another histone acetyltransferase complex that affects histone H3 acetylation is also
linked to H3K4 methylation. Yng1 is a member of the yeast NuA3 complex, which also
contains the histone acetyltransferase, Sas3 (268-270). Yng1 contains a PHD finger that
was shown to interact specifically with H3K4 trimethylated peptides (268;269). A point
mutation in Yng1’s PHD finger results in decreased levels of H3K14 acetylation and a
decrease in RNA transcripts of certain genes (271).
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H3K4 methylation is generally associated with active transcription; however,
because it functions as a docking site, the transcriptional response is determined by the
effector protein that interacts with the methylated residue. Therefore, H3K4 methylation
could potentially be a mark of transcriptional repression. This was hypothetical until the
human ING2 protein was found to interact with H3K4 methylation (272;273). ING2 is a
subunit of the mSin3a-HDAC repressive complex (273). The PHD finger of ING2
interacts with H3K4 di- and trimethylation (272;273). This interaction causes H3K4
trimethylation to play a transcriptionally repressive role (273).

1.4.2

PTMs that modulate H3K4 methylation
H3K4 methylation is not the only modification that recruits histone modifiers to

affect the post-translational modifications found on local histones. Other modifications
have been shown to directly affect H3K4 methylation. One modification that has been
shown to affect H3K4 methylation in a trans-histone mechanism is monoubiquitination
of H2B (67-73;274;275). In S. cerevisiae, Rad6 and Bre1 are the E2 conjugating enzyme
and the E3 ubiquitin ligase, respectively, that ubiquitinates H2B at lysine 123 (274-276).
Deletion of either of these enzymes causes loss of H2B monoubiquitination (274;275).
Interestingly, loss of these enzymes, as well as a H2B lysine 123 point mutation, affects
both H3K4 and H3K79 methylation (274;275). Loss of H2B K123 monoubiquitination
causes a complete loss of H3K4 di- and trimethylation and a global decrease in H3K4
monomethylation (67;69;70;73). There are a couple of different models to how H2B
monoubiquitination affects H3K4 methylation. The first model is that Rad6/Bre1 actually
ubiquitinates the Set1 complex member, Swd2 (277). This then promotes the recruitment
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of another complex member Spp1, which promotes H3K4 methylation (277). However, a
recent publication contradicts this model. They show that as long as ubiquitin is tethered
to the nucleosome, either through H2B or H2A, H3K4 and H3K79 methylation can be
observed (278). They show this occurs even in the absence of Bre1, which would suggest
that it the nucleosomal monoubiquitination by Rad6 and Bre1, and not Swd2
ubiquitination, that is important for the establishment of these two modifications (278).
The other model that was proposed involved the Set1 complex being recruitment without
Swd2 (68). This complex would be considered inactive (68). Monoubiquitination would
then recruit Swd2 bringing it to the Set1 complex activating the complex’s ability to
methylate H3K4 (68). Further investigation of this cross-talk will need to be done to
determine exactly how H2B monoubiquitination affects H3K4 methylation.
As previously mentioned H3R2me2s has been found to colocalize with H3K4
trimethylation (263). However, the other H3R2 dimethyl form, asymmetric dimethylation
(H3R2me2a), and H3K4 trimethylation are mutually exclusive (279). Interestingly, data
suggests that there is cross-talk between these two marks in that H3K4 trimethylation
affects the establishment of H3R2me2a and vice versa (279;280). The histone
methyltransferase that asymmetrically dimethylates H3R2 was found to be PRMT6 (279).
H3K4 trimethylation was shown to prevent PRMT6 from dimethylating H3R2 (279).
Furthermore, H3R2me2a was found to prevent H3K4 trimethylation by inhibiting the
MLL complex from interacting with the H3 N-terminal tail (279). Further analysis in
yeast suggested the model that H3R2me2a prevents the binding of the yeast Set1
complex member Spp1 to the H3 N-terminal tail thus preventing methylation by Set1
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(280). These data suggest that H3R2me2a inhibits the establishment of H3K4
trimethylation by blocking the ability of Set1 to methylate its substrate (279;280).
There has been a long standing connection between H3K4 methylation and
histone acetylation. Not only are they both associated with active transcription, but as
previously mentioned, H3K4 trimethylation has been shown to promote histone
acetylation through the recruitment of histone acetyltransferase complexes (266;268-271).
However, if acetylation affects the levels of H3K4 methylation had not been thoroughly
examined. Deletion of the histone acetyltransferase GCN5 (the HAT subunit of the
SAGA complex) had been shown to reduce global and gene specific H3K4 trimethylation
levels (281;282). This correlation between Gcn5 and H3K4 trimethylation was also
observed through mass spectrometry analysis (282). This connection suggests that there
is cross-talk between H3K4 trimethylation and the acetylation sites that Gcn5 targets.
To analyze which non-essential residues on each of the four core histones
modulate H3K4 trimethylation, one study created a library of individual point mutations
of all the non-essential residues to an alanine and analyzed global H3K4 trimethylation
levels (283). One interesting observation that came from this study is that the mutation of
H3K14 to either an alanine, arginine, or glutamine resulted in a dramatic decrease in
H3K4 trimethylation levels (283). This was interesting because H3K14 is a known
acetylation site and one that is targeted by Gcn5 (284-287). There is also strong
correlation between the enrichment pattern of H3K4 trimethylation and H3K14
acetylation (42). They are both enriched at the transcriptional start site (TSS) and 5’-ORF
of actively transcribed genes (42). These data suggest that there could be cross-talk
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between H3K4 trimethylation and H3K14 acetylation. However, the mechanism of this
cross-talk was not characterized.
Recently, two studies have been published that began to describe the mechanism
of this cross-talk (288;289). One study used a double deletion yeast strain to reduce
H3K14 acetylation levels. The strain analyzed had one of the subunits of the SAGA
complex that eliminates its HAT activity, ADA2, deleted and the HAT subunit of the
NuA3 complex, SAS3, deleted (288). They show that deletion of both of these genes
resulted in a global and gene specific decrease in both H3K14 acetylation and H3K4
trimethylation (288;290). They then showed that deletion of the H3K4 demethylase, Jhd2,
recovers H3K4 trimethylation levels but not H3K14 acetylation levels (288). They
suggest that H3K14 acetylation affects Jhd2’s demethylase activity (288).
The other recent study also suggests that H3K14 acetylation affects H3K4
trimethylation through Jhd2. This study suggests that unmodified H3K14 correlates with
H3K4 trimethylation due to their analysis with H3K14 point mutations to arginine, which
is theorized to mimic the unmodified lysine residue, and glutamine, which is theorized to
mimic the acetylated lysine residue (289). Based on their data that H3K14Q, but not
H3K14R, causes a reduction in H3K4 trimethylation, they propose a model in which
unmodified H3K14 promotes H3K4 trimethylation (289). Interestingly, they also show
that mutation of H3P16 affects H3K4 trimethylation in a Jhd2 dependent manner (289).
They suggest it is due to the isomerization of the proline residue and that acetylation
affects this isomerization process (289). However, even with these two studies there are
many questions about the cross-talk between H3K14 acetylation and H3K4
trimethylation that have not been answered, such as does H3K14 acetylation correlate
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with H3K4 trimethylation, which is conflicting between the studies, what is the
mechanism of how H3K14 acetylation affect Jhd2’s ability to demethylate H3K4
trimethylation, is this cross-talk conserved through other organisms, what is the
biological function of this cross-talk, and does acetylation also effect the
methyltransferase activity of Set1.

1.5

Summary

In my thesis dissertation I have focused on further characterizing the cross-talk
between H3K4 trimethylation and H3K14 acetylation. I show deletion of the HAT
subunit of the SAGA complex, GCN5, results in a global and gene specific decrease in
H3K4 trimethylation levels and this decrease was through the demethylase activity of
Jhd2. Furthermore, I show that levels of Jhd2 interacting with chromatin can be
modulated by H3 acetylation levels. Deletion of GCN5 not only decreases levels of H3K4
trimethylation and H3K14 acetylation but also results in about a two-fold increase in the
levels of Jhd2 interacting with chromatin at the loci that were analyzed. Deletion of three
histone deacetylases, RPD3, HDA1, and HOS2, results in a global increase in H3
acetylation levels and H3K4 trimethylation levels and about a 80% decrease in Jhd2
interacting with chromatin at specific loci. I show through in vitro analysis that acetylated
histone H3 N-terminal peptides prevent the interaction between Jhd2 and the H3 tail. I
also provide evidence that this cross-talk between H3K4 trimethylation and H3K14
acetylation is conserved for the human homologue JARID1B and the Drosophila
homologue LID, and that this cross-talk plays a role in transcriptional elongation. Finally,
I give evidence that H3 acetylation affects H3K4 trimethylation’s characteristic
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enrichment pattern. Deletion of the HDAC RPD3 results in increased H3K4
trimethylation, most notably at the 3’-ORF without affecting the levels of either the
H3K4 demethylase Jhd2 or methyltransferase Set1 bound to chromatin. This indicates
that histone acetylation may play a role in the catalytic activity of either Jhd2 or Set1
resulting in the low levels of H3K4 trimethylation observed at the 3’-ORF of actively
transcribed genes.
Aberrant histone H3K4 methylation and H3 acetylation have been shown in many
human diseases, most notably in cancer. These two modifications are tightly correlated in
that H3K4 trimethylation affects H3 acetylation levels through recruitment of HATs and
that H3 acetylation levels affect H3K4 trimethylation levels through the demethylase
Jhd2. Due to the conservation of Jhd2 from yeast to human and the connections that the
JARID1 family have on both development and diseases, using yeast to study how Jhd2
modulates H3K4 trimethylation can give significant insight to how Jhd2’s homologues
function, which would in turn give insight into how these histone demethylases function
in human diseases.
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CHAPTER 2. THE TURNOVER OF H3K14 ACETYLATION CONTROLS H3K4
TRIMETHYLATION LEVELS VIA A CONSERVED MECHANISM OF
DEMETHYLATION

2.1

Declaration of collaborative work

In this study, all Western blot quantification and statistics were done by Gabriel
Rangel. All Drosophila work was done by Rachel Stegeman as a collaboration with Vikki
Weake from the Department of Biochemistry at Purdue University. The synthetic
peptides received as in collaboration with Brian Strahl from the Department of
Biochemistry and Biophysics and the Lineberger Comprehensive Cancer Center at the
University of North Carolina School of Medicine. The peptides were synthesized by
Krzystof Krajewski in the Strahl lab. The 3-HDAC Saccharomyces cerevisiae strain
(JR471) was given to us by Joseph Reese from the Department of Biochemistry and
Molecular Biology at Pennsylvania State University. All other experiments and analysis
were done by Kayla Harmeyer.

2.2

Introduction

The dynamic nature of post-translational modifications of residues in the H3 Nterminal tail has been characterized as a key regulator of gene expression. Among these
modifications is methylation of lysine residues. In budding yeast the primary sites of
methylation are lysines 4, 36 and 79 on histone H3, though only methylation on lysines 4
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and 36 have been shown to be enzymatically removed by histone demethylases
(67;118;171;186;191;291;292). Methylation of histone H3 lysine 4 (H3K4) is a mark that
is commonly associated with active gene transcription (140;171;293). In Saccharomyces
cerevisiae, the enzyme Set1, found to be active in the multiprotein complex Set1C or
COMPASS, is the methyltransferase that is responsible for mono-, di-, and trimethylation
of histone H3K4 (121;147;148;150). Jhd2 is the only known histone demethylase in S.
cerevisiae responsible for targeting and removing this modification (67;185;186).The
human enzymes that control the levels of this mark, both the methyltransferases and
demethylases, have been linked to a wide range of diseases. The histone demethylases in
humans that remove H3K4 methylation are part of the JARID1 family and are linked to
diseases including breast cancer, prostate cancer and X-linked mental retardation
(209;210;227;231;294).
The modulation of H3K4 methylation has been linked to other histone
modifications both on histone H3 (cis) or on another histone (trans). One such example
that has been widely studied but not completely understood is the trans-histone cross-talk
between H2B monoubiquitination and both H3K4 and H3K79 methylation.
Ubiquitination of H2B K123 mediated by Bre1 and Rad6 is necessary for the
establishment of H3K4 di- and trimethylation and for wild-type levels of H3K4
monomethylation (68-73). Other modifications on histone H3 have also shown to impact
H3K4 methylation. H3R2 methylation and H3K4 trimethylation has been shown to be
mutually exclusive, and the reason for this exclusiveness has been suggested to be caused
by H3R2 methylation preventing the Set1 subunit Spp1 from recognizing the histone tail
(279;280). Other work has been done showing a strong correlation between two marks
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associated with active transcription, H3K4 trimethylation and histone acetylation,
specifically the acetylation of H3K14. Both marks have been shown to be co-localized at
the 5’ end of actively transcribed genes (42;288). An even stronger link between these
two marks has been demonstrated by showing that global H3K4 trimethylation levels are
reduced by either mutating the H3K14 site or by deletion of the histone acetyltransferases
that target H3K14 (281-283;288). The reduction of H3K4 trimethylation observed
through the combined deletion of H3 specific histone acetyltransferases Sas3 and the
SAGA complex member Ada2 has been suggested to be through the histone demethylase
Jhd2 (288). Moreover, a recent publication has proposed the model that H3K14
acetylation affects the proline isomerization of H3P16, which in turn affects H3K4
methylation through Jhd2 and Spp1, a member of the COMPASS methyltransferase
complex (289). However, until this study the mechanism of how H3K14, specifically
H3K14 acetylation, affects Jhd2’s ability to demethylate H3K4 has not been established.
In this study we establish the mechanistic relationship between H3K14 and the
H3K4 histone demethylase Jhd2. Through histone mutations we were able to show that
the reduction of global H3K4 trimethylation levels in H3K14 mutant strains was
dependent on Jhd2’s demethylase activity. In addition, we further establish that by
increasing or decreasing H3 acetylation levels in vivo we were able to modulate H3K4
trimethylation levels. Interestingly, we demonstrate for the first time that the deletion of
GCN5 leads to higher levels of Jhd2 protein interacting with chromatin while deletion of
histone deacetylases results in reduced levels, indicating that the interaction of Jhd2 and
chromatin as well as H3K4 trimethylation levels can be directly modulated through
altering the levels of H3 acetylation. Through in vitro binding analysis, we show that the
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interaction between Jhd2 and the H3 N-terminal tail is greatly reduced when acetylated
lysine residues are present. Through yeast and Drosophila genetics, we show data that
suggest that this mechanism of cross-talk between H3K4 trimethylation and H3K14
acetylation through histone demethylases is conserved. Furthermore, we show that
modulation of H3K4 trimethylation through Jhd2’s demethylase activity could play a role
in transcriptional elongation.

2.3
2.3.1

Results

Mutation of H3K14 causes reduced H3K4 trimethylation levels
To study the mechanism of how H3K4 trimethylation can be affected by other

residues on histone H3, we began with a reported observation that mutation of H3K14, a
known acetylation site, caused a dramatic decrease in global H3K4 trimethylation levels
(283). However, there is conflicting data concerning the degree of reduction of H3K4
trimethylation with the different mutations of the lysine residue. One study reported a
dramatic decrease when H3K4 trimethylation was mutated to an alanine, an arginine, or a
glutamine (283). Another study concludes that H3K4 trimethylation is reduced when the
lysine is mutated to an alanine or glutamine, but to a much less extent when the lysine is
mutated to an arginine (289). Due to the nature of the mutations, where arginine mimics
the unacetylated lysine residue and glutamine mimics the acetylated lysine residues, they
concluded that unmodified H3K14 is associated with H3K4 trimethylation, which
conflicts with the current model (289). Therefore, we set out to clarify the affects that
H3K14 mutations have on H3K4 trimethylation and to further test this relationship
between the two marks in relation to demethylase activity of Jhd2.
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H3K4 trimethylation levels were decreased 54% when H3K14 was mutated to an
arginine and 73% when mutated to a glutamine compared to wild-type (WT) (Figure
2.1A and 2.1C; Table 2.8). Furthermore, this decrease was specific for H3K4
trimethylation. H3K4 di- and monomethylation, as well as H3K36 and H3K79
trimethylation levels, were unchanged when H3K14 was mutated (Figure 2.1A; Figure
2.2A and 2.2B; Table 2.8). Mutating H3K9, another acetylation site, did not affect H3K4
trimethylation levels, suggesting that the observed change in H3K4 trimethylation levels
were specific for the mutation of the H3K14 acetylation site (Figure 2.1A and 2.1C;
Table 2.8). To determine if this change in H3K4 trimethylation was due to changes in
transcript levels of the H3K4 histone methyltransferase SET1 or histone demethylase
JHD2, quantitative real-time PCR (qRT-PCR) was used. The transcript levels of SET1
and JHD2 were not significantly altered when H3K14 was mutated indicating that the
mutation at the H3K14 acetylation site does not affect the transcript levels of either H3K4
modifier (Figure 2.2C and 2.2D; Table 2.9).
Due to the strong correlation between the two marks, we wanted to understand
how the mutation of H3K14 causes the decrease in H3K4 trimethylation. The H3K4
histone demethylase Jhd2 has been recently shown as the possible mechanism mediating
this cross-talk (288). However, how Jhd2 is mediating this cross-talk or if it’s directly due
to Jhd2’s demethylase activity has not been demonstrated. To show that the observed
decrease in H3K4 trimethylation in a H3K14 mutant strain is directly caused by Jhd2,
H3K14 was mutated in a jhd2 strain. Western blot analysis was used to observe that
H3K4 trimethylation recovered to WT levels when JHD2 was deleted in either the
H3K14R or H3K14Q mutant (Figure 2.1B and 2.1D; Table 2.10). Furthermore, this
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change was specific to H3K4 trimethylation as no change was observed in H3K4 monoor dimethylation, as well as H3K36 and H3K79 trimethylation (Figure 1B, Figure 2.2E
and 2.2F; Supplementary Table 2.10). To determine if this decrease was due to Jhd2’s
demethylase activity, WT Jhd2 and the catalytically inactive mutant jhd2H427A were
added back to the jhd2 H3K14R and H3K14Q mutant strains (Figure 2.1E). Compared
to the H3K14R and H3K14Q with endogenous Jhd2, a jhd2∆ strain with empty vector
showed an increase in H3K4 trimethylation levels. When WT Jhd2 was expressed in the
H3K14 mutant strains, a decrease H3K4 trimethylation levels was observed that was
comparable to the H3K14 mutant strain with endogenous Jhd2. However, the
catalytically inactive mutant did not decrease H3K4 trimethylation levels. Based on these
observations, we were able to conclude that Jhd2’s demethylase activity is responsible for
the reduction in global H3K4 trimethylation levels when the H3K14 acetylation site is
mutated to either an arginine or a glutamine.

2.3.2

Jhd2 causes reduced global and gene specific H3K4 trimethylation levels when
histone acetyltransferase GCN5 is deleted
We show that mutating H3K14 affects H3K4 trimethylation levels through Jhd2;

however, this affect is similar when mutated to a glutamine or arginine. Though these
mutations are to mimic the acetylated and unmodified lysine residue, respectively, there
is a possibility that they are not acting as exact mimic to the different modification state
of H3K14. Therefore, to further establish the cross-talk between H3K4 trimethylation and
H3K14 acetylation through Jhd2’s demethylase activity, we wanted to modulate H3K14
acetylation levels in vivo by deleting a histone acetyltransferase known to target H3K14
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for acetylation. Previous studies have shown that deletion of the acetyltransferase subunit
of the SAGA complex GCN5 decreases not only in histone H3 acetylation levels but also
H3K4 trimethylation levels (281;282). However, what mediates this cross-talk has not
been fully characterized. Based on the observed decrease in H3K4 trimethylation levels,
we hypothesized that Jhd2 is modulating H3K4 trimethylation levels in a gcn5 strain.
To test this, Western blot analysis was used to observe global H3 acetylation levels and
H3K4 trimethylation levels. Compared to global methylation and acetylation levels of a
WT strain, both a decrease in H3K9, K14, and K18 acetylation levels and H3K4
trimethylation levels were observed in a gcn5∆ strain (Figure 2.1F). To determine if this
decrease is in fact due to the histone demethylase Jhd2, a jhd2 gcn5 strain was
generated. When JHD2 was deleted in the gcn5 strain, global H3K4 trimethylation
levels were increased to near WT levels, but H3K9, 14, and 18 acetylation levels
remained similar to a gcn5 (Figure 2.1F). This global analysis of H3K4 trimethylation
and H3 acetylation levels was also investigated in an ada2∆ strain. Ada2 is a member of
the SAGA histone acetylation complex, and deletion of this protein results in loss of the
histone acetyltransferase activity of Gcn5 (295). We show that a decrease of H3K4
trimethylation and H3K9, K14, and K18 acetylation levels are observed in an ada2∆
strain (2.4A). Furthermore, H3K4 trimethylation levels were again recovered in a jhd2∆
ada2∆ strain, similar to what was observed when GCN5 was deleted. This indicates that
it is the acetyltransferase activity of Gcn5 and not the protein itself that results in the
decrease of H3K4 trimethylation by Jhd2.
To show that these changes in H3K4 trimethylation were occurring at a specific
gene locus, the H3K4 trimethylation levels at the promoter, 5’-ORF, and 3’-ORF of
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PYK1 and PMA1 were analyzed using ChIP analysis (Figure 2.3A and 2.3B; Table 2.11).
H3K4 trimethylation levels were reduced at the promoter, 5’-ORF, and 3’ORF for both
genes in a gcn5 strain and restored to near WT levels in a jhd2 gcn5 strain (Figure
2.3A and 2.3B; Table 2.11). This indicates that the decrease in H3K4 trimethylation
observed in a gcn5∆ strain can be recovered to WT levels when JHD2 is deleted and that
the global changes observed occur at the same loci. ChIP analysis was also performed to
analyze H3K14 acetylation levels at PYK1 and PMA1. A decrease in H3K14 acetylation
levels was observed at the promoter, 5’-ORF, and 3’-ORF of both PYK1 and PMA1 in a
gcn5∆ strain (Figure 2.3C and 2.3D; Table 2.12). Interestingly, though global levels
remain unchanged when both GCN5 and JHD2 were deleted, an increase in H3K14
acetylation levels was observed in the jhd2 gcn5 strain at both PYK1 and PMA1. This
suggests another histone acetyltransferase may be compensating for the loss of GCN5. To
ensure that the changes in H3K4 trimethylation and H3K14 acetylation observed is not
due to changes in gene expression of either PYK1 or PMA1, transcript analysis was
performed using qRT-PCR. Transcript levels of PYK1 and PMA1 were unchanged in a
gcn5∆ and jhd2∆gcn5∆ strain compared to WT levels (Figure 2.4B and 2.4C;
Supplementary Table 2.13), suggesting that the changes in the post-translational marks
analyzed were not a result in changes of transcription of either gene. Taken together these
data suggest that Jhd2 is playing an active role to reduce H3K4 trimethylation when the
histone acetyltransferase GCN5 is deleted.
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2.3.3

Deletion of GCN5 results in higher levels of Jhd2 interacting with chromatin
To determine how deletion of GCN5 affects Jhd2 to result in the decreased levels

of H3K4 trimethylation, we wanted to analyze if Gcn5 affects how Jhd2 interacts with
chromatin. First, GCN5 was deleted in a yeast strain that expresses JHD2 with an
integrated C-terminal 3xFLAG tag. To determine if the C-terminal tag affects how Jhd2
functions, global H3K4 trimethylation levels were analyzed in a WT and a gcn5∆
background with Jhd2-3xFLAG. About a 50% decrease in H3K4 trimethylation levels
were observed in the gcn5∆ background strain (Figure 2.5A and 2.5B; Table 2.14),
indicating that the tag does not affect Jhd2’s ability to demethylate H3K4 trimethylation.
Furthermore, global levels of Jhd2 protein were analyzed comparing WT to a gcn5∆
strain. Through Western blot analysis indicated that there may be a slight increase in Jhd2
protein levels in a gcn5∆ strain, quantification of multiple blots showed no significant
change in Jhd2 protein levels (Figure 2.5A and 2.5B; Table 2.15).
To determine if the observed decrease of H3K4 trimethylation in a gcn5∆ strain is
due to increased levels of Jhd2 at chromatin, ChIP analysis was used to analyze Jhd23xFLAG levels at PYK1 and PMA1 in a WT and a gcn5∆ background. Jhd2 was observed
to interact with the promoter, 5’-ORF, and 3’-ORF at both genes in a WT background
(Figure 2.5C and 2.5D; Table 2.16). Interestingly, a 2-3 fold increase in Jhd2 association
with chromatin was observed in a gcn5∆ strain across both genes (Figure 2.5C and 2.5D;
Table 2.16). Together, our data suggest that loss of GCN5 causes higher levels of Jhd2 at
chromatin, which leads to the observed decrease in H3K4 trimethylation levels both
globally and gene specifically.
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2.3.4

Deletion of three histone deacetylases results in an increase of H3K4
trimethylation levels and decreased levels of Jhd2 at chromatin
Deletion of GCN5 resulted in decreased levels of H3K14 acetylation and H3K4

trimethylation due to increased levels of Jhd2 at chromatin. However, if H3K14
acetylation is directly affecting the level of Jhd2 interaction with chromatin, an increase
in H3K14 acetylation levels should show an opposite effect. Due to the compensational
nature of histone deacetylases (HDACs), three HDACs were deleted, RPD3, HDA1, and
HOS2. To test if deletion of these three HDACs results in a significant increase in global
H3K4 trimethylation and H3 acetylation levels, Western blot analysis was performed,
and when compared to WT a dramatic increase in H3K4 trimethylation and H3K9, K14,
and K18 acetylation was observed (Figure 2.6A).
ChIP analysis was then use to determine the level of Jhd2 associated with
chromatin in the 3-HDAC∆ strain. A 3xFLAG was integrated C-terminal to JHD2 in the
3-HDAC∆ strain. To analyze Jhd2-3xFLAG expression in the 3-HDAC∆, Western blot
analysis was performed using a FLAG specific antibody, and the blot indicated that there
were actually higher global levels of Jhd2-3xFLAG in a 3-HDAC∆ strain compared to a
WT background (Figure 2.7A). Interestingly, when a ChIP analysis was performed a
decrease in chromatin association of Jhd2 was observed at the 5’- and 3’-ORF of PYK1
and PMA1 in the 3-HDAC∆ strain compared to a WT background (Figure 2.6B and 2.6C;
Table 2.17). No significant change in Jhd2 levels was observed at either promoter (Figure
2.6B and 2.6C; Table 2.17). Transcript analysis determined that deletion of the 3 HDACs
do not alter the mRNA levels of either PYK1 or PMA1 (Figure 2.7B and 2.7C; Table
2.18). Taken together, by deleting three HDACs, we were not only able to see an increase
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global H3 acetylation and H3K4 trimethylation levels but also a decrease in the level of
Jhd2 at chromatin at the 5’- and 3’-ORF of both PYK1 and PMA1. This exciting result
indicates for the first time that levels of Jhd2 at chromatin can be modulated by either
decreasing H3K14 acetylation levels through deletion of the HAT GCN5 or increasing
H3K14 acetylation by deleting three HDACs.

2.3.5

Cross-talk between H3K4 trimethylation and H3K14 acetylation is conserved
To test if this mechanism of cross-talk between H3K4 trimethylation and H3K14

acetylation is conserved by other H3K4 histone demethylases in other organisms, we
tested if the human H3K4 demethylase JARID1B, a homologue to Jhd2, can be expressed
and had catalytic activity when expressed in yeast. The sequence of JARID1B was cloned
into a yeast expression vector behind a constitutively active promoter. This promoter was
previously used to show overexpression of Jhd2 caused a global decrease in H3K4
trimethylation levels (67). The catalytically inactive human demethylase was also cloned
into a yeast expression vector to be used as a negative control. Compared to a WT strain
expressing an empty vector, overexpression of Jhd2 resulted in a reduction of global
H3K4 trimethylation, similar to what has been previously reported. Interestingly,
expression of JARID1B in yeast using the same promoter also caused a reduction in
global H3K4 trimethylation and this reduction was not observed when the catalytically
inactive JARID1B was expressed (Figure 2.8A). This indicates that JARID1B is a
functional histone demethylase in yeast.
Because JARID1B is functional in yeast, it can be expressed in yeast strains
expressing H3K14 mutations to determine if JARID1B has a similar phenotype to Jhd2.
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Both Jhd2 and JARID1B were expressed in either a WT or H3K14R strain with the
endogenous JHD2 deleted. Expression of Jhd2 when H3K14 is mutated to an arginine
resulted in lower levels of H3K4 trimethylation levels when compared to when Jhd2 is
expressed with WT histone H3 (Figure 2.8B). This is consistent with our previous results
that indicate that the global decrease in H3K4 trimethylation when H3K14 is mutated is a
result of Jhd2’s demethylase activity (Figure 2.1). Interestingly, when JARID1B is
expressed in the H3K14R strain, a decrease in H3K4 trimethylation was also observed
compared to when JARID1B is expressed with WT histone H3 (Figure 2.8B). This
indicates that the ability of the lysine 14 residue in histone H3 to affect H3K4
trimethylation through the histone demethylase may be conserved in human with the
JARID1 family.
Another way of testing if this mechanism of cross-talk is conserved through other
organisms is to determine if deletion or knock-down of the histone acetyltransferase
GCN5 affects not only H3K14 acetylation levels but also H3K4 trimethylation levels.
Drosophila melanogaster has a single homologue of Jhd2, LID (194-196). Furthermore,
Gcn5 is also conserved making Drosophila a desirable model to use to study the
conservation of this mechanism (264-266). Drosophila UAS-RNAi lines were used to
knock-down dGcn5 and dSet1. From third-instar larvae. RNAi constructs for dGcn5 and
dSet1, as well as Luciferase as the negative control, were expressed from enGAL4 in the
posterior half of the wing imaginal discs as indicated by the positive GFP signal (Figure
2.8C). The wing imaginal discs were then stained for H3K4 trimethylation and H3K14
acetylation levels to compare the cells that had either dGcn5 or dSet1 knock-down to the
cells that did not express the RNAi constructs. When dSet1 is knocked-down, a decrease

53
in the H3K4 trimethylation signal is observed in the cells with the positive GFP signal
(Figure 2.8C). However, knock-down of dSet1 had no effect on H3K14 acetylation levels.
When comparing the posterior half of the wing imaginal disc that is expressing the dGcn5
RNAi construct to the cells that are not, a decrease in H3K14 acetylation and H3K4
trimethylation is observed (Figure 2.8C). This indicates that there is a cross-talk between
the two histone post-translational marks, and by knocking-down the histone
acetyltransferase dGcn5 we were able to modulate H3K4 trimethylation levels similar to
yeast. This suggests that the Drosophila homologue LID is acting in a similar manner to
Jhd2 again showing the conserved nature of this cross-talk mechanism.

2.3.6

Overexpression of Jhd2 results in a 6-AU sensitivity phenotype and deletion of
Jhd2 partially rescues gcn5∆ 6-AU sensitivity phenotype
To determine the biological role of this cross-talk between H3K4 trimethylation

and H3K14 acetylation, we wanted to test if modulation of H3K4 trimethylation by Jhd2
affected growth on 6-azouracil (6-AU). Deletion of GCN5 or SET1 or a H3K4R mutant
has previously been reported to cause a slow growth phenotype when grown on 6-AU
indicating that both H3K4 trimethylation and H3 acetylation are important for proper
growth when exposed to the drug (187;296;297). 6-AU is a drug that depletes the cellular
pool of nucleotides resulting in sensitivity when there is a defect in transcriptional
elongation. To determine if H3K4 modulation by Jhd2 plays a role in transcriptional
elongation and affects cell growth on 6-AU, Jhd2 was overexpressed from a
constitutively active promoter. Expression of Jhd2 from this promoter results in a
reduction of global H3K4 trimethylation levels; however, this decrease is not observed
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when the catalytically inactive Jhd2 mutant is expressed (Figure 2.9A)(67). To test
sensitivity to 6-AU, a growth assay using strains overexpressing Jhd2 or the catalytically
inactive mutant was performed. These strains were spotted on plates containing 100
g/mL 6-AU or no 6-AU in a 5-fold serial dilution. These plates were then inculated at
either 30C or 35C. Interestingly, overexpression of Jhd2 led to a sensitive phenotype
when exposed to 6-AU (Figure 2.9B). This phenotype was dependent on Jhd2’s catalytic
activity as overexpression of the catalytically inactive mutant grew similar to a WT strain
(Figure 2.9B). This indicates that reduction of H3K4 trimethylation through
overexpression of Jhd2 has a negative effect on transcriptional elongation.
To determine if the slow growth phenotype of a gcn5∆ strain could be recovered
in a jhd2∆ gcn5∆ strain, a growth assay was performed in the presence of 6-AU. The
growth assay was performed by spotting a 5-fold serial dilution of the indicated yeast
strains on plates with either no 6-AU or plates containing 100 g/mL 6-AU. These plates
were then incubated at either 30C or 35C. A 6-AU sensitivity phenotype was observed
for a set1 strain and a gcn5 strain when compared to WT at both temperatures (Figure
2.9A). Interestingly, when JHD2 was deleted in a gcn5 background a partial restoration
of growth was observed on the 6-AU plates, most notably when the plates were incubated
at 35C (Figure 2.9A). This indicates that the 6-AU phenotype observed in a gcn5 strain
is partially due to the decrease in H3K4 trimethylation in this strain, and by restoring
H3K4 trimethylation to WT levels by deleting JHD2, we were able to partially restore
growth on 6-AU. Taken together our model suggests that H3K14 acetylation mediated by
Gcn5 blocks Jhd2 from interacting with its H3 N-terminal tail substrate. Through the
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removal of H3K14 acetylation by histone deacetylases, Jhd2 can now interact with its
substrate leading to decreased levels of H3K4 trimethylation (Figure 2.9B). This
indicates that cycling of H3K14 acetylation directly affects H3K4 trimethylation through
the histone demethylase Jhd2.

2.4
2.4.1

Material and Methods

Construction of yeast strains and plasmids
All yeast strains and plasmids used are described in the Tables 2.1 through 2.3.

SDBY1426, SDBY1440, SDBY1443, and SDBY1445 were generated by amplifying the
KanMX cassette using PCR with genomic DNA from the Open Biosystems jhd2∆ strain
using standard protocols. SDBY1442 was generated through PCR of yeast the HygMX
cassette using the genomic DNA from SDBY1065 (67) using standard protocols (298).
SDBY1441, SDBY1444, and SDBY1446 were generated as previously described (298).
SDBY1447 was generated through amplifying the 3xFLAG::KanMX from SDBY1107
genomic DNA using standard protocols.
Site-directed mutagenesis (Stratagene) was used to produce the histone H3
mutants with a CEN, TRP based plasmid (pJH18). All of the histone mutant constructs
that were generated were confirmed through sequencing performed by the Purdue
University Center for Cancer Research DNA sequencing facility. All histone plasmids
used are listed in Table 2.2. pHND49 plasmid was generated through the PCR
amplification from genomic DNA of the integrated Jhd2-3xFLAG strain including Jhd2’s
own promoter (496 bp upstream of the transcriptional start site or TSS). The Jhd23xFLAG PCR was cloned into the pRS416 vector using the HindIII and XhoI restriction
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sites. pHND50 was made through site-directed mutagenesis (Stratagene) of pHND49 and
was confirmed through sequencing performed by the Purdue University Center for
Cancer Research DNA sequencing facility. pKMH04 was generated by digesting the
PYK1p from pDPM1/PYK1p using the SacI and XbaI restrictions sites. The digested
PYK1p was then ligated into the pRS416 vector that was also cut digested with SacI and
XbaI. pKMH05 was made in a similar manner in that the PYK1p and N-terminally tagged
JHD2 was digested from pDPM4 using SacI and XhoI restriction sites. pKMH06 and
pKMH07 was generated through PCR amplification of JARID1B and JARID1B H499Y
from a pcDNA3.1 plasmid and was engineered to have a single N-terminal FLAG epitope.
The PCR products were both digested with BamHI and XhoI restriction enzymes and
ligated into the pKMH04 vector. All non-histone plasmids used are listed in
Supplementary Table 2.3.

2.4.2

Yeast extraction and Western blot analysis
Yeast extraction and Western blot analysis to detect histone modifications, Jhd2-

3XFLAG, and G6PDH were performed as previously described (121;299). For antibodies
used see Supplementary Material. Quantitative Western blot analysis was performed by
running whole-cell lysates on either a 15% (for analysis of histone H3) or 8% (for
analysis of Jhd2-3XFLAG) gel and transferred to a low-fluorescence PVDF membrane.
Fluorescently labeled secondary antibody was used (LI-COR, 926-32211) and the LICOR Odyssey imager was used to detect fluorescence at 800 nm. Each quantitative
western blot analysis was performed with at least three biological repeats. The relative
fold change for each band compared to WT or JHD2-3xFLAG in a WT background and
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statistical significance values are found in Tables 2.8, 2.10, 2.14, and 2.15. Quantification
of Western blots in this study was performed by Gabriel Rangel.

2.4.3

Gene expression analysis
RNA transcript levels were determined using quantitative real-time PCR (qRT-

PCR) as previously described (67;183). Three technical repeats were performed for each
of the three biological repeats. All Ct values were analyzed with ACT1 used as an
endogenous control and transcript levels of SET1, JHD2, PYK1, and PMA1 were
compared relative to the transcript level in a WT strain. The relative fold change for each
mRNA level compared to the WT strain and statistical significance values are found in
Tables 2.9, 2.13, and 2.18. The primer sequences for SET1, PYK1, and PMA1 and the
probe sets with indicated fluorescent dye (FAM) and quenchers (ZEN/ Iowa Black FQ)
used for JHD2 transcript analysis are described in the Tables 2.4 and 2.5.

2.4.4

Immunoprecipitation of Jhd2 from yeast cell extracts
Jhd2 was immunoprecipitated from WT BY4741 strain expressing FLAG-tagged

Jhd2 from the PYK1p as previously described with slight modification (67). Briefly,
cultures of WT expressing FLAG-JHD2 from the PYK1 promoter and a WT transformed
with an empty vector (pDPM1/PYK1p) were grown to mid-log phase. The soluble whole
cell extract was generated by resuspending cells in lysis buffer (40 mM HEPES-NaOH
pH 7.5, 350 mM NaCl, 0.1% tween-20, 10% glycerol, 1 g each leupeptin, aprotinin, and
pepstatin A, 1 mM PMSF) and bead beating. After a Bradford assay was used to
normalize protein levels of the two whole cell lysates, M2 FLAG resin (Sigma) was
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added to the lysate and FLAG-Jhd2 was immunoprecipitated for about 2 hours at 4C.
The immunoprecipitation was washed three times with lysis buffer for 5 minutes each
and once with peptide binding buffer (40 mM HEPES-NaOH pH 7.5, 150 mM NaCl, 0.1%
tween-20, 10% glycerol, 1 g each leupeptin, aprotinin, and pepstatin A, 1 mM PMSF).
After immunoprecipitation, the amount of Jhd2 protein on the resin was determined by
adding 2X SDS sample buffer to 4% of the immunoprecipitated resin. The sample was
then boiled, centrifuged and loaded on an 8% SDS-PAGE gel along with a BSA standard
curve. The Alpha Innotech imager was used to quantify the bands to generate the
standard curve and determine the amount of Jhd2 bound to the resin.

2.4.5

In vitro binding analysis
The H3 N-terminal tail peptides were incubated with the immunoprecipitated

Jhd2 at a 1:1 ratio for 2 hours at 4C with rotations in peptide binding buffer (40 mM
HEPES-NaOH pH 7.5, 150 mM NaCl, 0.1% tween-20, 10 % glycerol, 1 g each
leupeptin, aprotinin, and pepstatin A, 1 mM PMSF). A list of the peptides used is found
in Table 2.7. The peptides were also incubated with the agarose beads used in the mock
immunoprecipitation as a negative control for background. The resin was then washed
three times with peptide binding buffer. After the last wash the resin was resuspended in
2X SDS sample buffer, boiled, centrifuged and loaded on either an 8% SDS-PAGE gel
for analysis of FLAG-Jhd2 levels or a tricine gel for analysis of peptide bound and
peptide input. The protein/peptides were then transferred to a PVDF membrane. FLAG antibody (Sigma, F7425) was used to detect FLAG-Jhd2 and streptavidin-HRP
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(Jackson ImmunoResearch Laboratories, 016-030-084) was used to analyze the level of
biotinylated peptide.

2.4.6

Chromatin immunoprecipitation analysis
Chromatin immunoprecipitation (ChIP) analysis was performed as previously

described (183;300). For antibodies used see section 2.3.10. Three technical repeats were
performed for each of the three biological repeats. The relative fold change was
compared to the WT or set1 strain (for analysis of histone modifications) or an untagged
control (for analysis of Jhd2-3xFLAG) and statistical significance values are found in
Tables 2.11, 2.12, 2.16 and 2.17. The probe sets used to analyze the promoter, 5’-ORF,
and 3’-ORF regions of PMA1 and PYK1 are described in the Table 2.6.

2.4.7

Fly lines
The following Drosophila UAS-RNAi lines: y1 v1; P{y+t7.7 v+t1.8=UAS-

LUC.VALIUM10} (22)attP2 (luciferase, Bloomington 35788); y1 sc* v1; Set1-RNAi
P{y+t7.7 v+t1.8=TRiP.HMS01837}attP2 (set1, Bloomington 38368); y1 v1; and w1118;
P{w+mC=UAS-Pcaf.dsRNA}tc2-c (gcn5, Bloomington 9332) (301) were crossed with
P{w+mC=UAS-Dcr-2.D}1, w1118; P{w+mW.hs=en2.4-GAL4}e16E, P{w+mC=UAS2xEGFP}AH2 (Bloomington 25752).

2.4.8

Immunofluorescence labeling of imaginal discs
The following primary antibodies were used for immunostaining of Drosophila

wing imaginal discs: -H3K14ac (Millipore, 07-353, 1:100 dilution); -H3K4me3
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trimethylation (Abcam, 12209, 1:200 dilution). Polyclonal secondary antibodies used for
imaging included -rabbit Alexa633 (Life technologies, A21071, 1:2000 dilution) and mouse Alexa568 (Life technologies, A11019, 1:2000 dilution). At least 20 discs were
dissected per genotype, and fluorescence intensities were compared between the posterior
and anterior compartments. Stained wing imaginal discs were mounted in 80% glycerol
supplemented with FluoroSave Reagent (Calbiochem) and imaged with an inverted
Nikon A1R Confocal Microscope. All Drosophila work in this study was performed by
Rachel Stegeman from Dr. Vikki Weake’s lab at Purdue University.

2.4.9

6-AU growth assay
Yeast strains containing the pRS416 plasmid (URA3, CEN) were grown in

synthetic drop-out media lacking uracil (SC-Ura). The overnight cultures were back
diluted to an OD600 of 0.1 and grown to log phase. Once reaching log phase, the cultures
were diluted to an OD600 0.01 and a fivefold serial dilutions were spotted on SC-Ura
plates or SC-Ura plates containing 6-AU (Sigma). Before photographs were taken of the
plates, the SC-Ura plates were grown for 2 days at both 30°C and 35°C. The SC-Ura
plates containing 6-AU were grown for 3 days at 30°C and for 5 days at 35°C before
photographs were taken.

2.4.10 Antibodies used for Western blot and ChIP analyses
Histone primary antibodies -H3 (Active Motif, 39163) at a 1:10,000 dilution, H3K4me1 (Active Motif, 39297) at a 1:2,500 dilution, -H3K4me2 (Upstate, 07-030) at
a 1:40,000 dilution, -H3K4me3 (Active Motif, 39159) at a 1:100,000 dilution, -
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H3K36me3 (Abcam, ab9050) at a 1:2,500 dilution, -H3K79me3 (Abcam, ab2621) at a
1:10,000 dilution, -H3K9ac (Upstate, 07-352) at a 1:10,000 dilution, -H3K14ac
(Millipore, 07-353) at a 1:5,000 dilution, and -H3K18ac (Active Motif, 39129) at a
1:10,000 dilution were used for Western blot analysis. The histone primary antibodies H3 (Abcam, ab1791), -H3K4me3 (Millipore, 07-473), and -H3K14Ac (Millipore, 07353) were for ChIP analysis. Other primary antibodies used were -G6PDH (Sigma,
A9521) and polyclonal rabbit -FLAG (Sigma, F7425) for Western blot analysis at a
1:40,000 and a 1:5,000 dilution, respectively, and monoclonal mouse -FLAG (Sigma,
F1804) for Western blot analysis at a 1:5,000 dilution and ChIP analysis.

2.5

Discussion

Here we report how histone acetyltransferase and deacetylases affect H3K4
trimethylation through changes in histone H3K14 acetylation levels. We have determined
that the changes observed in H3K4 trimethylation levels are due to the histone
demethylase Jhd2. Furthermore, we show that the levels of Jhd2 protein levels associated
with chromatin is dependent on histone acetyltransferases and histone deacetylases and
that H3 acetylation disrupts the ability of the H3K4 histone demethylase to interact with
its H3 N-terminal substrate. Importantly, we show that the human and Drosophila H3K4
demethylases JARID1B and LID may act through a similar mechanism showing that this
cross-talk is conserved. Altogether we describe a mechanism of how H3K14 acetylation
levels directly affect H3K4 trimethylation levels through demethylation. Finally we show
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that modulation of H3K4 trimethylation through Jhd2’s demethylase activity affects cell
growth in the presence of 6-AU indicating a role for Jhd2 in transcriptional elongation.

2.5.1

Nucleosomal recognition by Jhd2 to mediate histone demethylation
We show that the level of Jhd2 at chromatin is affected by histone

acetyltransferases and histone deacetylases. Furthermore, we show that Jhd2 can interact
with the H3 N-terminal tail and that this interaction is dependent on H3 acetylation. How
Jhd2 can distinguish between the unmodified and acetylated histone tail is still unknown.
When looking at the domains contained within Jhd2’s amino acid sequence, it is observed
to contain a plant homeodomain (PHD) finger, and this PHD finger has been shown to be
necessary for Jhd2’s demethylase activity (67;187). PHD fingers have been shown to
play an important role to mediate protein interaction with the nucleosome by binding
lysine residues, and have been found to be specific to the state of methylation of the
lysine residue, including those unmodified, mono-, di- or trimethylation (302). This
specificity has been shown to be a key player in the cross-talk between methylated lysine
residues and the establishment or removal of other histone modifications
(268;272;273;302-304).
We show that the human homologue of Jhd2, JARID1B/KDM5B, may act in a
similar mechanism dependent on H3K14 acetylation. Though not much work has been
done on the specificity of Jhd2’s PHD finger, multiple studies have looked at the
recognition specificity of the PHD fingers in JARID1B. JARID1B has been shown to
contain three PHD fingers (35;138;209). Through sequence alignment, Jhd2’s PHD
finger is shown to be similar to JARID1B’s N-terminal PHD finger, termed PHD1 (35).
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PHD1 has been shown by two groups to bind specifically to an unmodified H3 Nterminal tail (35;139). This is similar to what we have observed for full length Jhd2
(Figure 2.6D). Both groups demonstrate through in vitro analysis that the addition of
methyl groups on H3K4 disrupts this interaction; however, methylation of H3K9 does not
(35;139). How acetylation affects the interaction between PHD1 and the H3 N-terminal
tail peptide has not been investigated. Further investigation on if the PHD finger of Jhd2
is mediating the interaction with the H3 N-terminal tail and if the structure of the PHD
finger does not allow Jhd2 to interact with an acetylated H3 N-terminal tail will need to
be performed.

2.5.2

Histone deacetylases and histone demethylases in transcriptional resetting
Histone deacetylases and H3K4 demethylases have been shown to be tightly

correlated. Not only do both remove marks associated with active transcription, both the
human demethylase JARID1B and the Drosophila demethylase LID have been shown to
interact with histone deacetylases in multi-subunit complexes, the Mi-2/NuRD complex
and the RLAF/RLAF-N complexes, respectively (35;198;200;215). The major function
of the Mi2/NuRD complex is to restore active genes to their repressed state. Along with
containing histone deacetylase 1 (HDAC1), the NuRD complex also has ATP-dependent
chromatin remodeling activity (35;305). Though Jhd2 has not been found to directly
interact with a histone deacetylase, our study elucidates mechanistically why this
interaction between H3K4 demethylases and histone deacetylases has potentially evolved
in other organisms. Based on our model, the histone deacetylases and demethylases work
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synergistically to first deacetylate histone H3 which would allow the demethylation of
H3K4 trimethylation.
In Drosophila, LID is found to be in multiple complexes and interestingly has
been implicated in both transcriptional activation and repression. The RLAF and RLAFN complexes (RLAF-N contains the histone chaperone NAP1) contains both LID and
Rpd3, and has been demonstrated to repress NOTCH target genes (200). The role that
LID plays as a transcriptional activator has been more difficult to characterize. One
model suggests that LID can bind to Rpd3 and this prevents Rpd3 from deacetylating its
substrates (198). Another study found that LID may serve a different function to assist in
transcriptional activation through its demethylase activity (306). This model suggests
LID along with ASH2-assocated dKMT2s act in transcriptional resetting of a gene. The
histone methyltransferase leads to the promoter escape of RNA polymerase II (RNAPII)
through the methylation of H3K4. As transcriptional elongation progresses, LID is
recruited to reset chromatin back to its original state for the next transcription cycle to
begin. This idea of the resetting of chromatin is one that has also been associated with
histone deacetylase activity. In yeast, the recruitment of Rpd3S to the open reading frame
by Set2 mediated H3K36 trimethylation has been shown to be important in resetting the
chromatin state to prevent cryptic transcription (98;307;308). Furthermore, other studies
have shown the recruitment of the Set3 histone deacetylase complex to the 5’-ORF of
actively transcribed genes, and that the Set3 complex acts as a transcriptional activator
(183;304). Our model supports the idea of transcriptional resetting through a step-wise
manner of histone deacetylation followed by H3K4 demethylation, in particularly this
helps explain the association of Jhd2 at transcriptionally active genes. In our model, as
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transcription is initiated the Set1 and SAGA complexes are recruited to chromatin. The
presence of the SAGA complex leads to higher levels of H3K14 acetylation which
prevents demethylation by Jhd2. As RNAPII progresses through elongation, H3K14
acetylation is removed by histone deacetylases, which allows Jhd2 to remove H3K4
trimethylation. Therefore, our model further supports the ability of histone demethylases
to assist in transcription cycling. However, further work needs to be done to fully
understand if Jhd2 is playing an active role in this process.

2.5.3

Proper H3K4 methylation levels are necessary for efficient transcriptional
elongation
We show that deletion of the histone acetyltransferase GCN5 causes S. cerevisiae

to be sensitive to 6-azouracil (6-AU). 6-AU is believed to cause transcriptional
elongation stress by reducing the nucleotide pool in the cell. Therefore, deletion of
proteins involved in transcriptional elongation has been shown to be sensitive when 6-AU
is present. Though Gcn5 has been characterized as being important in transcriptional
initiation through its interaction at the promoter of specific genes, studies have also
shown that Gcn5 interacts with chromatin in throughout the coding region of actively
transcribed genes (264;266;296;309-311). These studies have shown that Gcn5 and
H3K14 acetylation is involved in elongation in S. pombe (296;309;310). One model is
that Gcn5 and another histone acetyltransferase Esa1 increase the RSC elongation
complex occupancy and also enhances nucleosome eviction to aid in the elongation
process (296). Interestingly, maintaining H3K14 acetylation levels are also important in
this elongation process (309;310). We and other labs have shown that loss of H3K4
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methylation or Set1, the H3K4 methyltransferase, also leads to a 6-AU sensitivity
(297;312). We further show that if you delete JHD2 in a gcn5∆ strain, we were able to
moderately rescue the gcn5∆ the 6-AU sensitivity phenotype. Taken together this
suggests that recovery of H3K4 trimethylation in a jhd2∆gcn5∆ restores the balance of
H3K4 methylation throughout the gene, which could result in a partial rescue of an
elongation defect. However, if H3K4 methylation plays a role in transcriptional
elongation has not been thoroughly investigated. Therefore, if H3K4 methylation
throughout the open reading frame also affects RSC occupancy and/or nucleosome
eviction would help characterize what role H3K4 methylation and/or Jhd2 plays in
transcription elongation.
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Figure 2.1 H3K4 trimethylation levels are modulated by Jhd2 when H3K14 is
mutated or GCN5 is deleted.
(A) H3K14 was mutated to either arginine or glutamine and shuffled into a wild-type
(WT) background strain. Whole cell extracts were analyzed by immunoblots probed for
-H3K4 mono-, di-, and trimethylation, -H3K36 trimethylation, and -H3K79
trimethylation specific antibodies. Histone H3 was used as a loading control. (C) Three
biological repeats of the immunoblot in A were quantified. The results were normalized
to histone H3 and set relative to WT. Error bars represent the standard error of the mean.
(B) The H3K14R and H3K14Q plasmids were expressed in a jhd2∆ strain. Immunoblots

68
of the whole cell extracts were used to analyze global H3K4 mono-, di-, and
trimethylation, H3K36 trimethylation, and H3K79 trimethylation levels. Histone H3 was
used as a loading control. (D) Three biological repeats of the immunoblot in B were
quantified. The results were normalized to histone H3 and set relative to WT. Error bars
represent the standard error of the mean. (E) A complementation assay was performed by
transforming an empty vector, JHD2, or the catalytically inactive jhd2H427A into a
jhd2∆ strain expressing either H3K14R or H3K14Q. Both JHD2 constructs were
expressed off JHD2’s endogenous promoter and were C-terminally 3xFLAG tagged.
Immunoblots were used to analyze H3K4 trimethylation levels. Immunoblots probing for
FLAG was used to show equal expression of Jhd2 and jhd2H427A, and histone H3 was
used as a loading control. (F) JHD2 was deleted in a gcn5∆ strain and whole cell extracts
were analyzed by immunoblots probed with -H3K4 trimethylation antibody and H3K9, -H3K14, and -H3K18 acetylation antibodies. Histone H3 was used as a loading
control. Quantification of Western blots in this study was performed by Gabriel Rangel.
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Figure 2.2 Mutation of H3K14 in either a WT or jhd2∆ background does not affect
H3K4 dimethylation or H3K36 trimethylation and does not affect transcript levels
of SET1 or JHD2.
(A and B) Three biological repeats of the immunoblots with -H3K4 dimethylation (A)
and -H3K36 trimethylation (B) specific antibodies in Figure 2.1A were quantified. The
results were normalized to histone H3 and set relative to WT. Error bars represent the
standard error of the mean. (C and D) Transcript analysis of SET1 (C) and JHD2 (D)
were determined in a WT histone or histone mutant strains using quantitative real-time
PCR (qRT-PCR). ACT1 (actin) was used for normalization as an internal control, and the
transcript levels were set relative to WT. Three biological repeats were used with three
technical repeats each. The error bars represent the standard error of the mean. (E and F)
Three biological repeats of the immunoblots with -H3K4 dimethylation and -H3K36
trimethylation specific antibodies in Figure 2.1B were quantified. The results were
normalized to histone H3 and set relative to WT. Error bars represent the standard error
of the mean. Quantification of Western blots in this study was performed by Gabriel
Rangel.
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Figure 2.3 Deletion of GCN5 causes gene specific reduction of H3K4 trimethylation
levels dependent on JHD2.
ChIP was performed with α-H3K4 trimethylation (A and B) and α-H3K14 acetylation (C
and D) antibodies for the indicated strains. qRT-PCR analysis was performed with probes
targeted to toward the promoter, 5’-open reading frame (ORF), and 3’-ORF of PYK1 (A
and C) and PMA1 (B and D). Input and histone H3 were used for normalization. ChIP
analysis of H3K4 trimethylation is relative to a set1∆ strain. H3K14 acetylation ChIP
analysis is relative to a WT strain. Three biological repeats were used for all ChIP
analysis with three technical repeats each. The error bars represent the standard error of
the mean.
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Figure 2.4 Deletion of ADA2 causes reduction of H3K4 trimethylation levels
dependent on Jhd2 similar to a gcn5∆, and transcript levels of PYK1 and PMA1 are
not altered when GCN5 or JHD2 and GCN5 are deleted.
Deletion of ADA2 causes reduction of H3K4 trimethylation levels dependent on Jhd2
similar to a gcn5∆, and transcript levels of PYK1 and PMA1 are not altered when GCN5
or JHD2 and GCN5 are deleted. (A) JHD2 was deleted in an ada2∆ strain and whole cell
extracts were analyzed by immunoblots probed with -H3K4 trimethylation antibody and
-H3K9, -H3K14, and -H3K18 acetylation antibodies. Histone H3 was used as a
loading control. (B and C) Transcript analysis of PYK1 (B) and PMA1 (C) were analyzed
in WT strain and the indicated deletion strains using qRT-PCR. ACT1 was used for
normalization as an internal control, and transcript levels were set relative to WT. Three
biological repeats were used with the three technical repeats each.
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Figure 2.5 Jhd2 protein interacts with chromatin at higher levels in a gcn5∆ strain.
GCN5 is deleted in a strain with JHD2 endogenously tagged at the C-terminus with
a 3xFLAG.
Jhd2 protein interacts with chromatin at higher levels in a gcn5∆ strain. GCN5 is deleted
in a strain with JHD2 endogenously tagged at the C-terminus with a 3xFLAG. (A)
Western blot analysis was used to detect Jhd2-3xFLAG protein levels in a WT and gcn5∆
background in whole cell extracts. An -FLAG antibody was used to detect Jhd2 protein
levels and immunoblots were also probed with -H3K4 trimethylation and -H3K14
acetylation antibodies. Histone H3 was used as a loading control. (B) Five biological
repeats of the immunoblot in A were quantified. The results were normalized to histone
H3 levels. The H3K4 trimethylation and H3K14 acetylation levels were set relative to a
WT strain. Jhd2-3xFLAG protein levels were set relative to the Jhd2-3xFLAG strain
expressed in a WT background. The error bars represent the standard error of the mean.
(C and D) ChIP analysis was used to analyze the levels of Jhd2 protein across the
promoter, 5’-ORF, and 3’-ORF across PYK1 (C) and PMA1 (D) using an -FLAG
antibody in WT and gcn5∆ backgrounds. Input was used for normalization, and the levels
of Jhd2-3xFLAG were set relative to an untagged control. Three biological repeats were
used with three technical repeats each. The error bars represent the standard error of the
mean. Quantification of Western blots in this study was performed by Gabriel Rangel.
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Figure 2.6 Interaction between Jhd2 and chromatin is reduced when three HDACs
are deleted and H3 acetylation disrupts the interaction between Jhd2 and the Nterminal H3 tail.
Interaction between Jhd2 and chromatin is reduced when three HDACs are deleted and
H3 acetylation disrupts the interaction between Jhd2 and the N-terminal H3 tail. (A)
JHD2 was C-terminally 3xFLAG tagged at its endogenous locus in a strain with RPD3,
HDA1, and HOS2 deleted (3-HDAC∆). Whole cell extracts were used to analyze
immunoblots probed with -H3K4 trimethylation and -H3K9, -H3K14, and -H3K18
acetylation specific antibodies. Histone H3 was used as a loading control. (B and C) ChIP
analysis using an -FLAG antibody was used to analyze Jhd2-3xFLAG levels across the
promoter, 5’-ORF, and 3’-ORF of PYK1 (B) and PMA1 (C) in a WT and 3-HDAC∆
strain. Input was used for normalization and the levels of Jhd2-3xFLAG were set relative
to an untagged control. Three biological repeats were used with three technical repeats
each. The error bars represent the standard error of the mean. (D) WT FLAG-Jhd2 was
expressed in S. cerevisiae and purified using an -FLAG antibody conjugated agarose
beads. Purified Jhd2 was then incubated with either unmodified, H3K14 acetylated,
H3K18 acetylated, or H3K14 and H3K18 acetylated H3 N-terminal tail peptides (aa 120) that were C-terminally biotinylated. Western blot analysis using either an -FLAG
antibody or streptavidin conjugated with HRP was used to analyze the interaction
between Jhd2 and the H3 N-terminal peptides. An immunoprecipition using a yeast cells
line that expressed an empty vector was used as a negative control.
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Figure 2.7 Higher levels of Jhd2-3xFLAG are observed in a 3-HDAC∆ strain, but
no changes of PYK1 or PMA1 transcript are observed.
Higher levels of Jhd2-3xFLAG are observed in a 3-HDAC∆ strain, but no changes of
PYK1 or PMA1 transcript are observed. (A) Immunoblots of whole cell extracts from
strains expressing JHD2 C-terminally 3xFLAG tagged at JHD2’ s endogenous locus in a
WT or 3-HDAC∆ background strain were used to analyze Jhd2-3xFLAG protein levels
with an -FLAG antibody. Untagged WT control was used as a negative control. G6PDH
was used as a loading control. (B and C) Transcript analysis of PYK1 (B) and PMA1 (C)
were analyzed in a WT strain and JHD2-3xFLAG strain in either a WT or 3-HDAC∆
background using qRT-PCR. ACT1 was used for normalization as an internal control, and
transcript levels were set relative to WT. Three biological repeats were used with the
three technical repeats.

76

Figure 2.8 Expression of human JARID1B causes a further decrease in H3K4
trimethylation levels when H3K14 is mutated and knock-down of Gcn5 in
Drosophila results in a reduction of H3K4 trimethylation in wing imaginal discs.
Expression of human JARID1B causes a further decrease in H3K4 trimethylation levels
when H3K14 is mutated and knock-down of Gcn5 in Drosophila results in a reduction of
H3K4 trimethylation in wing imaginal discs. (A) H3K4 trimethylation was analyzed from
WT yeast with empty vector or expressing FLAG-JHD2, FLAG-JARID1B, or FLAGJARID1B H499Y, the catalytically inactive mutant, from the yeast PYK1 promoter.
Whole cell extracts were analyzed with immunoblots using an -H3K4 trimethylation
specific antibody. An -FLAG antibody was used to analyze expression of FLAG-Jhd2,
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FLAG-JARID1B, and FLAG-JARID1B H499Y. Histone H3 was used as a loading
control. (B) FLAG-JHD2 and FLAG-JARID1B were expressed from the yeast PYK1
promoter in a jhd2∆ strain with WTH3 or H3K14R. Whole cell extracts were analyzed
with immunoblots with an -H3K4 trimethylation specific antibody. An -FLAG
antibody was used to analyze expression of FLAG-Jhd2 and FLAG-JARID1B. Histone
H3 was used as a loading control. (C) Wing imaginal discs from Drosophila third-instar
larvae were stained with antibodies specific to H3K4 trimethylation and H3K14
acetylation. DNA was visualized using DAPI. RNAi constructs against Luciferase (nonspecific control), Set1, and Gcn5 were expressed under enGAL4 in the posterior half of
the wing imaginal disc. The domain of knockdown is indicated by the positive GFP
signal. Scale bars are shown in merged image measuring 50mm.
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Figure 2.9 Modulation of H3K4 trimethylation by Jhd2 results in differences in cell
growth when exposed to 6-AU.
(A) H3K4 trimethylation was analyzed from WT yeast with empty vector or expressing
FLAG-JHD2 or FLAG-jhd2 H427A, the catalytically inactive mutant, from the yeast
PYK1 promoter. Whole cell extracts were analyzed with immunoblots using an -H3K4
trimethylation specific antibody. An -FLAG antibody was used to analyze expression of
FLAG-Jhd2 and FLAG-jhd2 H427A. Histone H3 was used as a loading control. (B)
Yeast cells overexpressing with Jhd2 or the catalytically inactive mutant were assayed for
growth in the presence or absence of 100 µg/mL 6-AU at 30°C and at 35°C. (C) Yeast
cells with SET1, JHD2, GCN5, or both JHD2 and GCN5 deleted, as well as a WT strain,
were assayed for growth in the presence or absence of 100 µg/mL 6-AU at 30°C and at
35°C. (D) Our model depicts how differing the levels of H3K14 acetylation through both
Gcn5 and multiple HDACs directly affects H3K4 trimethylation through the demethylase
Jhd2. When SAGA is present and Gcn5 can catalytically acetylate the H3 N-terminal tail,
Gcn5 does not only prevent Jhd2 from interacting with chromatin at higher levels but
H3K14 acetylation disrupts Jhd2’s interaction with its H3 N-terminal tail substrate. When
HDACs are recruited to remove the H3K14 acetyl mark Jhd2 is now able interact with
the H3 N-terminal tail allowing for demethylation of H3K4 trimethylation. Showing how
cycling of H3K14 acetylation would allow the cycling of H3K4 trimethylation.
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Table 2.1 Yeast strains
Yeast Strain Genotype
WZY42
MATa; ura3-52; lys2-801; ade2-101; trp163;
his200; leu21; hht1-hhf1::pWZ405-F2F9-LEU2;
hht2-hhf2::pWZ403-F4F10-HIS3
SDBY1001 as WZY42 with pJH18
SDBY1004 as WZY42 with pHCL54
SDBY1423 as WZY42 with pKMH01
SDBY1424 as WZY42 with pKMH02
SDBY1425 as WZY42 with pKMH03
SDBY1426 MATa; ura3-52; lys2-801; ade2-101; trp163;
his200; leu21; hht1-hhf1::pWZ405-F2F9-LEU2;
hht2-hhf2::pWZ403-F4F10-HIS3; jhd2::HygMX
SDBY1427 as SDBY1426 with pJH18
SDBY1428 as SDBY1426 with pHCL54
SDBY1429 as SDBY1426 with pKMH01
SDBY1430 as SDBY1426 with pKMH02
SDBY1431 as SDBY1423 with pRS416
SDBY1432 as SDBY1428 with pRS416
SDBY1433 as SDBY1429 with pRS416
SDBY1434 as SDBY1429 with pHND49
SDBY1435 as SDBY1429 with pHND50
SDBY1436 as SDBY1424 with pRS416
SDBY1437 as SDBY1430 with pRS416
SDBY1438 as SDBY1430 with pHND49
SDBY1439 as SDBY1430 with pHND50
BY4741
MAT his3 leu20 LYS2 met150 ura30
SDBY1440 BY4741: MAT his3 leu20 LYS2 met150
ura30 jhd2::KanMX
gcn5
BY4741: MAT his3
leu20 LYS2 met150 ura30 gcn5::KanMX
SDBY1441 BY4741: MAT his3 leu20 LYS2 met150
ura30 gcn5::HygMX
SDBY1210 BY4741: MAT his3 leu20 LYS2 met150
ura30 set1::HygMX
SDBY1442 BY4741: MAT his3 leu20 LYS2 met150
ura30 gcn5::KanMX jhd2::HygMX
SDBY1443 BY4741: MAT his3 leu20 LYS2 met150
ura30 gcn5::HygMX jhd2::KanMX
SDBY1444 BY4741: MAT his3 leu20 LYS2 met150
ura30 ada2::HygMX
SDBY1445 BY4741: MAT his3 leu20 LYS2 met150
ura30 ada2::HygMX jhd2::KanMX

Reference
(313)

(314)
(314)
This study
This study
This study
This study

This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
Open Biosystems
This study
Open Biosystems
This study
(183)
This study
This study
This study
This study
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Table 2.1 continued
SDBY1107 BY4741: MAT his3 leu20 LYS2 met150
ura30 JHD2 3xFLAG::KanMX
SDBY1246 BY4741: MAT his3 leu20 LYS2 met150
ura30 JHD2 3xFLAG::KanMX gcn5::HygMX
JR471
BY4705: MATa hda1::HIS3 rpd3::LEU2
hos2::LYS2
SDBY1447 BY4705: MATa hda1::HIS3 rpd3::LEU2
hos2::LYS2 JHD2 3xFLAG::KanMX
SDBY1448 as BY4741 with pDPM1/PYK1p
SDBY1449 as BY4741 with pDPM4
SDBY1450 as SDBY1001 with pKMH04
SDBY1451 as SDBY1001 with pKMH05
SDBY1452 as SDBY1001 with pKMH06
SDBY1453 as SDBY1001 with pKMH07
SDBY1454 as SDBY1427 with pKMH05
SDBY1455 as SDBY1429 with pKMH05
SDBY1456 as SDBY1427 with pKMH06
SDBY1457 as SDBY1429 with pKMH06
SDBY1468 as BY4741 with pKMH04
SDBY1469 as BY4741 with pKMH05
SDBY1470 as BY4741 with pKMH08
Table 2.2 Histone Plasmids
Plasmid
H3
pJH18
WT
pHCL54
K4R
pKMH01
K14R
pKMH02
K14Q
pKMH03
K9R

H4
WT
WT
WT
WT
WT

Table 2.3 Other Plasmids
Plasmid
Insert gene
pRS416
None
pHND49
JHD2-3xFLAG
pHND50
jhd2 H427A-3XFLAG
pDPM1/PYK1p None
pDPM4
FLAG-JHD2
pKMH04
None
pKMH05
FLAG-JHD2
pKMH06
FLAG-JARID1B
pKMH07
FLAG-JARID1B H499Y
pKMH08
FLAG-jhd2 H427A

Parent
pRS314
pJH18
pJH18
pJH18
pJH18

Promoter
None
JHD2p
JHD2p
PYK1p
PYK1p
PYK1p
PYK1p
PYK1p
PYK1p
PYK1p

(67)
This study
(315)
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

Source
(121)
(314)
This study
This study
This study

Vector
pRS416
pRS416
pRS416
pRS415
pRS415
pRS416
pRS416
pRS416
pRS416
pRS416

Source
(316)
This study
This study
(67)
(67)
This study
This study
This study
This study
This study
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Table 2.4 Primers for qRT-PCR analysis
Primer name
Sequence
ACT1-001F
TGGATTCCGGTGATGGTGTT
ACT1-002R
TCAAAATGGCGTGAGGTAGAGA
SET1-185F
CACACGCGTCTTCTGGTTCAT
SET1-186R
TGATAGTGACCAGAACGCGAAT
PYK1-003F
CCGAAGAATTGTACCCAGGTAGA
PYK1-005R
TTCTGATTTCTGGACCCTTGGT
PMA1-007F
TGCTAAGACTTACGATGACGCTGC
PMA1-008R
TTCGTCGTCGACACCGTGATTAGA
Table 2.5 Probe sets for qRT-PCR analysis
Primer name
Sequence 5’-3’
JHD2-ANYF (+1023 bp)
TCAGCACCGTATTTAACTGTCGTT
JHD2-ANYR (+975 bp)
GGAAGAGATGTTTTGGAGCTTAGTG
A
JHD2-ANYM1 (+1003 bp - +1017 bp)
ACTGCGACGATTCTT
Yeast-Acti-ANYF (+815 bp)
CTCTCTACCTCACGCCATTTTGA
Yeast-Acti-ANYR (+898 bp)
CCACGTTCACTCAAGATCTTCATCA
Yeast-Acti-ANYM2 (+842 bp - +856 bp) CTACCGGCCAAATCG
Table 2.6 Probe sets for ChIP analysis
Primer name Sequence 5’-3’
PMA1
/56-FAM/CCGCTTATG/ZEN/CTCCCCTCCATTAGTT/3IABkFQ/
promoter
TGACGAAACGTGGTCGATG
AAATTAGATGTTAGACGATAATGATAGGAC
PMA1 5’
/56-FAM/TTGCCGCCG/ZEN/GTGAAGCTAGA/3IABkFQ/
GACAGTGATAACGATGGTCCAG
ACCGTAAGATGGGTCAGTTTG
PMA1 3’
/56FAM/CGTGTCTGG/ZEN/ATCTGGTCTATCGGTATCT/3IABkFQ/
ACTGGACTGATATTGTTACTGTCG
CATCAATCTGTCAAAGGCTTCAG
PYK1
/56promoter
FAM/CGAATATCG/ZEN/TTTTGATGGCGAGCCTTT/3IABkFQ/
AGAGGTTCTTGGAAATGAAAAGTTAC
CCTTCCCATATGATGCTAGGTAC
PYK1 5’
/56FAM/AGAATTGTA/ZEN/CCCAGGTAGACCATTGGC/3IABkFQ/
TTCTGATTTCTGGACCCTTGG
CATTGACAACGCCAGAAGTC
PYK1 3’
/56FAM/CTCTCACTT/ZEN/GTACAGAGGTGTCTTGGGA/3IABkFQ/
TCAGAGACAGGTTCCTTTTCG
TTACCAGATGCCCAAGAGC
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Table 2.7 Synthesized peptides used for in vitro binding assay (See Fig. 2.6C)
Peptide name
Sequence
Unmodified
ARTKQTARKSTGGKAPRKQL-K(Biot)-NH2
H3K14Ac
ARTKQTARKSTGGK(Ac)APRKQL-K(Biot)-NH2
H3K18Ac
ARTKQTARKSTGGKAPRK(Ac)QL-K(Biot)-NH2
H3K14Ac + K18Ac ARTKQTARKSTGGK(Ac)APRK(Ac)QL-K(Biot)NH2
The peptides used in this study were synthesized by Krzysztof Krajewski from Dr. Brian
Strahl’s lab at University of North Carolina
Table 2.8 Quantitative Western blot analysis of histone methylation relative to WT
(See Figure 2.1A and Figure 2.2A)
Strain
Histone
Fold change relative to WT P value
modification
H3K4R
H3K4me3
-70.57 +/- 0.01
P<0.0001
WT
H3K4me3
H3K14R
H3K4me3
-2.17 +/- 0.12
P<0.01
H3K14Q
H3K4me3
-3.67 +/- 0.09
P<0.001
H3K9R
H3K4me3
1.15 +/- 0.19
0.473
H3K4R
H3K4me2
-45.04 +/- 0.02
P<.0001
WT
H3K4me2
H3K14R
H3K4me2
1.34 +/- 0.26
0.262
H3K14Q
H3K4me2
1.23 +/- 0.14
0.181
H3K9R
H3K4me2
-1.09 +/- 0.06
0.229
H3K4R
H3K36me3
1.33 +/- 0.14
0.078
WT
H3K36me3
H3K14R
H3K36me3
1.09 +/- 0.17
0.606
H3K14Q
H3K36me3
-1.05 +/- 0.05
0.377
H3K9R
H3K36me3
1.04 +/- 0.26
0.896
*Data represent three biological repeats
Quantification of Western blots in this study was performed by Gabriel Rangel.
Table 2.9 qRT-PCR analysis of histone H3 mutants relative to WT (See Figure 2.2B)
Strain
Gene name
RQ
Fold change relative to WT P value
H3K4R
SET1
0.96
-1.05 +/- 0.25
0.87
WTH3
SET1
1
H3K14R
SET1
0.77
-1.30 +/- 0.06
0.02
H3K14Q
SET1
0.87
-1.54 +/- 0.13
0.37
H3K9R
SET1
0.82
-1.21 +/- 0.06
0.03
H3K4R
JHD2
1.09
1.09 +/- 0.09
0.38
WTH3
JHD2
1
H3K14R
JHD2
1.10
1.10 +/- 0.07
0.25
H3K14Q
JHD2
1.15
1.15 +/- 0.09
0.18
H3K9R
JHD2
1.06
1.06 +/- 0.11
0.57
*Data represent three biological repeats and three technical repeats each.
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Table 2.10 Quantitative Western blot analysis of histone methylation relative to WT
(See Figure 2.1D and Figure 2.2C)
Strain
Histone
Fold change relative to
P value
modification
WT
H3K4R
H3K4me3
-33.69 +/- 0.01
P<.0001
WT
H3K4me3
H3K4me3
1.51+/- 0.27
0.131
jhd2
H3K14R
H3K4me3
-1.77 +/- 0.07
P<.01
H3K4me3
1.02 +/- 0.14
0.899
jhd2 + H3K14R
H3K14Q
H3K4me3
-2.01 +/- 0.06
P<.001
H3K4me3
-1.14 +/- 0.16
0.464
jhd2 +H3 K14Q
H3K4R
H3K4me2
-21.97 +/- 0.14
P<0.0001
WT
H3K4me2
H3K4me2
1.08 +/- 0.18
0.494
jhd2
H3K14R
H3K4me2
1.29 +/- 0.23
0.096
H3K4me2
-1.06 +/- 0.13
0.462
jhd2 + H3K14R
H3K14Q
H3K4me2
1.34 +/- 0.22
0.063
H3K4me2
1.28 +/- 0.37
0.258
jhd2 + H3K14Q
H3K4R
H3K36me3
1.06 +/- 0.21
0.779
WT
H3K36me3
H3K36me3
1.03 +/- 0.09
0.746
jhd2
H3K14R
H3K36me3
1.08 +/- 0.05
0.166
H3K36me3
1.32 +/- 0.12
0.052
jhd2 + H3K14R
H3K14Q
H3K36me3
1.10 +/- 0.04
0.094
H3K36me3
1.21 +/- 0.19
0.343
jhd2 + H3K14Q
*Data represent three biological repeats.
Quantification of Western blots in this study was performed by Gabriel Rangel.
Table 2.11 ChIP analysis of H3K4 trimethylation in BY4741 WT, set1, jhd2,
gcn5, and jhd2gcn5 strains (See Figure 2.3B and 2.3D)
Strain
Gene location
RQ
Fold change relative to set1∆
PYK1 promoter
1
set1
PYK1 promoter
75.92
75.92 +/- 31.82
jhd2
WT
PYK1 promoter
65.78
65.78 +/- 33.64
PYK1 promoter
49.78
49.78 +/- 6.36
gcn5
PYK1
promoter
106.29
106.29 +/- 18.27
jhd2 gcn5
PYK1 5’
1
set1
PYK1 5’
348.90
348.90 +/- 102.84
jhd2
WT
PYK1 5’
302.37
302.37 +/- 111.98
PYK1 5’
108.74
108.74 +/- 21.36
gcn5
PYK1 5’
218.20
218.20 +/- 31.71
jhd2 gcn5
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Table 2.11 continued
PYK1 3’
1
set1
PYK1
3’
95.28
95.28 +/- 31.95
jhd2
WT
PYK1 3’
59.65
59.65 +/- 17.90
PYK1 3’
26.07
26.07 +/- 4.79
gcn5
PYK1
3’
63.29
63.29 +/- 13.54
jhd2 gcn5
PMA1 promoter
1
set1
PMA1 promoter
51.80
51.80 +/- 11.10
jhd2
WT
PMA1 promoter
35.55
35.55 +/- 7.39
PMA1 promoter
18.06
18.06 +/- 3.00
gcn5
PMA1 promoter
48.37
48.37 +/- 8.64
jhd2 gcn5
PMA1
5’
1
set1
PMA1 5’
256.46
256.46 +/- 72.15
jhd2
WT
PMA1 5’
190.94
190.94 +/- 78.00
PMA1 5’
47.83
47.83 +/- 6.20
gcn5
PMA1 5’
119.94
119.94 +/- 20.48
jhd2 gcn5
PMA1 3’
1
set1
PMA1
3’
54.69
54.69 +/- 17.78
jhd2
WT
PMA1 3’
30.20
30.20 +/- 13.50
PMA1
3’
7.47
7.47 +/- 4.00
gcn5
PMA1 3’
30.01
30.01 +/- 4.78
jhd2 gcn5
*Data represent three biological repeats with three technical repeats each.
Table 2.12 ChIP analysis of H3K14 acetylation in BY4741 WT, set1, jhd2, gcn5,
and jhd2gcn5 strains (See Figure 2.3C and 2.3E)
Strain
Gene location
RQ
Fold change relative to WT
PYK1 promoter
0.85
-1.17 +/- 0.15
set1
PYK1 promoter
1.04
1.04 +/- 0.12
jhd2
WT
PYK1 promoter
1
PYK1 promoter
0.65
-1.54 +/- 0.09
gcn5
PYK1
promoter
1.00
1.00 +/- 0.14
jhd2 gcn5
PYK1 5’
0.58
-1.73 +/- 0.06
set1
PYK1 5’
0.97
-1.03 +/- 0.14
jhd2
WT
PYK1 5’
1
PYK1 5’
0.32
-3.09 +/- 0.07
gcn5
PYK1 5’
0.55
-1.83 +/- 0.11
jhd2 gcn5
PYK1
3’
0.76
-1.31 +/- 0.14
set1
PYK1 3’
0.99
-1.01 +/- 0.25
jhd2
WT
PYK1 3’
1
PYK1 3’
0.45
-2.24 +/- 0.06
gcn5
PYK1 3’
0.72
-1.38 +/- 0.12
jhd2 gcn5
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Table 2.12 continued
PMA1 promoter
0.78
-1.29 +/- 0.09
set1
PMA1
promoter
1.06
1.06 +/- 0.15
jhd2
WT
PMA1 promoter
1
PMA1 promoter
0.31
-3.25 +/- 0.04
gcn5
PMA1
promoter
0.52
-1.93 +/- 0.12
jhd2 gcn5
PMA1 5’
0.63
-1.58 +/- 0.12
set1
PMA1 5’
0.83
-1.21 +/- 0.18
jhd2
WT
PMA1 5’
1
PMA1 5’
0.26
-3.89 +/- 0.04
gcn5
PMA1 5’
0.49
-2.03 +/- 0.10
jhd2 gcn5
PMA1
3’
1.08
1.08 +/- 0.15
set1
PMA1 3’
1.09
1.09 +/- 0.25
jhd2
WT
PMA1 3’
1
PMA1 3’
0.48
-2.10 +/- 0.12
gcn5
PMA1 3’
0.77
-1.29 +/- 0.18
jhd2 gcn5
*Data represent three biological repeats with three technical repeats each.
Table 2.13 qRT-PCR analysis of RNA transcripts in gcn5 and jhd2gcn5 strains
relative to WT (See Figure 2.3B)
Strain
Gene name
RQ
Fold change relative to
P value
WT
PYK1
1.29
1.29 +/- 0.18
0.114
set1
PYK1
1.18
1.18
+/0.07
0.025
jhd2
WT
PYK1
1
PYK1
1.35
1.35 +/- 0.11
0.011
gcn5
PYK1
1.25
1.25
+/0.08
0.010
jhd2 gcn5
PMA1
1.51
1.51 +/- 0.22
0.077
set1
PMA1
1.95
1.95 +/- 0.41
0.081
jhd2
WT
PMA1
1
PMA1
1.17
1.17 +/- 0.14
0.29
gcn5
PMA1
1.79
1.79 +/- 0.18
0.0005
jhd2 gcn5
*Data represent four biological repeats (PYK1) and three biological repeats (PMA1) with
three technical repeats each.
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Table 2.14 Quantitative Western blot of H3K4 trimethylation and H3K14
acetylation in the gcn5 Jhd2-3xFLAG strain (See Figure 2.5B)
Strain
Histone modification
Fold change
P value
relative to WT
WT
H3K4me3
Jhd2-3xFLAG
H3K4me3
-1.03 +/- 0.11
0.772
H3K4me3
-1.71
+/0.08
0.0001
gcn5 Jhd2-3xFLAG
WT
H3K14ac
Jhd2-3xFLAG
H3K14ac
1.10 +/- 0.10
0.246
H3K14ac
2.00 +/- 0.09
0.0001
gcn5 Jhd2-3xFLAG
*Data represent five biological repeats.
Quantification of Western blots in this study was performed by Gabriel Rangel.
Table 2.15 Quantitative Western blot Jhd2-3xFLAG in WT and gcn5 background
strains (See Figure 2.5B)
Strain
Antibody target
Fold change relative to
P value
Jhd2-3xFLAG
WT
FLAG
-25.81 +/- 0.15
< 0.0001
Jhd2-3xFLAG
FLAG
FLAG
1.17 +/- 0.13
0.135
gcn5 Jhd23xFLAG
*Data represent five biological repeats.
Quantification of Western blots in this study was performed by Gabriel Rangel.
Table 2.16 ChIP analysis comparing Jhd2-3XFLAG binding in a gcn5 strain to a
Jhd2-3xFLAG in a WT background (See Figure 2.5C)
Strain
Gene location
RQ
Fold change relative P value
to Jhd2-3xFLAG
WT
PYK1 promoter
1
-4.06 +/- 1.57
0.122
Jhd2-3xFLAG
PYK1 promoter
4.06
PYK1 promoter
9.18
2.26 +/- 1.45
0.075
gcn5 Jhd2-3xFLAG
WT
PYK1 5’
1
-5.50 +/- 0.80
0.005
Jhd2-3xFLAG
PYK1 5’
5.50
PYK1 5’
15.72
2.85 +/- 3.06
0.006
gcn5 Jhd2-3xFLAG
WT
PYK1 3’
1
-4.19 +/- 1.06
0.040
Jhd2-3xFLAG
PYK1 3’
4.19
PYK1 3’
10.12
2.42 +/- 1.36
0.026
gcn5 Jhd2-3xFLAG
WT
PMA1 promoter
1
-3.38 +/- 1.27
0.134
Jhd2-3xFLAG
PMA1 promoter
3.38
PMA1
promoter
12.18
3.60 +/- 4.17
0.114
gcn5 Jhd2-3xFLAG
WT
PMA1 5’
1
-5.54 +/- 1.49
0.038
Jhd2-3xFLAG
PMA1 5’
5.54
PMA1 5’
14.86
2.68 +/- 0.52
0.004
gcn5 Jhd2-3xFLAG
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Table 2.16 continued
WT
PMA1 3’
1
-4.59 +/- 1.25
Jhd2-3xFLAG
PMA1 3’
4.59
PMA1 3’
13.24
2.88 +/- 1.84
gcn5 Jhd2-3xFLAG
*Data represent three biological repeats with three technical repeats each.

0.046
0.018

Table 2.17 ChIP analysis comparing Jhd2-3XFLAG binding in the 3-HDAC
strain to a Jhd2-3xFLAG strain in a WT background (See Figure 2.6B)
Strain
Gene location
RQ
Fold change relative P value
to Jhd2-3xFLAG
WT
PYK1 promoter
1
-7.14 +/- 0.17
<0.0001
Jhd2-3xFLAG
PYK1 promoter
7.14
5.78
-1.23 +/- 1.82
0.500
3HDAC Jhd2-3xFLAG PYK1 promoter
WT
PYK1 5’
1
-5.31 +/- 3.01
0.057
Jhd2-3xFLAG
PYK1 5’
5.31
0.72
-8.08 +/- 0.42
0.061
3HDAC Jhd2-3xFLAG PYK1 5’
WT
PYK1 3’
1
-10.93 +/- 2.35
0.013
Jhd2-3xFLAG
PYK1 3’
10.93
2.00
-5.45 +/- 0.81
0.023
3HDAC Jhd2-3xFLAG PYK1 3’
WT
PMA1 promoter 1
-3.26 +/- 1.18
0.129
Jhd2-3xFLAG
PMA1 promoter 3.26
1.20 +/- 2.47
0.824
3HDAC Jhd2-3xFLAG PMA1 promoter 3.91
WT
PMA1 5’
1
-4.33 +/- 1.56
0.10
Jhd2-3xFLAG
PMA1 5’
4.33
PMA1
5’
1.27
-3.40 +/- 0.42
0.13
3HDAC Jhd2-3xFLAG
WT
PMA1 3’
1
-5.09 +/- 0.71
0.005
Jhd2-3xFLAG
PMA1 3’
5.09
2.15
-2.47 +/- 0.65
0.038
3HDAC Jhd2-3xFLAG PMA1 3’
*Data represent three biological repeats with three technical repeats each.
Table 2.18 qRT-PCR analysis of RNA transcripts in the 3-HDAC strain relative to
WT (See Figure 2.7B)
Strain
Gene name
RQ
Fold change
P value
relative to WT
WT
PYK1
1
Jhd2-3xFLAG
PYK1
1.20
1.20 +/- 0.10
0.111
PYK1
1.03
1.03 +/- 0.11
0.766
3HDAC Jhd2-3xFLAG
WT
PMA1
1
Jhd2-3xFLAG
PMA1
0.91
-1.10 +/- 0.05
0.117
PMA1
0.90
-1.11 +/- 0.07
0.213
3HDAC Jhd2-3xFLAG
* Data represent three biological repeats with three technical repeats each.
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CHAPTER 3. ELUCIDATING THE ROLE OF HISTONE DEACETYLASES IN
MODULATING H3K4 TRIMETHYLATION

3.1

Declaration of collaborative work

In this study the integrated N-terminally 3xFLAG-SET1 yeast strain (SDBY1559)
was made by Yueping Zhang. The 3-HDAC Saccharomyces cerevisiae strain (JR471)
was given to us by Joseph Reese from the Department of Biochemistry and Molecular
Biology at Pennsylvania State University. All other experiments and analysis were done
by Kayla Harmeyer.

3.2

Introduction

Histone modifications have been shown to be a critical contributor to gene
regulation (11;39). Through either altering the higher order chromatin structure or
recruitment of effector proteins, histone post-translational modifications play a direct role
in many DNA template processes (11;39). One of these post-translational modifications
is histone methylation. In Saccharomyces cerevisiae there are three major sites of histone
methylation, H3K4, H3K36, and H3K79 (118). Methylation of each these sites is
correlated with active transcription, and each of these modifications has different
enrichment patterns across actively transcribed genes (42;86;105). For H3K4 methylation,
H3K4 trimethylation is enriched at the transcriptional start site and 5’- open reading

90
frame (ORF) (42). H3K4 dimethylation is found mostly in the middle of active genes,
and H3K4 monomethylation is enriched at the 3’-ORF (42). H3K36 methylation is
associated with transcriptional elongation and found throughout the open reading frame
(42;98;307). H3K79 methylation is also found throughout the ORF of actively
transcribed genes, but the role of which is not fully characterized, though it is thought to
play a role in creating boundaries between euchromatin and heterochromatin
(42;124;317). The location of histone methylation across the open reading frame of
actively transcribed genes can play distinct roles throughout transcription. As mentioned
H3K36 trimethylation is involved in transcriptional elongation (98;307). H3K36
methylation is thought to play a role in reestablishing a more condensed chromatin state
after the elongating RNA polymerase II (RNA PolII) progresses through the open reading
frame (98;307). The methyltransferase that targets H3K36 methylation is Set2 (318). Set2
has been shown to associate with the serine-2 phosphorylated form of RNA PolII’s CTD
(carboxy-terminal domain), which is also associated with the elongated form of RNA
PolII (172;319). Set2 is thought to methylate H3K36 after the elongating RNA PolII,
which would then recruit the Rpd3S complex through the PHD finger of one of its
complex members, Rco1 (98;307;320;321). This is a histone deacetylase complex that
helps recondense the chromatin (98;307;320;321). Disruption of this pathway results in
cryptic transcription (98;308).
Though how the H3K36 methylation pattern in established and how deacetylation
functions in this pathway throughout the openreading frame have been described, there is
much unknown about the H3K4 trimethylation pattern, such as how this pattern is
established and maintained throughout transcription. Like Set2, Set1 has been shown to
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interact with RNAPII’s CTD, but with the serine-5 phosphorylated form (171). However,
it is unknown if this interaction or some other mechanism results in the observed pattern
of H3K4 trimethylation across an actively transcribed genes. Like H3K36 trimethylation,
H3K4 methylation has also been shown to be a docking site for enzymes that modulate
H3 acetylation. Interestingly, H3K4 has also been shown to be modulated by
acetyltransferase and deacetylases (288) (unpublished data). Histone acetylation has been
shown to modulate H3K4 trimethylation levels through the H3K4 histone demethylase
Jhd2 (288;289) (unpublished data). In this model, the unacetylated H3K14 site promotes
demethylation by Jhd2, and this mechanism has been suggested to be conserved (288)
(unpublished data). However, if H3 acetylation affects H3K4 trimethylation independent
of the histone demethylase or if this mechanism of cross-talk modulates the pattern of
H3K4 methylation across the open reading frame is not known. We show that the
deletion of three histone deacetylases results in a global and gene specific increase in
H3K4 trimethylation levels. Further analysis revealed that the histone deacetylase Rpd3
is the individual histone deacetylase that has the greatest effect on H3K4 trimethylation
levels at the 3’-ORF of two actively transcribed genes analyzed. This increase of H3K4
trimethylation is not due to alteration in the binding patterns of the H3K4
methyltransferase Set1 or the demethylase Jhd2. Therefore, here we characterize a
potential new mechanism of cross-talk between the histone deacetylase Rpd3, the
deacetylase commonly associated with H3K36 trimethylation, and H3K4 trimethylation
at the 3’-ORF of actively transcribed genes.
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3.3
3.3.1

Results

Deletion of 3 histone deacetylases increase H3K4 and H3K36 trimethylation,
decreases H3 levels, and alters gene expression of specific genes
We have previously shown that globally deletion of the three histone deacetylases,

RPD3, HDA1, and HOS2 (3-HDAC) increase global H3K4 trimethylation, and H3K9,
H3K14, and H3K18 acetylation levels (Figure 2.6A). We also show that deletion of these
three HDACs caused about an 80% decrease in the levels of the histone demethylase
Jhd2 associating with chromatin at the 5’-ORF and 3’-ORF of PYK1 and PMA1 (Figure
2.6B and 2.6C). However, how H3K4 trimethylation was altered across a gene was not
known. Also, data have indicated that deletion of the histone demethylase Jhd2 does not
significantly alter H3K4 trimethylation levels globally or at a specific gene locus (186)
(Figure 2.1F, 2.3A and 2.3B). Therefore, the increase in H3K4 trimethylation when the
three histone deacetylases were deleted could alter the function or chromatin association
of other proteins, in addition to Jhd2, to affect H3K4 trimethylation levels. To further
characterize how deletion of the histone deacetylases RPD3, HDA1, and HOS2 affect
global H3K4 methylation levels, whole cell extracts of a WT strain and 3-HDAC strain
were compared. Western blot analysis showed that global H3K4 trimethylation and
dimethylation were increased in the 3-HDAC strain (Figure 3.1A). However, no
difference between H3K4 monomethylation levels was observed (Figure 3.1A). To
determine if deletion of the three HDACs affect the other methylation site, whole cell
H3K36 and H3K79 trimethylation levels were analyzed. No global change was observed
for H3K36 trimethylation in a 3-HDAC strain, but a potential increase H3K79
trimethylation might be observed in a 3-HDAC strain (Figure 3.1B).
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To analyze how H3K4 trimethylation levels were altered across the open reading
frame of genes in a 3-HDAC strain, ChIP analysis was performed. H3K4 trimethylation
has analyzed at the promoter, 5’-ORF, and 3’-ORF of two active genes, PYK1 (Figure
3.2A) and PMA1 (Figure 3.2B) in both WT and 3-HDAC strains. The H3K4
trimethylation signals were then set relative to the H3K4 trimethylation signal for a set1.
Because Set1 is the only H3K4 methyltransferase, deletion of SET1 results in loss of
mono-, di-, and trimethylation. Therefore, any H3K4 trimethylation signal observed in a
set1 would assumedly be background. Consistent with the global H3K4 trimethylation
analysis in a 3-HDAC strain, H3K4 trimethylation levels were increased at the promoter,
5’-ORF, and 3’-ORF of both genes analyzed compared to a WT strain (Figure 3.2A and
3.2B). However, the changes observed at the promoter of both PYK1 and PMA1 were not
statistically significant. The H3K4 trimethylation levels at the 5’-ORF of PYK1 and
PMA1 increased 4.32 fold and 3.10 fold (Figure 3.2A and 3.2B and Table 3.4).
Interestingly, the greatest difference observed was at the 3’-ORF of both genes. There
was a 16.24 fold increase in H3K4 trimethylation levels in a 3-HDAC strain compared
to WT at the 3’-ORF of PYK1 and 14.86 fold increase at the 3’-ORF of PMA1 (Figure
3.2A and 3.2B and Table 3.4).
As a control to show specificity, H3K36 trimethylation levels across PYK1 and
PMA1 were analyzed using ChIP (Figure 3.2C and 3.2D). Western blot analysis showed
no change in H3K36 trimethylation comparing the 3-HDAC strain to the WT strain
(Figure 3.1B). Therefore, no changes in H3K36 trimethylation was expected at the genes
analyzed. Interestingly, altered levels of H3K36 trimethylation were observed in a 3-
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HDAC strain (Figure 3.2C and 3.2D). At both PYK1 and PMA1 a 7-fold and a 5-fold,
respectively, increase of H3K36 trimethylation was observed at the 3’-ORF (Figure 3.2C
and 3.2D and Table 3.5). No significant change in H3K4 trimethylation was observed at
the promoter or 5’-ORF of either gene.
H3 acetylation levels were also analyzed at these two genes. Previous analysis of
the combinatorial deletion of RPD3, HDA1, and HOS2 showed only a moderate increase
(about 2-fold) in H3 acetylation levels at two constitutively active genes, including PMA1
(321). Due to the significant fold increase in both H3K4 and H3K36 trimethylation, we
wanted to reanalyze the amount of histone acetylation increase found in the 3-HDAC
strain compared to WT. Acetylation levels of three different sites were analyzed: H3K9ac
(Figure 3.3A and 3.3D), H3K14 acetylation (Figure 3.3B and 3.3E), and H3K18
acetylation (Figure 3.3C and 3.3F) at the promoter, 5’-ORF and 3’-ORF of PYK1 (Figure
3.3A-C) and PMA1 (Figure 3.3D-F). The analysis of these acetylation sites indicated a
significant increase in H3K9ac, H3K14ac, and H3K18ac levels at each loci analyzed
ranging from an 11 fold increase to an 80 fold increase depending on the loci and
acetylation site analyzed.
To analyze H3K4 and H3K36 trimethylation and H3 acetylation the ChIP signals
were normalized to input and the signal (Ct value) of an H3 ChIP. By performing this
control it was noticed that H3 levels were dramatically decreased in a 3-HDAC strain at
the promoter, 5’-ORF and 3’-ORF of both PYK1 and PMA1 (Figure 3.4A and 3.4C). This
eviction of nucleosomes has been previously reported when RPD3, HDA1, and HOS2
were all deleted (321). However, this was at an inducible gene (321). When constitutively
active genes were analyzed, including PMA1, there was no change in H3 eviction (321).
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This greatly differs from the dramatic changes we observed in the H3 ChIP analysis
comparing WT and the 3-HDAC strain (Figure 3.4A and 3.4C). Interestingly, the
highest level of H3 levels observed in the 3-HDAC were at the promoters compared to
the 5’-ORF and 3’-ORF of both genes. To determine if the increase in H3K4
trimethylation that was observed in the 3-HDAC strain was due to this decrease in H3
levels leading to higher transcript levels, RNA transcript of both PYK1 and PMA1 were
analyzed in a 3-HDAC compared to a WT strain (Figure 3.4B and 3.4D). Interestingly,
there was no statistical difference in the PYK1 transcript level (Figure 3.4B) and a
statistically significant decrease in PMA1 transcript level (Figure 3.4D) was observed in
the 3-HDAC strain compared to a WT. Therefore, the increase in H3K4 trimethylation
levels observed in a 3-HDAC strain was not a result of an increase in transcription of
these genes. Also, taken together this suggests that even though there was less histone H3
at PYK1 and PMA1, there is a higher percentage of H3 that have H3K4 trimethylation
found at the 5’-ORF and 3’-ORF of those genes in a 3-HDAC strain.
Though the transcript levels of PYK1 and PMA1 are either unchanged or slightly
decreased in a 3-HDAC strain, it is unknown if the transcript levels are altered for other
genes that are not as highly transcribed. To test if other gene transcripts are changed,
transcript levels of 6 other genes were analyzed (Figure 3.5). These genes were selected
based on previous reports suggesting low expression under the conditions that the
cultures were grown under to determine if deleting the three histone deacetylases affects
these lowly expressed genes. PCK1 encodes a key enzyme involved in gluconeogenesis
and is repressed when glucose is present (322). YFR057W is a subtelomeric gene. DAN1
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is repressed under aerobic growth (323). IME1 and SPO11 encode proteins that are
involved in meiosis (324;325). Interestingly, the deletion of RPD3, HDA1, and HOS2 has
differing effects on the transcript levels of each gene analyzed (Figure 3.5). Most of the
transcripts did increase in the 3-HDAC strain indicating a loss of silencing. PCK1,
YFR057W, and DAN1 showed the most significant increase in transcript levels (Figure
3.5). There were differing expression changes when comparing the two meiotic genes.
An about 8 fold increase in transcript was observed for SPO11 (Figure 3.5 and Table
3.11). However, no significant change was observed for IME1 (Figure 3.5 and Table
3.11). This is interesting because transcriptional repression of IME1 has been depicted to
be controlled by the expression of a long noncoding RNA that extends into IME1’s
promoter (326). Therefore, further analysis will need to be done to determine how
deletion of the three HDACs effect expression of this long noncoding RNA and IME1.
Furthermore, this indicates that the 3-HDAC strain has specific effects on individual
genes and not just a global loss of gene silencing. Therefore, further analysis would need
to be performed to fully understand the differences between the effects observed across
the genome, specifically looking at strand specific transcripts to determine if the long
noncoding RNAs and the genes that are modulated by them are affected by deletions of
these three HDACs.

3.3.2

Deletion of RPD3 causes increased levels of H3K4 trimethylation at the 3’-ORF
of genes
Though an increase of global and gene specific H3K4 trimethylation was

observed in the 3-HDAC strain, we wanted to determine if an increase in H3K4
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trimethylation levels could be observed in the individual deletions of the histone
deacetylase without the loss of H3 levels. To determine which histone deacetylase has the
greatest effect of H3K4 methylation levels, a global analysis of H3K4 methylation and
H3 acetylation was analyzed in the individual HDAC deletion strains. Globally, the
deletion of RPD3 showed about a two-fold increase in both H3K4 tri- and dimethylation
levels (Figure 3.6A and 3.6B). There were no global differences observed for either
H3K4 di- or trimethylation for hda1 and hos2 strains (Figure 3.6A and 3.6B). No
changes in H3K4 monomethylation was observed for any of the individual HDAC
deletion strains (Figure 3.6A and 3.6B). Interestingly, the changes in H3 acetylation
levels varied depending on the HDAC that was deleted. The rpd3 strain was the only
HDAC deletion analyzed that resulted in an increase in acetylation levels at each of the
three sites analyzed, H3K9, H3K14, and H3K18 (Figure 3.6A and 3.6C).
To analyze where across a gene H3K4 trimethylation levels were altered in the
rpd3 strain, ChIP analysis was used to determine H3K4 trimethylation levels across the
promoter, 5’-ORF, and 3’-ORF of PYK1 (Figure 3.7A) and PMA1 (Figure 3.7B).
Consistent with the global analysis, there was no significant change in H3K4
trimethylation levels in the hos2 strain (Figure 3.7A and 3.7B). Deletion had a modest
but significant increase in H3K4 trimethylation levels at the 5’ and 3’- ORFs or the genes
analyzed (Figure 3.7A and 3.7B). Interestingly, the most significant increase in H3K4
trimethylation was observed at the 3’-ORF of both genes in the rpd3 strain; whereas, no
change in H3K4 trimethylation levels were observed at the promoter and a slight, but
significant, increase was observed at the 5’-ORF (Figure 3.7A and 3.7B). Taken together
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these data suggest that Rpd3 is the histone deacetylase that has the greatest effect on
H3K4 trimethylation levels and this effect is primarily at the 3’-ORF.

3.3.3

Levels of Jhd2 or Set1 are not altered across genes in a rpd3 strain.
To determine how Rpd3 affects H3K4 trimethylation levels at the 3’-ORF of the

genes analyzed, ChIP analysis was used to determine if the levels of the histone
demethylase, Jhd2, or the histone methyltransferase, Set1, were altered across PYK1 and
PMA1 in a rpd3 strain. We have previously shown that there was a decrease in Jhd2
protein levels at the 5’-ORF and 3’-ORF of PYK1 and PMA1 in the 3-HDAC strain
(Figure 2.7B and 2.7C). Therefore, to determine if Jhd2 levels are decreased when only
RPD3 was deleted ChIP analysis was used. First, a Western blot of whole cell extracts
showed that Jhd2-3xFLAG was expressed at similar levels in a WT compared to the
rpd3 strain (Figure 3.7A). Next, Jhd2 protein levels were compared at the promoter, 5’ORF and 3’-ORF of PYK1 and PMA1 in WT and rpd3 backgrounds. Interestingly, there
are no differences in the levels of Jhd2 interacting with chromatin when rpd3 strain
compared to a WT background (Figure 3.7B). This indicates that deletion of RPD3 is not
sufficient in altering Jhd2’s interaction with chromatin, and that the increase in H3K4
trimethylation at the 3’-ORF of these genes is not due to the loss of the demethylase at
these loci.
Because no changes in Jhd2 were observed at PYK1 and PMA1 in a rpd3 strain,
the next hypothesis is that deletion of RPD3 causes increased levels of the histone
methyltransferase Set1 at the 3’-ORF of these genes resulting in the observed increase in
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H3K4 trimethylation levels. To test this, a yeast strain with 3xFLAG that was integrated
N-terminally to the SET1 locus in the genome was used. Whole cell extracts were
analyzed via a Western blot to determine if Set1 protein levels were altered in a rpd3
strain. This Western blot analysis determined that Set1 protein levels are not altered when
RPD3 was deleted (Figure 3.8C). ChIP analysis was then performed targeting 3xFLAGSet1 at the promoter, 5’-ORF, and 3’-ORF of PYK1 and PMA1 in WT and rpd3
backgrounds. This ChIP analysis indicated that there was no alteration in Set1 protein
levels associated with chromatin in a rpd3 strain compared to a WT background (Figure
3.8D). Therefore, these data show that the increase in H3K4 trimethylation levels at the
3’-ORF of genes in a rpd3 strain are not due to altered localization of the H3K4
demethylase or methyltransferase across the genes analyzed.

3.4
3.4.1

Materials and methods

Construction of yeast strains
All yeast strains used are described in Table 3.1. SDBY1558 was generated as

previously described (298). To construct the N-terminal 3xFLAG-SET1 strain,
SDBY1559, PCR was used make a linear fragment and to add flanking sequencing to a
3xFLAG with the KanMX marker flanked by loxP sites from the pUG6-3flag plasmid.
This linear PCR product was transformed into a BY4741 WT strain using the standard
transformation procedure (298). To select for cells that had the KanMX containing PCR
product incorporated into the genome, the transformed cells were selected on YPD with
G418. PCR was used to verify proper of the PCR product in the yeast genome. After
verification, the cells were then transformed with the pSH47 plasmid, which encodes the
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URA3 marker and the Cre recombinase. Cre was then expressed behind the GAL1
promoter in 2% galactose to induce expression the Cre recombinase. The expression of
Cre removed the KanMX selection marker leaving a single loxP site. The cells were
selected on both YPD and YPD with G418 to select for loss of the KanMX marker.
Correct recombination by Cre was then verified using PCR. Finally, 6-AU was used to
remove the pSH47 plasmid. SDBY1560 was generated using the genomic DNA of
SDBY1559 to amplify the HygMX cassette with PCR using standard protocols.

3.4.2

Yeast extraction and Western blot analysis
To detect histone modifications, histone H3, Jhd2-3xFLAG, 3xFLAG-Set1, and

G6PDH, yeast extraction and Western blot analyses were performed as previously
described (121;327). The antibodies used are discussed in section 3.3.5. For Western blot
analysis for the individual HDAC deletion strains (Figure 3.6A), densitometry was used
to quantify levels of histone modifications analyzed relative to histone H3. Relative fold
change values compared to WT are found in Table 3.11.

3.3.3

Chromatin immunoprecipitation analysis
Chromatin immunoprecipitation (ChIP) analysis was performed as previously

described (184;300). The antibodies used are discussed in section 3.3.5. For each ChIP
experiment, three biological repeats were performed with three technical repeats, unless
indicated. For ChIP analysis targeting H3K4 trimethylation, the relative fold change was
set relative to either a set1 strain or WT strain, as indicated, and normalized to the
histone H3 ChIP signal and input. For ChIP analysis targeting histone H3 acetylation, the

101
relative fold change was set relative to a WT strain and normalized to the histone H3
ChIP signal and input. For the ChIP analysis targeting either Jhd2-3xFLAG or 3xFLAGSet1, the relative fold change was set relative to an untagged control and normalized to
input. The relative values and statistical analysis are found in Tables 3.4-3.9 and 3.123.14. The probe sets for promoter, 5’-ORF, and 3’-ORF of PYK1 and PMA1 used for
ChIP analysis are found in Table 3.3.

3.4.3

Gene expression analysis
Gene expression analysis was performed by RNA isolation and quantitative real-

time PCR (qRT-PCR) as previously described (67;184). For each expression analysis,
three technical repeats were performed for three biological repeats. ACT1 was used as an
endogenous control to calculate all Ct values. For each of the genes analyzed, the
transcript levels were set relative to the transcript level in a WT strain. Statistical analysis
and relative fold change values are found in Table 3.10.

3.4.4

Antibodies used for Western blot and ChIP analyses
Histone primary antibodies -H3 (Active Motif, 39163) at a 1:10,000 dilution, -

H3K4me1 (Active Motif, 39297) at a 1:2,500 dilution, -H3K4me2 (Upstate, 07-030) at
a 1:40,000 dilution, -H3K4me3 (Active Motif, 39159) at a 1:100,000 dilution, H3K36me3 (Abcam, ab9050) at a 1:2,500 dilution, -H3K79me3 (Abcam, ab2621) at a
1:10,000 dilution, -H3K9ac (Upstate, 07-352) at a 1:10,000 dilution, -H3K14ac
(Millipore, 07-353) at a 1:5,000 dilution, and -H3K18ac (Active Motif, 39129) at a
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1:10,000 dilution were used for Western blot analysis. Other primary antibodies used
were -G6PDH (Sigma, A9521) at a 1:40,000 dilution, polyclonal rabbit -FLAG
(Sigma, F7425) at a 1:5,000 dilution for Western blot analysis of Jhd2-3FLAG and
3xFLAG-Set1. For ChIP analysis, the histone primary antibodies -H3 (Abcam, ab1791),
-H3K4me3 (Millipore, 07-473), -H3K36me3 (Abcam, ab9050), -H3K9ac (Upstate,
07-352), -H3K14ac (Millipore, 07-353), and -H3K18ac (Active Motif, 39129)
antibodies were used. The monoclonal mouse -FLAG (Sigma, F1804) was used for
ChIP analysis of both Jhd2-3xFLAG and 3xFLAG-Set1.

3.5

Discussion

In this study we characterize the modulation of H3K4 trimethylation by histone
deacetylases. Deletion of three histone deacetylases, RPD3, HDA1, and HOS2, results in
global and gene specific increases in H3K4 trimethylation. Interestingly, though a global
change in H3K36 trimethylation is not observed, ChIP analysis showed an increase in
H3K36 trimethylation levels at the 3’-ORF of the genes analyzed in the 3-HDAC strain.
The deletion of the three HDACs also results in a decrease in histone H3 levels. Though
H3 levels are decreased and H3K4 trimethylation and H3 acetylation levels are increased
at PYK1 and PMA1, no increase in gene transcripts are observed. To determine if deletion
of the three HDACs affected transcript levels of any genes, especially genes that are
silent or repressed under the growth conditions used, six other genes were screened.
Through this analysis it was determined that there is a loss of silencing or derepression of
transcription at a subset of the genes analyzed. To better understand how histone
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deacetylation affects H3K4 trimethylation we wanted to study a single HDAC deletion
that affects H3K4 trimethylation but does not alter histone H3 levels. Deletion of RPD3
was shown to not only increase global H3K4 di- and trimethylation levels but also was
shown to have the most effect on H3K4 trimethylation levels at the 3’-ORF of the gene
analyzed.
The histone deacetylase Rpd3 is found in two complexes, Rpd3L and Rpd3S
(98;328;329). Rpd3L has been shown to localize at gene promoters to inhibit expression
(98). Rpd3, specifically in the Rpd3S complex, has been previously shown to be
important for suppression of cryptic transcription. The current model is that H3K36
trimethylation recruits the Rpd3S histone deacetylase complex to the open reading frame
of actively transcribed genes (98;307). Deletion of either SET2, the H3K36
methyltransferase, or components of the Rpd3S complex results in increased levels of H4
acetylation (98). Furthermore, this study also found increased levels of H3K4
trimethylation when these Rpd3S complex members are deleted or when SET2 was
deleted (98). This is thought to be a result of the activation of the cryptic promoter within
the genes analyzed (98). However, there is another model that suggests that the serine-5
phosphorylated CTD of RNAPII recruits the Rpd3S complex to chromatin, and H3K36
trimethylation then activates its deacetylase activity (320;321). This model suggests that
Rpd3S complex does not require H3K36 trimethylation to be recruited to actively
transcribed genes, and therefore, may be playing other roles at those genes (320;321).
With both models, it is not clear to how the deletion of RPD3 or members of the Rpd3S
complex affects H3K4 trimethylation. Therefore, how Rpd3 affects H3K4 trimethylation
either through expression from cryptic promoters or in another pathway is of interest.
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Mutations in the Spt6, a nucleosome remodeler, and Spt16, a member of the FACT
complex, were shown to cause cryptic transcription (330;331). Genome wide analysis
was done in both of these mutant strains to show those genes that encode a cryptic
transcript (330). However, neither PYK1 nor PMA1 was observed to have a cryptic
transcript in the microarrays performed for either of the mutant strains (330). Further
Northern blot analysis will need to be performed to determine if a cryptic transcript does
exist for PYK1 or PMA1 in a rpd3 strain to determine if the observed increase in H3K4
trimethylation is dependent on cryptic transcription.
Northern blot analysis using sense and anti-sense probes could also determine if
the transcription of a non-coding RNA could be causing the increase in H3K4
trimethylation observed. Analysis of the GAL10-GAL1 locus has found that transcription
of the long non-coding RNA (ncRNA) results in the deposition of H3K4 trimethylation
(332;333). One study indicated that the H3K4 trimethylation deposited by the
transcription of the ncRNA causes an attenuated activation of GAL1 when placed in
media containing galactose and not glucose (333). Interestingly, this study also suggested
that Rpd3 was also recruited to this region by H3K4 di- and trimethylation by the Rpd3S
subunit Rco1 (333). However, they did not directly test this interaction with in vitro
analysis, and other reports have shown that the PHD finger of Rco1 interacts with H3K36
trimethylation (334).
If a cryptic promoter or transcription of a ncRNA are not found for either PYK1 or PMA1
this would suggest a new model for how deletion of Rpd3 and increase in acetylation
affects H3K4 trimethylation levels. Furthermore, how H3K4 trimethylation levels are
increased without changes in the levels of Set1 or Jhd2 binding to the chromatin are
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unknown. Therefore, by studying the mechanism of how deletion of Rpd3 affects the
H3K4 trimethylation, either through modulating acetylation levels or by affecting the
activity of cryptic promoters, will give insight to how and why the pattern of H3K4
trimethylation levels is maintained throughout the open reading frame of actively
transcribed genes. One model would be that changes in acetylation levels do not affect
the location of the methyltransferase or demethylase but affects their activity. Our
previous study has shown that H3 acetylation at either H3K14 or H3K18 disrupts the
interaction between Jhd2 and the H3 N-terminal tail (Figure 2.6D). Another study had
found that H3K14 acetylation may affect Jhd2’s activity (288). An interesting possibility
is that histone acetylation could play multiple roles in preventing demethylation of H3K4
trimethylation, both by modulating the levels of Jhd2 interacting with chromatin and by
attenuating its demethylase activity. Another possibility is that acetylation could promote
the activity of Set1. In vitro analysis of MLL1 has shown that acetylation of lysine 9 or
lysine 14 enhances its methyltransferase activity (161). Therefore, Rpd3 could be playing
a role in maintaining the H3K4 trimethylation enrichment pattern by affecting Set1’s
methyltransferase activity either though directly interacting with the complex or through
modulating histone acetylation levels, which is supported by the analysis of MLL1.
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Figure 3.1 Global H3K4 trimethylation levels are increased in the 3-HDAC strain.
(A) Western blot analysis was used to with whole cell extracts to analyze global H3K4
mono-, di- and trimethylation and H3K14 acetylation using modification specific
antibodies comparing WT and the 3-HDAC strain. Histone H3 was used as a loading
control. (B) To analyze what H3 methylation sites are affected, whole cell extracts were
analyzed for global H3K4, H3K36, and H3K79 trimethylation using Western blot
analysis. Histone H3 was used as a loading control.
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Figure 3.2 Deletion of three histone deacetylases results in a gene specific increase
in H3K4 and H3K36 trimethylation.
(A and B) ChIP analysis was used to analyze H3K4 trimethylation across the promoter,
5’-ORF, and 3’-ORF across PYK1 (A) and PMA1 (B) using an α-H3K4 trimethylation
specific antibody comparing WT and 3-HDAC strains. H3K4 trimethylation signals
were normalized to input and histone H3. (C and D) ChIP analysis was used to analyze
H3K36 trimethylation levels across the promoter, 5’-ORF, and 3’-ORF of PYK1 (C) and
PMA1 (D) comparing WT and 3-HDAC strains. H3K36 trimethylation levels were
normalized to histone H3 levels and to input. For both H3K4 and H3K36 methylation
ChIP analysis, three biological repeats were used with three technical repeats each. The
error bars represent the standard error of the mean.
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Figure 3.3 Gene specific histone acetylation levels are increased in a 3-HDAC
strain.
ChIP analysis was used to analyze H3K9 acetylation (A and D), H3K14 acetylation (B
and E), and H3K18 acetylation (C and F) at the promoter, 5’-ORF, and 3’-ORF of PYK1
(A-C) and PMA1 (D-F). ChIP analysis of H3 acetylation levels were normalized to
histone H3 levels and input. Three biological repeats were used with three technical
repeats each. The error bars represent the standard error of the mean.
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Figure 3.4 H3 levels are dramatically decreased in the 3-HDAC strain without an
increase in transcript level of either PYK1 or PMA1.
(A and C) A histone H3 antibody was used to analyze H3 levels across PYK1 (A) and
PMA1 (C). (B and D) Transcript analysis of PYK1 (B) and PMA1 (D) were analyzed in
the WT and 3-HDAC strains using qRT-PCR. ACT1 was used for normalization as an
internal control, and transcript levels were set relative to WT. For ChIP and transcript
analysis, three biological repeats were used with three technical repeats each. The error
bars represent the standard error of the mean.
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Figure 3.5 Deletion of three histone deacetylases results in the derepression of a
subset of genes.
Transcript analysis was used to analyze the transcript analysis of six genes comparing
WT and the 3-HDAC strains. ACT1 was used as an internal control for normalization,
and the transcript levels were set relative to WT.
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Figure 3.6 Deletion of the histone deacetylase RPD3 results in global increase of
H3K4 di- and trimethylation.
(A) To compare the individual deletions of RPD3, HDA1, and HOS2, global analysis of
H3K4 tri-, di-, and monomethylation and H3K9, K14, and K18 acetylation using Western
blot analysis of whole cell extracts. Histone H3 levels were used as a loading control. (B
and C) The immunoblot A was quantified using densitometry. These results were
normalized to histone H3 and set relative to WT.
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Figure 3.7 H3K4 trimethylation levels are greatly increased at the 3’-ORF when
RPD3 is deleted.
(A and B) ChIP analysis was performed using an α-H3K4 trimethylation specific
antibody targeting the promoter, 5’-ORF, and 3’-ORF of PYK1 (A) and PMA1 (B) in the
individual HDAC deletion strains. ChIP analysis of H3K4 trimethylation was normalized
to histone H3 and input and set relative to a set1 strain. Three biological repeats were
used with three technical repeats each. The error bars represent the standard error of the
mean.
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Figure 3.8 Deletion of the histone deacetylase RPD3 does not alter the localization
of the H3K4 histone demethylase Jhd2 or the histone methyltransferase Set1 across
the open reading frame.
(A) Whole cell extracts of WT, JHD2-3xFLAG, and rpd3 JHD2-3xFLAG strains were
analyzed by Western blot analysis. An α-FLAG antibody was used to analyze protein
levels of Jhd2 and an α-G6PDH antibody was used as a loading control. (B) ChIP
analysis was used to analyze Jhd2-3xFLAG levels across the promoter, 5-ORF, and 3’ORF of PYK1 and PMA1. An α-FLAG antibody was used to specifically target Jhd23xFLAG at the loci analyzed. Input was used for normalization. The error bars represent
the standard error of the mean of three technical repeats. (C) Western blot analysis of WT,
3xFLAG-SET1, and rpd3 3xFLAG-SET1 was used for global analysis to analyze Set1
protein levels. Whole cell extracts were used. An α-FLAG antibody was used to analyze
Set1 protein levels, and G6PDH was used as a loading control. (D) ChIP analysis of
3xFLAG-Set1 was used to analyze Set1 protein levels across the promoter, 5’-ORF and
3’-ORF of PYK1 and PMA1. An α-FLAG antibody was used to specifically target
3xFLAG-Set1. Input was used for normalization. Three biological repeats were used with
three technical repeats each. The error bars represent the standard error of the mean.

114
Table 3.1 Yeast strains
Yeast Strain Genotype
BY4741
MAT his3 leu20 LYS2 met150 ura30
JR471
BY4705: MATa hda1::HIS3 rpd3::LEU2
hos2::LYS2
SDBY1210 BY4741: MAT his3 leu20 LYS2 met150
ura30 set1::HygMX
set2
BY4741: MAT his3 leu20 LYS2 met150
ura30 set2::KanMX
dot1
BY4741: MAT his3 leu20 LYS2 met150
ura30 dot1::KanMX
SDBY1558
BY4741: MAT his3 leu20 LYS2 met150
ura30 rpd3::HygMX
hda1
BY4741: MAT his3 leu20 LYS2 met150
ura30 hda1::KanMX
hos2
BY4741: MAT his3 leu20 LYS2 met150
ura30 hos2::KanMX
SDBY1559
BY4741: MAT his3 leu20 LYS2 met150
ura30 SET1p:3xFLAG-SET1
SDBY1560
BY4741: MAT his3 leu20 LYS2 met150
ura30 SET1p:3xFLAG-SET1 rpd3::HygMX
SDBY1107
BY4741: MAT his3 leu20 LYS2 met150
ura30 JHD2 3xFLAG::KanMX
SDBY1561
BY4741: MAT his3 leu20 LYS2 met150
ura30 JHD2 3xFLAG::KanMX rpd3::HygMX
Table 3.2 Primers for qRT-PCR analysis
Primer name
Sequence
ACT1-001F
TGGATTCCGGTGATGGTGTT
ACT1-002R
TCAAAATGGCGTGAGGTAGAGA
PYK1-003F
CCGAAGAATTGTACCCAGGTAGA
PYK1-005R
TTCTGATTTCTGGACCCTTGGT
PMA1-007F
TGCTAAGACTTACGATGACGCTGC
PMA1-008R
TTCGTCGTCGACACCGTGATTAGA
PCK1-F
TCAGACAAGAATTGGCTCTTAGTGA
PCK1-R
ACGGCAGCTGGAGCATTG
YFR057W-001F
CGGCCAAGTCAAGCGGTAT
YFR057W-002R
CTTTGATCCTTACTCGTGATATTGGA
DAN1-001F
GGCGATTTCACCACCATGTT
DAN1-002R
CCGGTGATCATTCTGGTCACT
IME1-001F
TCCCCTAGAAGTTGGCATTTTG
IME1-002R
CCAAGTTCTGCAGCTGAGATGA

Reference
Open Biosystems
(315)
(184)
Open Biosystems
Open Biosystems
This study
Open Biosystems
Open Biosystems
This study
This study
(67)
This study
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Table 3.2 continued
SPO11-001F
CGGAACTCCCTGTTCAAACG
SPO11-002R
CGCCAATGACAGGAAATGC
Table 3.3 Probe sets for ChIP analysis
Primer name
Sequence 5’-3’
PMA1
/56-FAM/CCGCTTATG/ZEN/CTCCCCTCCATTAGTT/3IABkFQ/
promoter
TGACGAAACGTGGTCGATG
AAATTAGATGTTAGACGATAATGATAGGAC
PMA1 5’
/56-FAM/TTGCCGCCG/ZEN/GTGAAGCTAGA/3IABkFQ/
GACAGTGATAACGATGGTCCAG
ACCGTAAGATGGGTCAGTTTG
PMA1 3’
/56FAM/CGTGTCTGG/ZEN/ATCTGGTCTATCGGTATCT/3IABkFQ/
ACTGGACTGATATTGTTACTGTCG
CATCAATCTGTCAAAGGCTTCAG
PYK1
/56promoter
FAM/CGAATATCG/ZEN/TTTTGATGGCGAGCCTTT/3IABkFQ/
AGAGGTTCTTGGAAATGAAAAGTTAC
CCTTCCCATATGATGCTAGGTAC
PYK1 5’
/56FAM/AGAATTGTA/ZEN/CCCAGGTAGACCATTGGC/3IABkFQ/
TTCTGATTTCTGGACCCTTGG
CATTGACAACGCCAGAAGTC
PYK1 3’
/56FAM/CTCTCACTT/ZEN/GTACAGAGGTGTCTTGGGA/3IABkFQ/
TCAGAGACAGGTTCCTTTTCG
TTACCAGATGCCCAAGAGC

Table 3.4 ChIP analysis of H3K4 trimethylation in BY4741 WT strain and the 3HDAC strain normalized to a BY4741 set1 strain (See Figure 3.2A and 3.2B)
Strain
Gene location
RQ
Fold change
P value between WT
relative to set1
and 3-HDAC
PYK1 promoter
1
set1
WT
PYK1 promoter
83.96
83.96 +/- 23.19
215.31
215.31 +/- 80.44
0.191
3-HDAC PYK1 promoter
PYK1 5’
1
set1
WT
PYK1 5’
165.57
165.57 +/- 9.43
715.61
715.61 +/- 252.14 0.094
3-HDAC PYK1 5’
PYK1 3’
1
set1
WT
PYK1 3’
32.81
32.81 +/- 3.58
532.77
532.77 +/- 64.08
0.001
3-HDAC PYK1 3’
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Table 3.4 continued
PMA1 promoter 1
set1
WT
PMA1 promoter 71.19
71.19 +/- 41.90
141.11 +/- 57.45
0.381
3-HDAC PMA1 promoter 141.11
PMA1 5’
1
set1
WT
PMA1 5’
81.68
81.68 +/- 22.58
253.45
253.45 +/- 75.99
0.096
3-HDAC PMA1 5’
PMA1 3’
1
set1
WT
PMA1 3’
13.93
13.93 +/- 5.20
207.05
207.05 +/- 45.67
0.014
3-HDAC PMA1 3’
* Data represent three biological repeats with three technical repeats each.
Table 3.5 ChIP analysis of H3K36 trimethylation in BY4741 WT strain and the 3HDAC strain normalized to a BY4741 set2 strain (See Figure 3.2C and 3.2D)
Strain
Gene location
RQ
Fold change
P value between WT
relative to set1
and 3-HDAC
PYK1 promoter
1
set2
WT
PYK1 promoter
90.13
90.13 +/- 41.39
68.03
68.03 +/- 46.30
0.740
3-HDAC PYK1 promoter
PYK1 5’
1
set2
WT
PYK1 5’
126.99
126.99 +/- 10.34
152.23
152.23 +/- 84.75
0.782
3-HDAC PYK1 5’
PYK1 3’
1
set2
WT
PYK1 3’
106.61
106.61 +/- 20.50
746.77
746.77 +/- 124.53 0.007
3-HDAC PYK1 3’
PMA1 promoter 1
set2
WT
PMA1 promoter 37.61
37.61 +/- 11.71
19.53 +/- 8.37
0.278
3-HDAC PMA1 promoter 19.53
PMA1 5’
1
set2
WT
PMA1 5’
88.36
88.36 +/- 2.46
90.69
90.69 +/- 44.46
0.961
3-HDAC PMA1 5’
PMA1 3’
1
set2
WT
PMA1 3’
71.63
71.63 +/- 18.38
358.72
358.72 +/- 91.03
0.037
3-HDAC PMA1 3’
* Data represent three biological repeats with three technical repeats each.
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Table 3.6 ChIP analysis of H3K9ac in the 3-HDAC strain relative to a BY4741
WT strain (See Figure 3.3A and 3.3D)
Strain
Gene location
RQ
Fold change relative
P value between
to set1
WT and 3-HDAC
WT
PYK1 promoter 1
12.61 +/- 4.61
0.057
3-HDAC PYK1 promoter 12.61
WT
PYK1 5’
1
PYK1
5’
44.11
44.11 +/- 22.58
0.129
3-HDAC
WT
PYK1 3’
1
23.77
23.77 +/- 9.45
0.074
3-HDAC PYK1 3’
WT
PMA1 promoter 1
11.12 +/- 1.59
0.012
3-HDAC PMA1 promoter 11.12
WT
PMA1 5’
1
32.52
35.52 +/- 12.27
0.062
3-HDAC PMA1 5’
WT
PMA1 3’
1
PMA1
3’
12.88
12.88 +/- 1.61
0.002
3-HDAC
* Data represent three biological repeats with three technical repeats each.
Table 3.7 ChIP analysis of H3K14ac in the 3-HDAC strain relative to a BY4741
WT strain (See Figure 3.3B and 3.3E)
Strain
Gene location
RQ
Fold change relative
P value between
to set1
WT and 3-HDAC
WT
PYK1 promoter 1
15.75 +/- 6.19
0.076
3-HDAC PYK1 promoter 15.75
WT
PYK1 5’
1
PYK1
5’
28.96
28.96 +/- 15.42
0.144
3-HDAC
WT
PYK1 3’
1
30.38
30.38 +/- 3.64
0.001
3-HDAC PYK1 3’
WT
PMA1 promoter 1
11.24 +/- 0.89
>0.001
3-HDAC PMA1 promoter 11.24
WT
PMA1 5’
1
35.02
35.02 +/- 13.53
0.066
3-HDAC PMA1 5’
WT
PMA1 3’
1
PMA1
3’
55.61
55.61 +/- 2.72
>0.0001
3-HDAC
* Data represent three biological repeats with three technical repeats each.
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Table 3.8 ChIP analysis of H3K18ac in the 3-HDAC strain relative to a BY4741
WT strain (See Figure 3.3C and 3.3F)
Strain
Gene location
RQ
Fold change relative
P value between
to set1
WT and 3-HDAC
WT
PYK1 promoter 1
26.08 +/- 9.84
0.063
3-HDAC PYK1 promoter 26.08
WT
PYK1 5’
1
PYK1
5’
59.62
59.62 +/- 28.23
0.106
3-HDAC
WT
PYK1 3’
1
73.71
73.71 +/- 11.07
0.003
3-HDAC PYK1 3’
WT
PMA1 promoter 1
16.25 +/- 2.16
0.002
3-HDAC PMA1 promoter 16.25
WT
PMA1 5’
1
80.86
80.86 +/- 28.22
0.048
3-HDAC PMA1 5’
WT
PMA1 3’
1
PMA1
3’
68.17
68.17 +/- 7.99
0.001
3-HDAC
* Data represent three biological repeats with three technical repeats each.
Table 3.9 ChIP analysis of H3 in the 3-HDAC strain relative to a BY4741 WT
strain (See Figure 3.4A and 3.4C)
Strain
Gene location
RQ
Fold change relative
P value between
to set1
WT and 3-HDAC
WT
PYK1 promoter 1
-23.05 +/- 0.014
P < 0.0001
3-HDAC PYK1 promoter 0.043
WT
PYK1 5’
1
PYK1
5’
0.0087
-115.04 +/- 0.0039
P < 0.0001
3-HDAC
WT
PYK1 3’
1
0.0074
-136.07 +/- 0.0018
P < 0.0001
3-HDAC PYK1 3’
WT
PMA1 promoter 1
-14.05 +/- 0.012
P < 0.0001
3-HDAC PMA1 promoter 0.071
WT
PMA1 5’
1
0.012
-86.62 +/- 0.0036
P < 0.0001
3-HDAC PMA1 5’
WT
PMA1 3’
1
PMA1
3’
0.011
-92.75 +/- 0.0027
P < 0.0001
3-HDAC
* Data represent three biological repeats with three technical repeats each.
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Table 3.10 qRT-PCR analysis of RNA transcripts in the 3-HDAC strain relative to
WT (See Figure 3.4B and 3.4D and Figure 3.5)
Strain
Gene name
RQ
Fold change
P value
relative to WT
WT
PYK1
1
PYK1
0.078
-1.28 +/- 0.13
0.047
3-HDAC
WT
PMA1
1
PMA1
0.63
-1.60 +/- 0.03
0.0003
3-HDAC
WT
PCK1
1
PCK1
28.49
28.48 +/- 3.61
0.0016
3-HDAC
WT
YFR057W
1
YFR057W
20.38
20.38 +/- 5.70
0.027
3-HDAC
WT
DAN1
1
DAN1
25.54
25.54 +/- 2.80
0.0012
3-HDAC
WT
IME1
1
IME1
1.36
1.36 +/- 0.15
0.072
3-HDAC
WT
SPO11
1
SPO11
7.89
7.89 +/- 0.44
P < 0.0001
3-HDAC
WT
PMA1 3’UTR
1
PMA1 3’UTR
4.94
4.94 +/- 0.49
0.0013
3-HDAC
* Data represent three biological repeats with three technical repeats each.
Table 3.11 Quantitative Western blot of H3K4 methylation and H3 acetylation in
the single histone deacetylase deletion strains (See Figure 3.6B and 3.6C)
Strain
Histone modification
Fold change relative to
WT
H3K4me3
-72.60
set1
WT
H3K4me3
H3K4me3
2.17
rpd3
H3K4me3
-1.25
hda1
H3K4me3
-1.35
hos2
H3K4me2
-58.93
set1
WT
H3K4me2
H3K4me2
2.73
rpd3
H3K4me2
1.24
hda1
H3K4me2
1.22
hos2
H3K4me1
-216.35
set1
WT
H3K4me1
H3K4me1
1.17
rpd3
H3K4me1
1.12
hda1
H3K4me1
1.33
hos2
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Table 3.11 continued
H3K9ac
-1.55
set1
WT
H3K9ac
H3K9ac
3.94
rpd3
H3K9ac
1.89
hda1
H3K9ac
1.50
hos2
H3K14ac
-2.25
set1
WT
H3K14ac
H3K14ac
2.07
rpd3
H3K14ac
-1.22
hda1
H3K14ac
-1.42
hos2
H3K18ac
-1.03
set1
WT
H3K18ac
H3K18ac
2.90
rpd3
H3K18ac
2.33
hda1
H3K18ac
1.00
hos2
*Data represent three biological repeats with three technical repeats each.
Table 3.12 ChIP analysis of H3K4 trimethylation in BY4741 WT, set1, rpd3,
hda1, and hos2 strains relative to WT (See Figure 3.7A and 3.7B)
Strain
Gene location
RQ
Fold change relative P value
to WT
PYK1 promoter
0.006
0.006 +/- 0.003
< 0.0001
set1
WT
PYK1 promoter
1
PYK1 promoter
2.96
2.96 +/- 1.47
0.257
rpd3
PYK1 promoter
1.96
1.96 +/- 0.82
0.304
hda1
PYK1 promoter
1.46
1.46 +/- 0.65
0.518
hos2
PYK1
5’
0.002
-507.
86
+/0.0003
< 0.0001
set1
WT
PYK1 5’
1
PYK1
5’
1.63
1.60 +/- 0.04
< 0.001
rpd3
PYK1 5’
1.41
1.41 +/- 0.10
0.016
hda1
PYK1 5’
1.04
1.04 +/- 0.09
0.700
hos2
PYK1 3’
0.009
-110.54 +/- 0.003
< 0.0001
set1
WT
PYK1 3’
1
PYK1 3’
4.82
4.82 +/- 0.21
< 0.0001
rpd3
PYK1
3’
1.54
1.54
+/0.04
< 0.001
hda1
PYK1 3’
0.69
-1.45 +/- 0.08
0.021
hos2
PMA1 promoter
0.003
-381.02 +/- 0.001
< 0.0001
set1
WT
PMA1 promoter
1
PMA1 promoter
1.10
1.10 +/- 0.26
0.730
rpd3
PMA1 promoter
1.31
1.31 +/- 0.08
0.015
hda1
PMA1
promoter
1.06
1.06
+/0.14
0.668
hos2
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Table 3.13 continued
PMA1 5’
0.003
-318.9 +/- 0.001
< 0.0001
set1
WT
PMA1 5’
1
PMA1 5’
2.18
2.18 +/- 0.10
<0.001
rpd3
PMA1 5’
1.34
1.34 +/- 0.05
0.003
hda1
PMA1
5’
0.77
-1.30
+/0.07
0.028
hos2
PMA1 3’
0.016
-62.41 +/- 0.01
< 0.0001
set1
WT
PMA1 3’
1
PMA1 3’
3.98
3.98 +/- 0.62
0.009
rpd3
PMA1 3’
1.51
1.51 +/- 0.20
0.063
hda1
PMA1 3’
0.91
-1.10 +/- 0.12
0.496
hos2
*Data represent three biological repeats with three technical repeats each.
Table 3.13 ChIP analysis comparing Jhd2-3XFLAG binding in a rpd3 strain to
Jhd2-3xFLAG binding in a WT background normalized to an untagged control (See
Figure 3.8B)
Strain
Gene location
RQ
Fold change P value comparing
relative to
Jhd2 binding to
WT
WT
WT
PYK1 promoter 1
Jhd2-3xFLAG
PYK1 promoter 20.20
20.20 +/4.25
PYK1 promoter 18.55
18.55 +/0.590
rpd3 Jhd2-3xFLAG
0.40
WT
PYK1 5’
1
Jhd2-3xFLAG
PYK1 5’
5.33
5.33 +/- 0.91
PYK1 5’
5.35
5.35 +/- 0.11 0.947
rpd3 Jhd2-3xFLAG
WT
PYK1 3’
1
Jhd2-3xFLAG
PYK1 3’
9.12
9.12 +/- 2.33
PYK1
3’
10.19
10.19 +/0.836
rpd3 Jhd2-3xFLAG
0.86
WT
PMA1 promoter 1
Jhd2-3xFLAG
PMA1 promoter 8.94
8.94 +/- 0.56
PMA1
promoter
12.37
12.37 +/0.013
rpd3 Jhd2-3xFLAG
0.58
WT
PMA1 5’
1
Jhd2-3xFLAG
PMA1 5’
9.33
9.33 +/- 0.91
PMA1 5’
12.22
12.22 +/0.142
rpd3 Jhd2-3xFLAG
1.33
WT
PMA1 3’
1
Jhd2-3xFLAG
PMA1 3’
6.85
6.85 +/- 1.15
PMA1 3’
7.84
7.84 +/- 0.65 0.553
rpd3 Jhd2-3xFLAG
*Data represent three technical repeats each.
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Table 3.14 ChIP analysis comparing 3xFLAG-Set1 binding in a rpd3 strain to
3xFLAG-Set1 binding in a WT background normalized to an untagged control (See
Figure 3.8D)
Strain
Gene location
RQ
Fold change
P value comparing
relative to wt
Set1 binding to WT
WT
PYK1 promoter 1
3xFLAG-Set1
PYK1 promoter 5.30
5.30 +/- 1.24
6.47 +/- 1.93
0.638
rpd3 3xFLAG-Set1 PYK1 promoter 6.47
WT
PYK1 5’
3xFLAG-Set1
PYK1 5’
37.68
37.68 +/- 11.13
30.88
30.88 +/- 8.17 0.648
rpd3 3xFLAG-Set1 PYK1 5’
WT
PYK1 3’
1
3xFLAG-Set1
PYK1 3’
9.63
9.63 +/- 1.54
8.48
8.48 +/- 1.25
0.593
rpd3 3xFLAG-Set1 PYK1 3’
WT
PMA1 promoter 1
3xFLAG-Set1
PMA1 promoter 11.48
11.48 +/- 1.68
12.61 +/- 0.87 0.580
rpd3 3xFLAG-Set1 PMA1 promoter 12.61
WT
PMA1 5’
1
3xFLAG-Set1
PMA1 5’
23.83
23.83 +/- 2.99
23.47
23.47 +/- 3.03 0.937
rpd3 3xFLAG-Set1 PMA1 5’
WT
PMA1 3’
1
3xFLAG-Set1
PMA1 3’
6.84
6.84 +/- 1.45
PMA1
3’
7.41
7.41 +/- 1.22
0.777
rpd3 3xFLAG-Set1
*Data represent three biological repeats with three technical repeats each.
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CHAPTER 4. IMMEDIATE CHROMATIN IMMUNOPRECIPITATION AND
ANALYSIS

4.1

Declaration of collaborative work

In this study Paul South was involved in the initial design and optimization of the
iChIP procedure. All A. thaliana work was done by Brett Bishop in collaboration with
Joe Ogas from the Department of Biochemistry at Purdue University. All other
experiments and analysis were done by Kayla Harmeyer.

4.2

Introduction

Characterizing the dynamics of the chromatin structure and associated proteins is
fundamentally important in the understanding of cellular growth and differentiation.
Chromatin is the protein-DNA complex that packages DNA in the nucleus of eukaryotic
cells. The basic unit of chromatin is the nucleosome, which is composed of 146 base
pairs of DNA wrapped around an octamer of histone proteins (335;336). Changing how
the DNA is packaged in the nucleus affects many DNA templated processes, including
gene transcription and DNA repair and replication. As a result, detailed analysis of how
chromatin features change in time and space is critical in understanding how these
processes are regulated (271;336;337). Changes in DNA packaging can be modulated by
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a variety of chromatin associated proteins, such as transcription factors and remodelers,
and also by post-translation modifications (PTMs) on histones (86;271;335;338).
The development of chromatin immunoprecipitation (ChIP), ChIP-chip, and ChIP-seq
has led to a significant increase in the amount of information gained about the nature of
chromatin in respect to the localization of histone variants and of chromatin associated
proteins in the genome (337;339). Furthermore, these methods have revealed the
enrichment pattern of PTMs such as methylation, acetylation, and phosphorylation across
the genome, which has shed new light on how these epigenetic modifications impact
cellular processes (42). ChIP has also helped to elucidate how these modifications act as
docking or recruitment sites for transcription factors, chromatin remodelers, and even
other chromatin modifiers, thereby contributing mechanistic insight into regulation of
chromatin dynamics (271;335;336;338;339).
The successful application of ChIP-chip and ChIP-seq has resulted in a significant
increase in the amount of genome-wide information that has been generated and collected
for a variety of organisms. With the facile ability to generate vast amounts of genomewide ChIP data, it has become increasingly important to rapidly validate these data.
Unfortunately, standard ChIP methods are time consuming, expensive, quite laborious,
and are subject to high rates of experimental error due to the large number of steps
involved. Standard ChIP analysis typically takes 3-4 days, from growing cultures to data
analysis (300). To reduce the time of ChIP analysis, other groups have developed “Fast”
ChIP protocols that can significantly reduce the time to complete an experiment (340342). One reported fast ChIP protocol showed that incubation of antibody with
chromatin in an ultrasonic bath significantly reduces incubation time (340;341). This
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protocol also included treating the precipitated chromatin at 100°C with chelex-100 resin
to extract the DNA from proteins (340;341). This approach can be used in both standard
PCR and in quantitative real-time PCR (qRT-PCR), but the 15 minute incubation time in
an ultrasonic bath may not be sufficient for some antibody-epitope interactions, which
would significantly decrease the sensitivity of the ChIP procedure. In addition, the use of
chelex-100 resin not only leads to additional time and cost, but contamination of a PCR
reaction with chelex-100 resin prevents DNA amplification (343). Another ChIP
procedure demonstrated that after immunoprecipitation the chromatin does not need to be
eluted from the beads and these beads can be directly used for PCR (342). This protocol
can be used for standard PCR, but it was thought not to be compatible with qRT-PCR due
to background fluorescence caused by the beads. Furthermore, even with these
advancements in performing ChIP, there are still protein factors that have been difficult
or nearly impossible to detect (191;344;345). Because of these issues with the current
ChIP protocols, there is a need for a ChIP protocol that not only decreases the amount of
time and cost but also increases the sensitivity allowing for the study of the proteins and
PTMs that have been traditionally difficult to detect. Here we report a new chromatin
immunoprecipitation procedure, which we call immediate ChIP or iChIP.
Using iChIP one can take soluble chromatin to samples ready for qRT-PCR data
analysis in approximately 2.5 hours without the use of an ultrasonic bath or chelex-100
resin. Furthermore, we have optimized the procedure to allow the use of magnetic beads
in an on-bead PCR reaction using qRT-PCR to improve the sensitivity of the method. We
show that the iChIP method can successfully detect the highly abundant PTM histone H3
lysine 4 (H3K4) trimethylation in a similar enrichment pattern as produced by the
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standard ChIP protocol. Next, we compared iChIP versus standard ChIP to detect two
yeast histone demethylases, Jhd2 and Rph1, to demonstrate the increased sensitivity of
the iChIP protocol. Furthermore, we used iChIP to scan the promoter and ORF of four
actively transcribed genes for an enrichment pattern of H3K4 monomethylation and show
that only two of the four active genes had a 3’-ORF enrichment pattern. Taken together,
iChIP analysis indicates that there are at least two patterns of H3K4 monomethylation on
actively transcribed genes. We also analyzed the H3K4 monomethylation enrichment
pattern in yeast strains with gene deletions that lead to a loss of H2B monoubiquitination.
These data demonstrate the ability of iChIP to screen through multiple genes and yeast
strains to shed light on a biological question of how a PTM can affect the enrichment
pattern of another PTM across a gene’s promoter and ORF. Finally, we show the
versatility of iChIP on the more complex genome of Arabidopsis thaliana. PICKLE
(PKL), a CHD subfamily II ATP-dependent chromatin remodeling factor, is correlated
with the deposition of H3K27 methylation a mark commonly associated with
transcriptional repression. However, PKL also associates with the actively transcribed
gene ACT7 (346-348). We show that this association with ACT7 does not correlate with
H3K4 trimethylation, a PTM associated with active transcription. These studies show that
the iChIP method serves as a powerful tool to answer biological questions in a timely and
cost-effective manner with increased sensitivity.
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4.3

4.3.1

Results

Verification of iChIP through analysis of the pattern of H3K4 trimethylation
across actively transcribed genes
Many studies have characterized a specific pattern of H3K4 methylation across

the open reading frame (ORF) of actively transcribed genes, with H3K4 trimethylation
(H3K4me3) being enriched at the 5’-ORF and transcriptional start site, H3K4
dimethylation (H3K4me2) localized in the middle of the gene, and H3K4
monomethylation (H3K4me1) enriched at the 3’-ORF (42;87). To establish that iChIP
analysis is a reliable and robust method, iChIP was compared to a standard “long” ChIP
method (67;297;300) using an H3K4me3-specific antibody. The general scheme of the
iChIP protocol is depicted in Figure 4.1A and 4.7 and a detailed S. cerevisiae iChIP
protocol is depicted in Figure 4.6. Yeast cells were grown to log phase and crosslinked
with formaldehyde. After cell lysis and sonication, chromatin was purified. For the DNA
input control, 6.25% of soluble chromatin was removed and processed with a standard
PCR clean up kit (Qiagen). During the chromatin preparation, the H3K4me3 antibody
(Millipore) was conjugated to protein-G magnetic beads (DynaBeads, Life Technologies)
for 30 minutes. The soluble chromatin was then immunoprecipitated with the antibodyconjugated magnetic beads for 2 hours. After immunoprecipitation, the beads were
washed three times for 5 minutes each and resuspended in water. The H3K4me3 iChIP
sample was then analyzed using qRT-PCR at the promoter, 5’-ORF, and 3’-ORF of two
constitutively active genes, PYK1 and PMA1 (Figure 5.1B and Figure 5.1C). As a
negative control, H3K4me3 iChIP was performed in a yeast strain lacking the only
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known H3K4 histone methyltransferase, Set1. In the set1 strain, H3K4 mono-, di-, and
trimethylation are abolished (121). A standard ChIP method was also used to analyze the
H3K4me3 pattern across these two genes in both a wild-type (WT) strain and a set1
strain (Figure 4.1B and Figure 4.1C). Both methods showed the characteristic peak of
H3K4me3 at the 5’-ORF of both genes. Furthermore, the signal of the H3K4me3
detected compared to the signal of the set1 background was very similar between the
two methods, indicating that the iChIP method can be used to detect H3K4me3 in about 6
hours after formaldehyde cross-linking compared to the 3 days using standard ChIP. As a
control to show that the methylation detected at the two active genes PMA1 and PYK1
was specific, a silent subtelomeric gene, YFR057W, was analyzed for H3K4me3. Both
methods showed very low levels of H3K4me3 at YFR057W when compared to PYK1 and
PMA1, as expected due to the correlation between H3K4me3 and active transcription
(Figure 4.1D).

4.3.2

Histone demethylases, Jhd2 and Rph1, associate with the promoter, 5’-ORF, and
3’-ORF of actively
Studies have described protein factors that have been difficult or nearly

impossible to detect using the standard ChIP protocol (344;345). For example, it has been
reported that the yeast H3K4 histone demethylase Jhd2 cannot be analyzed using
standard ChIP methods (191). However, using the iChIP protocol, we were able to
readily detect Jhd2 and the H3K36 histone demethylase Rph1 interacting with the
promoter, 5’-ORF, and 3’-ORF of two actively transcribed genes, PYK1 and PMA1, with
a signal that was significantly over the untagged Jhd2 and untagged Rph1 background
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signal, respectively (Figures 4.2A-D). In contrast, a signal was not observed over
background for either Jhd2 or Rph1 using the standard ChIP method (Figures 4.2A-D).
The ability to analyze chromatin-associated proteins, which have been difficult to detect
using standard ChIP, makes the iChIP method a significant and important tool for future
work characterizing the association of these and other chromatin-associated proteins to
specific loci.

4.3.3

H3K4 monomethylation is enriched at the 3’-ORF for a subset of actively
transcribed genes and this enrichment is lost in both a rad6 and bre1 strains
Although genome-wide approaches can provide valuable initial information there

are limitations with every technology. For example, reports of false positives due to
sample bias and of low number of reads from certain targets necessitate validation and
follow-up analysis of genome-wide localization data (349). As previously mentioned
H3K4me1 has been shown to be enriched at the 3’-ORF of actively transcribed genes
(42;87). However, this particular histone modification has been challenging to study
using standard ChIP in yeast, so its biological role is not fully understood. To determine
if iChIP can be used to detect H3K4me1 in genomic regions, both WT and set1 strains
were crosslinked and soluble chromatin was isolated from these strains. The protein-G
magnetic beads were conjugated with a commercially available H3K4me1 antibody
(Active Motif) and used in the immunoprecipitation of soluble chromatin. Due to the
lesser amount of this modification, the amount of soluble chromatin used in the
immunoprecipitation was increased 1200% (300 L) compared to that used for
H3K4me3 ChIP (25 L). After the iChIP method was completed, qRT-PCR analysis was
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used to analyze H3K4me1 levels at the promoter, 5’-ORF, and 3’-ORF of four active
genes that according to ChIP-chip data have H3K4me1 3’-ORF enrichment (PYK1,
PMA1, MDH2, and HMG1) (42). Interestingly, the H3K4me1 iChIP results differ from
that of the ChIP-chip data. Relative to the background signal of a set1∆ strain, both PYK1
and MDH2 had an enrichment of H3K4me1 at the 3’-ORF, consistent with enrichment
pattern previously reported (Figure 4.3A). However, though H3K4me1 was detected at
the active genes PMA1 and HMG1, a 3’-ORF enrichment was not observed, differing
from the previously reported ChIP-chip data (Figure 4.3A).
Due to the ability to detect significant levels of H3K4 monomethylation at
actively transcribed genes using iChIP, we wanted to ask how other PTMs could affect
the enrichment pattern of H3K4 monomethylation. The histone crosstalk between H3K4
methylation and H2B K123 monoubiquitination has been thoroughly studied, but still not
completely understood. Multiple studies have shown that H2B monoubiquitination is
necessary for the establishment of H3K4 di- and trimethylation (67-73). Global H3K4 diand trimethylation were lost when RAD6 or BRE1, the gene encoding the E2 ubiquitinconjugating enzyme and the gene encoding the E3 ubiquitin ligase responsible for H2B
monoubiquitination, respectively, was deleted (Figure 4.4). However, though global
H3K4 monomethylation is reduced it is still detectable through Western blot analysis
(67;69;70;73) (Figure 4.4). This suggests that though Rad6 and Bre1 affect the overall
levels H3K4 monomethylation, some H3K4 monomethylation can be established even
with their absence. How exactly Rad6 and Bre1 affect H3K4 monomethylation across a
gene and if they play a role in the observed 3’ enrichment of H3K4 monomethylation is
largely unknown. One study showed that in a rad6∆ an increase in H3K4
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monomethylation was observed at the 5’-ORF of two actively transcribed genes, but also
that H3 levels at the locus were higher in a rad6∆ compared to WT (70). This study also
stated that no H3K4 monomethylation was observed at the 3’-ORF of the genes analyzed
in a rad6∆ strain. Another study also looked at H3K4 monomethylation across a gene in
both a rad6∆ and a bre1∆ strain but reported that no change in signal was observed
compared to WT (304).
To resolve these differences, iChIP was used to analyze the levels of H3K4
monomethylation in rad6 and bre1 strains across PYK1 and MDH2, the two genes
observed to have a 3’-ORF enrichment of monomethylation in a WT strain (Figure 4.3).
The ChIP analysis revealed that the 3’-ORF H3K4 monomethylation enrichment was lost
at PYK1 and MDH2 in both rad6 and bre1 strains (Figure 4.3B and 4.3C).
Interestingly, H3K4 monomethylation signal at the 3’-ORF of PYK1 was significantly
lower (p-value < 0.05) compared to the 5’-ORF signal of PYK1 in both rad6∆ and bre1∆
strains. This indicates that not only was the 3’-ORF enrichment lost, the levels of H3K4
monomethylation at the 3’-ORF of PYK1 is less than the 5’-ORF levels (Figure 4.3B and
4.3C). Furthermore, PMA1 and HMG1 were analyzed in a rad6∆ strain and bre1∆ strain,
and as observed in the WT strain, levels of H3K4 monomethylation were similar across
the promoter, 5’-ORF, and 3’-ORF (Figure 4.3B and 4.3C). Taken together, iChIP was
able to identify that there are two distinct patterns of H3K4 monomethylation and that
H2B ubiquitination is necessary for H3K4 monomethylation enrichment at the 3’ open
reading frame of some but not all genes.
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4.3.4

A. thaliana chromatin remodeler PKL localization does not correlated with H3K4
trimethylation enrichment at the active gene ACT7
We also wanted to test if iChIP could be used for more complex genomes. Here

we show that the iChIP method can be applied to study the relationship between
chromatin modifications and remodelers in Arabidopsis thaliana. PICKLE (PKL) is an
ATP-dependent remodeler that promotes H3K27me3, a mark associated with
transcriptional repression (346). Interestingly, PKL not only associates with H3K27me3
enriched genes but is also found at actively transcribed genes, such as the promoter of
ACT7 (346;350). The association of PKL with the promoter of ACT7 introduces the
possibility of a new role for PKL and raises the prospect that PKL may co-localize with
an epigenetic modification associated with actively transcribed genes such as H3K4me3.
Using iChIP to compare both PKL-cMYC and H3K4me3 localization at ACT7 and a
heterochromatic locus, MULE, we were able to quickly screen through multiple regions
to determine if there is any correlation between PKL localization and H3K4me3
enrichment (Figure 4.5A). In agreement with published genome-wide analyses,
H3K4me3 was observed to be enriched at the 5’-ORF of ACT7, and no H3K4me3
enrichment was observed at the heterochromatic gene MULE (Figure 4.5B). We observed
that although PKL preferentially associated with ACT7 relative to MULE, as reported
previously, the association of PKL at ACT7 was relatively constant in each region
examined and did not correlate with H3K4me3 enrichment (Compare Figure 4.5B and
Figure 4.5C). Therefore, using the iChIP method the localization of both H3K4me3 and
PKL could be quickly scanned across genes to show that even though PKL preferentially
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interacts with chromatin at actively transcribed genes, there is no correlation between
PKL interaction and the enrichment of H3K4 trimethylation.

4.4
4.4.1

Material and Methods

Construction of yeast strains
All yeast strains used in this study are described in Table 4.1. All strains were

grown overnight to saturation in YPD media. They were then back diluted to OD600 0.10.2 in 100 mL YPD and grown at 30C to mid-log phase (OD600 0.6-0.8). SDBY1319
was generated as previously described (351).

4.4.2

Formaldehyde cross-linking and generating soluble for S. cerevisiae
The generation of soluble chromatin was described previously (300). The cultures

were cross-linked with 1% formaldehyde for 15 min at room temperature, mixing
occasionally. The cells were then collected with centrifugation and washed. The cells
were again collected with centrifugation, transferred to a microcentrifuge tube, and
collected with centrifugation. The cell pellet was flash frozen in liquid nitrogen and
stored at -80C. The cell pellets were resuspended in 400 L sFA-140 lysis buffer (sFA140 refers to the FA-140 buffer used for Saccharomyces cerevisiae; 50 mM HEPESKOH, pH 7.5; 140 mM NaCl; 1 mM EDTA; 0.1% Triton X-100, and 0.1% sodium
deoxycholate). The cells were lysed by bead-beating with glass beads (BioSpec
11079105). The lysate was separated from the beads and sonicated (Misonix sonicator:
Power 6, 10 seconds, 6 times with 10 second rest) to shear the chromatin. Directly after
sonication, the lysate was placed on dry ice for 10 sec. The lysates were centrifuged for 5
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min at 4C at top speed and then for 10 min at 4C at top speed to separate soluble and
insoluble chromatin (~400 L). 25 L (6.25%) of soluble chromatin was removed and
processed for DNA input using a PCR purification kit (Qiagen 28106). The remaining
soluble chromatin can be immediately used for the immunoprecipitation or it can be
stored at -20C.

4.4.3

S. cerevisiae iChIP
1 L of antibody (H3, Abcam ab1791; H3K4me3, Millipore 07-473; H3K4me1,

Active Motif 39297; M2 FLAG, Sigma F1804) was conjugated to 10 L magnetic beads
(Dynabeads, Life Technologies 10004D) for about 30 min. The antibody bound beads
were then rotated with soluble lysate (100 L for H3; 25 L for H3K4me3; 300 L for
H3K4me1; 200 L for FLAG; for H3 and H3K4me3 the soluble lysate was brought up to
200 µL total volume with 1xPBS(-K)) for 2 hr at 4C. The beads were then washed at
room temperature for 5 min each with sFA-140 wash buffer (50 mM HEPES-KOH, pH
7.5; 140 mM NaCl; 1 mM EDTA; 0.1% Triton X-100), sFA-500 wash buffer (50 mM
HEPES-KOH, pH 7.5; 500 mM NaCl; 1 mM EDTA; 0.1% Triton X-100), and with
1xPBS(-K), pH 7.0 (39 mM NaH2PO4∙H2O; 32.3 mM Na2HPO4∙7 H2O; 154 mM NaCl).
50 L water was used to resuspend the beads.

4.4.4

S. cerevisiae standard ChIP
The standard ChIP protocol was performed as previously described with slight

modifications. (67;297;300). Soluble lysate (100 L for H3; 25 L for H3K4me3; 200
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L for FLAG; for H3 and H3K4me3 the soluble lysates were brought up to 200 L total
volume with sFA-140 lysis buffer) was rotated with 1 L antibody (H3, Abcam ab1791;
H3K4me3, Millipore 07-473; M2 FLAG, Sigma F1804) overnight at 4C with protease
inhibitors (0.2 g leupeptin, aprotinin, and pepstatin A, 0.2 mM PMSF). 12 L
Sepharose Protein G beads (GE Healthcare Life Sciences 17-0618-02) was added to each
lysate and incubated for 1 hr at 4C. The beads were then washed at room temperature for
10 min with sFA-140 wash buffer, sFA-500 wash buffer, and with LiCl/NP40 (10 mM
Tris-HCl, pH 8.0; 250 mM LiCl; 0.5% NP-40; 0.5% sodium deoxycholate; 1 mM EDTA).
The bound protein and DNA was eluted from the beads using 200 L elution buffer (1%
SDS; 0.1 M NaHCO3) by briefly vortexing the beads followed by 15 min rotation at room
temperature. This was repeated, and the two elution fractions were combined. After
combining the two elutions, 16 L 5 M NaCl was added to each sample. For DNA input,
10 L soluble chromatin was used. Both the elutions and the inputs were reverse crosslinked overnight at 65C. The DNA was then ethanol precipitated and dried. 180 L TE,
pH 8.0 (10 mM Tris; 1 mM EDTA) was used to resuspend the DNA followed by RNase
treatment (20 g; Sigma R6513) for 30 min at 37C. 20 L Proteinase K buffer (0.1 M
Tris-HCl, pH 7.8; 0.05 M EDTA; 5% SDS) was added followed Proteinase K treatment
(20 g; Sigma P2308) for 1 hr at 42C. The DNA was extracted with two
phenol/chloroform/IAA washes. The DNA was again ethanol precipitated, dried, and
resuspended in 50 L water.
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4.4.5

S. cerevisiae real-time PCR and statistical analysis
qRT-PCR was performed using the StepOnePlus Real-Time PCR System (Life

Technologies). To ensure equal amounts of DNA loaded, the samples were regularly
vortexed to ensure suspension of the beads. Also to be noted, low levels (0.1% Triton X100) must be used in the sFA-140 wash buffer and sFA-500 wash buffer to reduce
background fluorescence caused by detergents when performing an on-bead PCR
reaction. 1 L of the on-bead mixture and standard ChIP DNA were used for each of the
three technical repeats for each of the three biological repeats. The DNA was amplified
using TaqMan Master Mix (Life Technologies 4369510) and PrimeTime probe sets
(Integrated DNA Technologies) described in Table 4.2. The data were analyzed using the
Ct method. The mean relative fold changes, s.e.m., and statistical significance values
are found in Tables 4.4-4.8.

4.4.6

A. thaliana material and growth conditions
Seeds used in these studies were obtained from wild-type or transgenic plants

grown in parallel in an AR75 incubator (Percival Scientific) under 24 hr of illumination.
Seeds were allowed to dry for at least a month on the plant prior to collection. No other
treatment was applied (i.e. stratification) prior to use of the seeds. Plants were incubated
on synthetic media (352) and grown in a CU36L5 incubator (Percival Scientific) under
24 hr of illumination. Whole plants were collected 14 days post imbibition for ChIP
analysis.
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4.4.7

Isolating nuclei and generating soluble chromatin from A. thaliana
The nuclei extraction and generation of soluble chromatin from A. thaliana were

performed as previously described (346). Tissue was immersed in crosslinking solution
(0.002% Silwet; 10 mM Tris-HCl, pH8.0; 0.44 M Sucrose; 1% formaldehyde) under
house vacuum. After 10 min, 1/15 volume of 2 M glycine was added, and the vacuum
was reapplied for another 5 min. The tissues were washed and flash-frozen in liquid
nitrogen. The tissue was ground into a fine powder and resuspended in 10 mL of cold
Extraction Buffer 1 (0.4 M sucrose; 10 mM Tris-HCl, pH 8.0; 10 mM MgCl2) with
protease inhibitors (1x protease inhibitor cocktail; Sigma P9599). The following steps
were performed at 4ºC or on ice unless otherwise indicated. The lysate was filtered
through one layer of cheesecloth (VWR 21910-107). After filtering, the cheesecloth was
rinsed with another 10 mL of cold Extraction Buffer 1. All 20 mL of Extraction Buffer 1
containing tissue samples were then filtered through one layer of Miracloth (Calbiochem
475855) and centrifuged at 3,000x g for 20 min. The pellet was resuspended in 1.5 mL of
Extraction Buffer 2 (0.25 M sucrose; 10 mM Tris-HCl, pH 8.0; 10 mM MgCl2; 1% Triton
X-100) with protease inhibitors and centrifuged at 2,000x g for 10 min. Each pellet was
resuspended in another 1 mL of Extraction Buffer 2 with protease inhibitors and
centrifuged at 2,000x g. Each pellet was then resuspended in 600 µl of Extraction Buffer
3 (1.7 M sucrose; 10 mM Tris-HCl, pH 8.0; 2 mM MgCl2; 0.15% Triton X-100) with
protease inhibitors, layered on top of another 600 µL of Extraction Buffer 3 and
centrifuged (16,000x g, 1 hour). Pellets from each tube were resuspended in 750 µL of
HEPES buffer (50 mM HEPES-KOH, pH 7.5; 140 mM NaCl; 1% Triton X-100; 0.1%
Na deoxycholate; 1 mM EDTA) with protease inhibitors and the chromatin was sheared
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into ~250-750 bp fragments by sonication (Misonix sonicator: Power 6, 10 seconds, 6
times with 20 second rest). The tubes were then centrifuged (16,000x g, 10 min), and the
supernatant was transferred to a new tube.

4.4.8

A. thaliana iChIP protocol
1 µL of antibody (anti-H3, Abcam ab1791; anti-H3K4me3, Millipore 07-473), or

no antibody was conjugated to 10 L magnetic beads (Dynabeads, Life Technologies
10004D; equilibrated with PBS-T, 50% slurry) for about 30 min. Before performing the
immunoprecipitation, the soluble lysate was precleared by rocking with 5 µL of magnetic
beads (Dynabeads, Life Technologies 10004D; equilibrated with HEPES buffer, 50%
slurry) at 4C for 30 min. 200 µL of the precleared supernatant was added to the beads
conjugated with the respective antibodies and incubated for 2 hours. The beads were
washed sequentially with 1 ml of each of the following: aFA-140 wash buffer (aFA-140
buffer refers to the FA-140 buffer used for Arabidopsis thaliana; 50 mM HEPES-KOH,
pH 7.5; 140 mM NaCl; 1% Triton X-100; 1mM EDTA), aFA-500 wash buffer (as
HEPES buffer, but with 500 mM NaCl and 0.1% Na deoxycholate), and 1xPBS-T. For
the A. thaliana iChIP, on-bead analysis was not used due to the use of SYBR Green
Universal Master Mix for detection of PCR amplification. The immunocomplexes were
eluted by heating at 1000C for 10 min. The samples were cooled to room temperature.
The tubes were then spun at 12,000x g for 1 min and the supernatant removed to a new
tube.
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4.4.9

A. thaliana real-time PCR and statistical analysis
qRT-PCR was performed using the StepOnePlus Real-Time PCR System (Life

Technologies). 4 L of DNA was used for each of the three technical repeats for each of
the three biological repeats. The DNA was amplified using SYBR Green Universal
Master Mix (Life Technologies) and the primers described in Supplementary Table 4.3.
The data were analyzed using the Ct method for PKL-cMYC and the Ct method for
H3K4me3. The mean relative fold changes or Ct values, s.e.m., and statistical
significance values are found in Tables 4.9 and 4.10.

4.5

Discussion

In this study, we describe a new ChIP method that we term immediate ChIP or
iChIP, which greatly reduces the time and cost of performing ChIP analysis. The iChIP
method not only decreases the number of reagents and steps compared to other ChIP
methods but also allows for on-bead qRT-PCR analysis through optimization of the wash
buffers that are used. More importantly, the use of iChIP can improve sensitivity and
enable detection of chromatin-associated proteins and histone post-translational
modifications that were previously difficult or nearly impossible to detect.
Only two papers have shown ChIP data for Jhd2 and four papers for Rph1
(187;292;353-355). It has been reported that Jhd2 and Rph1 can bind 2-fold or less over
background in transcriptionally active intragenic regions, which is considerably lower
than our results using iChIP (Figure 4.2) (292). In addition, previous ChIP data indicated
that JHD2 had a potential 5’-ORF enrichment while Rph1 associated evenly across the
entire ORF (187;292). In contrast, iChIP showed that Jhd2 was evenly detected across
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the genes analyzed. Interestingly, Rph1 was enriched in the gene body of PYK1 while a
potential 5’-ORF enrichment was observed for Rph1 at PMA1 suggesting two different
patterns for Rph1 localization. Because iChIP for Jhd2 and Rph1 showed a 12 to 25-fold
enrichment over background and exhibited greater sensitivity than standard ChIP analysis,
the functional role of Jhd2 and Rph1 can now be explored. For example, by using iChIP,
it is now possible to elucidate how chromatin associated proteins, like Jhd2 and Rph1,
interact with and are recruited to chromatin. Both demethylases contain PHD fingers that
are known to interact with proteins and, interestingly, modified lysine residues (302).
With the increased sensitivity of iChIP further studies can be performed to determine if
these PHD fingers or other domains are involved in nucleosomal binding.
The characterization of the enrichment pattern of various histone PTMs by ChIP
has played a key role in understanding their cellular function. One modification that has
not been fully characterized, especially in yeast, is H3K4 monomethylation. H3K4
monomethylation has been found to play a complex role dependent on the location of the
modification. It has been suggested to play a role at enhancers in Drosophila and in
mammalian cells to help in the regulation of inactive enhancers to the transition to an
active state (142;145). Furthermore, studies have indicated that H3K4 monomethylation
at promoters can act to either activate or repress expression (356). Given the dramatically
different roles associated with H3K4 monomethylation, further understanding this mark
and its contribution to gene expression is important. ChIP-chip of H3K4
monomethylation in yeast previously indicated that H3K4 monomethylation is enriched
at the 3’-ORF of actively transcribed genes (42). In contrast, iChIP revealed that only half
of the actively transcribed genes examined had 3’-ORF enrichment. These data indicate
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that there are at least two distinct patterns of H3K4 monomethylation on actively
transcribed genes, which further illustrates the complexity of H3K4 monomethylation
and the roles it may play in transcription. Interestingly, when comparing the length of the
four actively transcribed genes analyzed the two genes that are relatively shorter show the
3’-ORF enrichment. This suggests that gene length could have an effect on the
enrichment of H3K4 monomethylation.
Several studies have reported that deletion of the E3 ubiquitin ligase, Bre1, or the
E2 conjugating enzyme, Rad6, leads to a loss of global H3K4 di- and trimethylation (6773). Interestingly, H2B monoubiquitination is not necessary for all H3K4
monomethylation, which is globally reduced but still present (Figure 4.4) (67;69;70;73).
Using iChIP we were able to show that 3’-ORF enrichment of H3K4 monomethylation
was lost when either RAD6 or BRE1 was deleted. This indicates that H2B
monoubiquitination is necessary for H3K4 monomethylation 3’-ORF enrichment in a
subset of actively transcribed genes and that the global decrease in H3K4
monomethylation observed in rad6∆ and bre1∆ strains (Figure 5.4) may be caused by the
loss of this enrichment pattern. Further studies using iChIP can now begin to elucidate
how H3K4 monomethylation is deposited on chromatin and if different types of
enrichment patterns across ORFs exist in yeast and other genomes.
Our data in Arabidopsis not only demonstrates that iChIP can be used to determine if
there is correlation between a PTM and a chromatin modifying enzyme, they also
demonstrate that iChIP is a robust approach for organisms with a more complex genomes
such as zebrafish, Drosophila, and mammalian cells. As a result, iChIP is likely to be of
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great utility for a wide range of laboratories to assist in the study chromatin and DNAtemplated processes.
Through the study of H3K4 monomethylation we show that iChIP can be used to
study the cross-talk between PTMs, but iChIP can also be used to quickly test the
association between a PTM and a chromatin-associated protein. Studies have found that
H3K4 methylation serves as a docking sight for other chromatin modifying proteins or
complexes, such histone acetyltransferase complexes, histone deacetylase complexes, and
chromatin remodelers (254;267;269;272;273;304). H3K4 methylation and the proteins
shown to associate with it are mostly associated with active transcription. However, a
recent publication has shown that the A. thaliana chromatin remodeler PKL, that is
associated with the establishment of the repressive H3K27 trimethylation mark, is also
found to be located at the promoter of genes that are actively transcribed. PKL contains a
PHD finger and two chromodomains, which are domains that have been shown to bind to
lysine methylation, including H3K4 trimethylation, leading to the possibility that PKL
may be associated with H3K4 trimethylation (254;267;269;272;273). Our results show
that enrichment of PKL does not correlate with the enrichment of H3K4 trimethylation at
the promoter region of ACT7. This observation reveals that another feature is likely to be
responsible for association of PKL with actively transcribed genes. Whether the same
feature contributes to recruitment of PKL at genes enriched for H3K27me3 is of
considerable interest. Our data in Arabidopsis not only demonstrates that iChIP can be
used to determine if there is correlation between a PTM and a chromatin modifying
enzyme, they also demonstrate that iChIP is a robust approach for organisms with a more
complex genomes such as zebrafish, Drosophila, and mammalian cells. As a result,

143
iChIP is likely to be of great utility for a wide range of laboratories to assist in the study
chromatin and DNA-templated processes.
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4.6

S. cerevisiae iChIP Procedure

Culturing and crosslinking cells
1.

Grow culture(s) of yeast to an optical density of 0.6 OD600/mL.
Note: For the S. cerevisiae ChIP analysis in this manuscript 100 mL
culture size was used; however, this can be adjusted depending on what is
targeted for ChIP and number of targets for ChIP.

2.

Crosslink cells with 2.7 mL of 37% wt/vol formaldehyde for every 100 mL of
culture. Incubate at room temperature for 15 minutes, mixing occasionally.

3.

Collect cells with centrifugation. Wash once with 10 mL H2O. Collect cells again
with centrifugation. Transfer culture to a 1.5 mL microcentrifuge tube with 1 mL
H2O, centrifuge, flash freeze cell pellet with liquid nitrogen, and store at -80°C.
Note: To ensure sufficient cell lysis, the cell pellets should be no more
than 50 mL of starting culture.
Pause Point: Can store cell pellet at -80°C.

Preparation of soluble chromatin
4.

Resuspend cells in 400 μL of sFA-140 lysis buffer.

5.

Add glass beads to the top of the solution. Beat beads 8 times in cold block with 1
minute rest between cycles. Change cold block after 4 cycles.

6.

Punch hole in bottom of tube to separate liquid from beads by placing tube into an
additional 1.5 mL microcentrifuge tube and centrifuging for 9 seconds at top
speed.
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7.

Sonicate cell lysate (Misonix sonicator: Power 6, 10 seconds, 6 times with 10
second rest), and place samples on dry ice for 10 seconds immediately after
sonication.

8.

Centrifuge samples for 5 minutes at top speed at 4°C. Transfer supernatant to a
new tube, and centrifuge samples at top speed for 10 minutes at 4°C. Transfer
supernatant to a new tube. This is the whole cell extract (WCE) containing soluble
chromatin.
Note: If lysate is not clear after the 10 min centrifugation, centrifuge the
sample again for 10 minutes at top speed at 4°C.
Pause Point: Can store soluble chromatin at -20°C.

9.

Transfer 25 μL (6.25%) of WCE to a microcentrifuge tube. Purify DNA for input
using Qiagen PCR purification kit (28106).

Immunoprecipitation
10.

To conjugate antibody to magnetic beads, add 10 μL of Protein G magnetic beads
(Dynabeads Life Technology 10004D), 200 μL of 1xPBS(-K), and antibody in a
1.5 mL microcentrifuge tube. Incubate antibody and beads at room temperature
with rotation for approximately 30 minutes.
Note: For the -H3K4me3, -H3K4me1, -H3, and -FLAG antibodies
used in Figure 1 and Supplemental Figure 1-2, 1 μL antibody serum was
used. This will need to be optimized for each protein targeted for ChIP.
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11.

Separate beads from 1xPBS(-K) buffer by placing the microcentrifuge tube on a
magnetic separator. Allow beads to adhere to side of tube and remove the
supernatant without disrupting the magnetic beads.

12.

Add needed volume of lysate to the magnetic beads conjugated to your antibody.
Add 1X PBS(-K) up to 200 μL total volume.
Note: Volume of lysate used for immunoprecipitation will need to be
optimized for each protein target. For some targets, a larger volume than
200 μL will need to be used.
Optimization: To reduce background, the lysate can be precleared with 5
μL magnetic beads not conjugated to antibody by rotating lysate and beads
for 30 minutes at 4°C.

13.

Rotate lysate and antibody-conjugated beads for 2 hours at 4°C.

14.

After immunoprecipitation, place samples on magnetic separator and remove
supernatant.

15.

For first wash, add 1 mL cold sFA-140 wash buffer. Rotate for 5 minutes at room
temperature. Place samples on magnetic separator, and remove supernatant.

16.

For second wash, add 1 mL cold sFA-500 wash buffer. Rotate for 5 minutes.
Place samples on magnetic separator, and remove supernatant

17.

For third wash, add 1 mL 1xPBS(-K). Rotate for 5 minutes. Place samples on
magnetic separator, and remove supernatant.
Optimization: To reduce background. Use the 1 mL 1xPBS(-K) to be
used in the third wash to transfer magnetic beads to a new microcentrifuge
tube.
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18.

Resuspend beads in 50 μL ddH2O.

qRT-PCR Analysis
19.

For qRT-PCR analysis TaqMan Master Mix (Life Technologies 4369510) was
used in 10 μL reactions (5 μL TaqMan Master Mix, 3.5 μL H2O, 0.5 μL
primer/probe mix (IDT), 1 μL DNA, either immunoprecipitation on magnetic
beads or purified DNA for input).
Note: Magnetic bead mixtures should be vortexed immediately prior to
aliquoting to ensure consistent suspension.

sFA-140 lysis buffer

sFA-140 wash buffer

sFA-500 wash buffer

50 mM HEPES-KOH, pH

50 mM HEPES-KOH, pH

50 mM HEPES-KOH, pH 7.5

7.5

7.5

500 mM NaCl

140 mM NaCl

140 mM NaCl

1 mM EDTA

1 mM EDTA

1 mM EDTA

0.1% Triton X-100

0.1% Triton X-100

0.1% Triton X-100

0.1% Na Deoxycholate

10xPBS(-K) Stock, pH 7.0
390 mM NaH2PO4∙H2O
323 mM Na2HPO4∙7 H2O
1.54 M NaCl
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Figure 4.1 iChIP reduces the time from soluble chromatin to analysis to
approximately 2.5 hours.
(A) Flow diagram depicting the steps of iChIP starting at soluble chromatin to
samples ready for qRT-PCR analysis. (B-D) PrimeTime qPCR probes were targeted
toward the promoter (P), 5’-ORF (5), and 3’-ORF (3) of two actively transcribed
genes PYK1 and PMA1, as well as a sub-telomeric gene YFR057W comparing iChIP
and standard ChIP methods. ChIP analysis was performed on BY4741 wild-type (WT)
and set1 strains using antibodies specific for H3K4me3 and histone H3. Input and
histone H3 were used for normalization. ChIP analysis is relative to the H3K4me3
signal for the set1 strain. Three biological replicates with three technical repeats
were used for all iChIP and standard ChIP analysis. The error bars represent the
standard error of the mean.
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Figure 4.2 iChIP can detect a greater range of factors compared to standard
ChIP.
(A-B) PrimeTime qPCR probes were targeted toward the promoter (P), 5’-ORF (5),
and 3’-ORF (3) of PYK1 and PMA1 comparing iChIP and standard ChIP methods
that were performed on BY4741 WT strain and a JHD2-3xFLAG strain with the tag
integrated at JHD2’s endogenous locus. (C-D) PrimeTime qPCR probes were
targeted toward the promoter (P), 5’-ORF (5), and 3’-ORF (3) of PYK1 and PMA1
comparing iChIP and standard ChIP methods that were performed on BY4741 WT
strain and a RPH1-3xFLAG strain with the tag integrated at RPH1’s endogenous
locus. An α-FLAG antibody was used for immunoprecipitation of both Jhd2-3xFLAG
and Rph1-3xFLAG for both ChIP methods. Input was used for normalization, and
ChIP analysis is relative to a WT untagged control. Three biological replicates with
three technical repeats were used for all iChIP and standard ChIP analysis. The error
bars represent the standard error of the mean.
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Figure 4.3 Two distinct patterns of H3K4 monomethylation were found using
iChIP.
(A-C) PrimeTime qPCR probes were targeted toward the promoter (P), 5’-ORF (5),
and 3’-ORF (3) of PYK1, MDH2, PMA1, and HMG1. (A-C) iChIP analysis was
performed on BY4741 set1, wild-type (WT), rad6 and bre1 strains using
antibodies specific for H3K4me1 and histone H3. Input and histone H3 were used for
normalization. iChIP analysis is relative to the H3K4me1 signal for the set1 strain.
Three biological replicates with three technical repeats were used for iChIP analysis.
The error bars represent the standard error of the mean.

151

Figure 4.4 Global H3K4 monomethylation is reduced in rad6∆ and bre1∆ strains.
Immunoblots of whole cell extracts from set1∆, WT, rad6∆, and bre1∆ strains were
analyzed using methylation specific antibodies targeting H3K4 mono-, di- and
trimethylation. A set1∆ strain was used as a negative control. H3 antibody was used
as a loading control
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Figure 4.5 iChIP can be utilized in a more complex genome such as A. thaliana.
(A) Schematic of the four different regions analyzed for H3K4me3 and PKL-cMYC
using region specific primers across the euchromatic gene ACT7 and the
heterochromatic gene MULE. (B) An antibody specific for H3K4me3 was used to
detect methylation levels at both genes using iChIP. The H3K4me3 signal is
normalized to input and histone H3. (C) iChIP analysis of PKL-cMYC was
performed using a MYC specific antibody, and the signal was normalized to input.
Three biological replicates were used for iChIP analysis. The error bars represent the
standard error of the mean. All work done with A. thaliana was performed by Brett
Bishop from Dr. Joe Ogas’ lab at Purdue University.
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Figure 4.6 Detailed flow diagram depicting the 19 steps needed to perform
iChIP in S. cerevisiae.
For further details about each step refer to S. cerevisiae iChIP Procedure.
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Figure 4.7 Detailed iChIP timeline.
This timeline illustrates the estimated time for each process leading to the total time
from culturing cells to getting data being approximately 6 hours. For further details
about each step refer S. cerevisiae iChIP Procedure.
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Table 4.1 Yeast strains used for iChIP and standard ChIP procedures
Yeast Strain Genotype
Reference
BY4741
Open
MAT his3 leu20 LYS2 met150 ura30
Biosystems
SDBY1210 BY4741: MAT his3 leu20 LYS2 met150
(154)
ura30 set1::HygMX
SDBY1107 BY4741: MAT his3 leu20 LYS2 met150
(67)
ura30 JHD2 3xFLAG::KanMX
SDBY1319 BY4741: MAT his3 leu20 LYS2 met150
This study
ura30 RPH1 3xFLAG::KanMX
rad6∆
Open
BY4741: MAT his3 leu20 LYS2 met150
Biosystems
ura30 rad6::KanMX
bre1∆
Open
BY4741: MAT his3 leu20 LYS2 met150
Biosystems
ura30 bre1::KanMX
Table 4.2
Primer
name
PYK1
promoter
PYK1 5’

PYK1 3’

PMA1
promoter
PMA1 5’
PMA1 3’

MDH2
promoter

Probe sets for iChIP and standard ChIP analysis in S. cerevisiae
Sequence 5’-3’
/56FAM/CGAATATCG/ZEN/TTTTGATGGCGAGCCTTT/3IABkFQ/
AGAGGTTCTTGGAAATGAAAAGTTAC
CCTTCCCATATGATGCTAGGTAC
/56FAM/AGAATTGTA/ZEN/CCCAGGTAGACCATTGGC/3IABkFQ/
TTCTGATTTCTGGACCCTTGG
CATTGACAACGCCAGAAGTC
/56FAM/CTCTCACTT/ZEN/GTACAGAGGTGTCTTGGGA/3IABkFQ/
TCAGAGACAGGTTCCTTTTCG
TTACCAGATGCCCAAGAGC
/56-FAM/CCGCTTATG/ZEN/CTCCCCTCCATTAGTT/3IABkFQ/
TGACGAAACGTGGTCGATG
AAATTAGATGTTAGACGATAATGATAGGAC
/56-FAM/TTGCCGCCG/ZEN/GTGAAGCTAGA/3IABkFQ/
GACAGTGATAACGATGGTCCAG
ACCGTAAGATGGGTCAGTTTG
/56FAM/CGTGTCTGG/ZEN/ATCTGGTCTATCGGTATCT/3IABkFQ/
ACTGGACTGATATTGTTACTGTCG
CATCAATCTGTCAAAGGCTTCAG
/56FAM/AAAGTCAAA/ZEN/TCGGACCTTCCCAACCT/3IABkFQ/
TTTGTTTAGTGGCATTTTGTGTTG
CCTTAGATACCTTCCGTAGTTCC
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Table 4.2 continued
MDH2 5’ /56-FAM/TGGTATCGG/ZEN/GCAGTCGTTATCGC/3IABkFQ/
CTGGTATTGCAACTGAGCTTTC
ATTGCCATTTTAGGTGCTGC
MDH2 3’ /56-FAM/ATTATTGCC/ZEN/TCTGGTGGACGGTGC/3IABkFQ/
AACTTCCCCATTGCTCCTG
GTTGCGTTCCATGTCGTTC
HMG1
/56-FAM/AGTGCGAAG/ZEN/AAAACGTAGTGCGAGT/3IABkFQ/
promoter GAAGAGTTGGAAGACCTTCAGC
AGATCCTATAGCTAGTACGGACC
HMG1 5’ /56FAM/TGAATGACG/ZEN/GATAGATAAGCGAATGCGG/3IABkFQ/
CGGCGAAACGACCAATTC
GTGTTGGAGTCTTTATTTGGAGC
HMG1 3’ /56-FAM/AGGTTTTGT/ZEN/TGGTTCAGCAGGTTTCC/3IABkFQ/
ACGATTTATATCAGTGGCGTCC
CGGCCATTTGGTTCAAAGTC
YFR057W /56promoter FAM/ACAAGGGAA/ZEN/CAATGAGCAGAGGGAAA/3IABkFQ/
CAAACAAGTAGGAATGCGAAAGG
AAGTGCTAAAGGAATCCCCAG
YFR057W /56-FAM/TGCTCGGCC/ZEN/AAGTCAAGCG/3IABkFQ/
5’
GCTTGGCGGTGTCTTTAATG
TGATATTTGGACCTACTAGTGTCTATAG
YFR057W /563’
FAM/TGTCAAAGG/ZEN/AATTTTTTGCGCCTAGTGC/3IABkFQ/
AAAGGATTTTAGCAACGACTTCG
TTGTCGAATCTTCCAGTAAATTTCTC
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Table 4.3 Primers for iChIP analysis in A. thaliana
Gene
Region Forward primer sequence 5’-3’
Reverse primer sequence 5’-3’
ACT7
ACT7

1
2

ACT7

3

ACT7

4

MULE

1

MULE

2

MULE

3

MULE

4

TTTCGGCCCGTTTTATCGT
GAGCCACCATGCTTCTCATT
TGGGGGTTGCTTGTTATGTG AACAGCGAGAGATCGACAG
A
AATACAGTGTCTGATCGGA GCGGAATTGGGATTTTTACC
GGAT
T
GAATAGTCCCTCGGGGTTG TCGTGTTGGAATCAGTTGAT
A
GA
CGAAGCGTTTGATCGGGTA TTCGACTGTTTACCAACTGG
T
A
CTTGGAACTTCCCGAGAGC CACCACTTCACAAACCCACC
TT
TA
CCCATGATTGACAGTCGTT
AGGGCTATGAGTTGCCAAG
GA
A
ACACCTTCGAGACTTCCCTT TGTACAGCGGCGTTAAAACA

Table 4.4 ChIP analysis of H3K4me3 comparing iChIP to standard ChIP
Procedure
Gene location
Fold change
P value
relative to set1
iChIP
PYK1 promoter
44.29 +/- 15.94
0.053
iChIP
PYK1 5’
216.79 +/- 33.37 0.003
iChIP
PYK1 3’
23.88 +/- 5.72
0.016
Standard
PYK1 promoter
47.83 +/- 14.28
0.031
Standard
PYK1 5’
161.06 +/- 37.43 0.013
Standard
PYK1 3’
26.30 +/- 6.41
0.017
iChIP
PMA1 promoter
50.90 +/- 14.12
0.024
iChIP
PMA1 5’
107.70 +/- 28.40 0.020
iChIP
PMA1 3’
15.17 +/- 5.56
0.063
Standard
PMA1 promoter
49.25 +/- 11.84
0.015
Standard
PMA1 5’
91.88 +/- 17.18
0.006
Standard
PMA1 3’
10.37 +/- 1.80
0.007
iChIP
YFR057W promoter
7.34 +/- 2.58
0.070
iChIP
YFR057W 5’
5.72 +/- 1.65
0.046
iChIP
YFR057W 3’
7.62 +/- 3.74
0.151
Standard
YF057W promoter
6.26 +/- 1.57
0.028
Standard
YFR057W 5’
5.79 +/- 1.42
0.028
Standard
YFR057W 3’
6.94 +/- 1.55
0.019
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Table 4.5 ChIP analysis of Jhd2-3xFLAG comparing iChIP to standard ChIP
Procedure
Gene location
Fold change
P value
relative to WT
iChIP
PYK1 promoter
11.37 +/- 2.51
0.015
iChIP
PYK1 5’
11.45 +/- 0.33
6.21x10-6
iChIP
PYK1 3’
13.50 +/- 3.25
0.018
Standard
PYK1 promoter
1.17 +/- 0.15
0.330
Standard
PYK1 5’
-1.03 +/- 0.18
0.874
Standard
PYK1 3’
-1.02 +/- 0.11
0.851
iChIP
PMA1 promoter
10.33 +/- 4.85
0.127
iChIP
PMA1 5’
8.40 +/- 1.03
0.002
iChIP
PMA1 3’
9.68 +/- 0.62
0.0002
Standard
PMA1 promoter
1.05 +/- 0.09
0.651
Standard
PMA1 5’
1.03 +/- 0.19
0.889
Standard
PMA1 3’
-1.03 +/- 0.14
0.809
Table 4.6 ChIP analysis of Rph1-3xFLAG comparing iChIP to standard ChIP
Procedure
Gene location
Fold change
P value
relative to WT
iChIP
PYK1 promoter
9.26 +/- 1.52
0.006
iChIP
PYK1 5’
16.96 +/- 2.27
0.002
iChIP
PYK1 3’
19.55 +/- 2.80
0.003
Standard
PYK1 promoter
1.15 +/- 0.24
0.566
Standard
PYK1 5’
1.35 +/- 0.24
0.219
Standard
PYK1 3’
1.32 +/- 0.29
0.335
iChIP
PMA1 promoter
15.47 +/- 3.72
0.018
iChIP
PMA1 5’
24.92 +/- 3.00
0.001
iChIP
PMA1 3’
20.53 +/- 1.77
0.0004
Standard
PMA1 promoter
1.30 +/- 0.38
0.476
Standard
PMA1 5’
1.28 +/- 0.25
0.316
Standard
PMA1 3’
1.30 +/- 0.13
0.079
Table 4.7 iChIP analysis of H3K4me1
Gene location
Fold change relative to set1
PYK1 promoter
4.76 +/- 1.36
PYK1 5’
4.87 +/- 0.90
PYK1 3’
24.73 +/- 5.55
MDH2 promoter
3.43 +/- 0.18
MDH2 5’
8.91 +/- 0.75
MDH2 3’
31.66 +/- 4.72
PMA1 promoter
5.12 +/- 1.48
PMA1 5’
8.60 +/- 1.21
PMA1 3’
5.31 +/- 0.32
HMG1 promoter
8.99 +/- 2.43
HMG1 5’
6.56 +/- 1.63
HMG1 3’
13.07 +/- 2.66

P value
0.051
0.012
0.013
0.0002
0.0005
0.003
0.050
0.003
0.003
0.030
0.027
0.011
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Table 4.8 iChIP analysis of H3K4me1 in a rad6∆ and bre1∆
rad6∆
bre1∆
Gene location
Fold change
Gene location
Fold change
relative to set1∆
relative to set1∆
PYK1 promoter
4.23 +/- 2.39
PYK1 promoter
2.61 +/- 1.08
PYK1 5’
4.11 +/- 0.27
PYK1 5’
5.11 +/- 0.78
PYK1 3’
1.47 +/- 0.21
PYK1 3’
1.89 +/- 0.29
MDH2 promoter
2.34 +/- 0.61
MDH2 promoter
2.21 +/- 0.66
MDH2 5’
3.47 +/- 0.34
MDH2 5’
6.02 +/- 2.65
MDH2 3’
4.56 +/- 2.76
MDH2 3’
5.04 +/- 2.85
PMA1 promoter
2.33 +/- 0.28
PMA1 promoter
1.45 +/- 0.34
PMA1 5’
2.63 +/- 0.69
PMA1 5’
3.55 +/- 1.06
PMA1 3’
1.99 +/- 0.98
PMA1 3’
1.39 +/- 1.06
HMG1 promoter
4.14 +/- 1.24
HMG1 promoter
5.76 +/- 3.37
HMG1 5’
9.14 +/- 1.91
HMG1 5’
10.87 +/- 2.88
HMG1 3’
6.33 +/- 2.85
HMG1 3’
5.64 +/- 2.45
Table 4.9 iChIP analysis of H3K4me3 in A. thaliana
Gene
Region
Ct
ACT7
1
0.14 +/- 0.01
ACT7
2
0.65 +/- 0.08
ACT7
3
0.16 +/- 0.03
ACT7
4
0.15 +/- 0.01
MULE
1
0.06 +/- 0.01
MULE
2
0.06 +/- 0.01
MULE
3
0.06 +/- 0.01
MULE
4
0.11 +/- 0.03
All work done with A. thaliana was performed by Brett Bishop from Dr. Joe Ogas’
lab at Purdue University.
Table 4.10 iChIP analysis of MYC-PKL in A. thaliana
Gene
Region
Fold change relative to WT
ACT7
1
4.58 +/- 0.40
ACT7
2
5.62 +/- 1.79
ACT7
3
3.65 +/- 0.75
ACT7
4
8.00 +/- 2.76
MULE
1
1.83 +/- 0.29
MULE
2
1.83 +/- 0.51
MULE
3
1.87 +/- 0.14
MULE
4
2.48 +/- 0.52

P value
0.039
0.019
0.050
0.015
0.051
0.082
0.072
0.087
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CHAPTER 5. SUMMARY AND FUTURE PROSPECTS

5.1

Declaration of collaborative work

In the Jhd2-nucleosomal interaction study, structural modeling of H2A and H2B
was done in PyMOL by Kelly Sullivan from Joe Kappock’s lab in the Department of
Biochemistry at Purdue University. All other experiments and analysis were done by
Kayla Harmeyer.
In mammalian iChIP optimization study, LNCaP cell maintenance and
formaldehyde cross-linking was performed by Renee Vickman in collaboration with
Tim Ratliff in the Department of Comparative Pathobiology at the Purdue University
College of Veterinary Medicine. The protocol for generating soluble chromatin from
mammalian cells was given to us by Peter Cheung from the Department of Medical
Biophysics at the University of Toronto. All other experiments and analysis were
done by Kayla Harmeyer.

5.2

Summary of results

To accommodate the entire genome inside the nucleus of a eukaryotic cell,
DNA is packaged in the DNA-protein complex called chromatin (1-5). Chromatin
consists of nucleosomes, which are 146 base pairs of DNA wrapped around an
octamer of four histone proteins (1-5). Two of each of these four histone proteins, H3,
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H4, H2A, and H2B, form the nucleosomal core (1-5). These histone proteins also
have tails that extend from the core and can be chemically modified. These posttranslational modifications include acetylation, phosphorylation, ubiquitination, and
methylation (11;39;40). These modifications can affect the high-order chromatin
structure by directly altering the chemical nature of the nucleosome and by acting as
docking sites for other proteins (11;39).
Lysine methylation has been found to act as a docking site for many proteins;
therefore, it has been found to be involved in many cellular processes, including X
inactivation, cell differentiation, and DNA damage (11;39;105;106;108;112;357). In
our studies, we use Saccharomyces cerevisiae as a model organism. In S. cerevisiae
there are three major sites of lysine methylation, H3K4, H3K36, and H3K79 (118).
The main focus of the studies presented in this thesis is the establishment and removal
of H3K4 methylation. This mark is commonly associated with active transcription
and found to have a specific enrichment pattern across actively transcribed genes
(42;86;105). H3K4 trimethylation is enriched at the 5’ end and transcriptional start
site (TSS) (42). H3K4 dimethylation is found throughout the open reading frame
(ORF), and H3K4 monomethylation is found enriched at the 3’ end (42).
H3K4 methylation is catalyzed by the histone methyltransferase Set1, found
in the multisubunit complex Set1C or COMPASS (117;121;147-149). The only
known histone demethylase found in S. cerevisiae to target H3K4 methylation is
JmjC domain-containing histone demethylase 2 or Jhd2 (67;118;185;186). This
demethylase is part of a large class of histone demethylases characterized with having
a catalytic JmjC domain capable of demethylating mono-, di-, and trimethylated
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lysine residues (127;132;133). Jhd2 has homologues in other organisms including
Drosophila and humans (194-197;201). The human homologues are found in the
JARID1 family, which includes four members: JARID1A (RBP2/KDM5A),
JARID1B (PLU1/KDM5B), JARID1C (SMCX/KDM5C), and JARID1D
(SMCY/KDM5D) (138;201-204). These proteins have been associated with multiple
diseases including cancer and mental retardation (201). Using the yeast model system
we can gain valuable information on how the histone demethylase Jhd2 functions,
which we can then apply to human demethylases. Jhd2 and Set1 are the only enzymes
found in yeast that directly modulate H3K4 methylation; however, other
modifications have been found to affect the establishment and removal of H3K4
trimethylation through Set1 and Jhd2 by what is called cross-talk. Here we use yeast
genetics to further study cross-talk between histone acetylation and H3K4
trimethylation to further understand the complex language of histone posttranslational modifications.

5.2.1

H3K4 trimethylation is modulated by H3K14 acetylation through histone
demethylation
H3K4 trimethylation is strongly correlated with H3 acetylation levels,

especially acetylation of H3K14. Both H3K4 trimethylation and H3K14 acetylation
have a similar enrichment pattern in that they are both enriched at the 5’ end and TSS
of actively transcribed genes (42). Studies have also shown that deletion of histone
acetyltransferases that target H3K14 results in not only a reduction in H3K14
acetylation levels but also H3K4 trimethylation levels (281;282;288). Furthermore, a
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mutational analysis of amino acid residues in each of the core histones found that
mutation of H3K14 causes a decrease in global H3K4 trimethylation levels (283). We
hypothesized that this reduction in H3K4 trimethylation levels when H3K14 was
mutated is a result of histone demethylation by Jhd2. We show that mutating lysine
14 to an arginine or a glutamine had similar effects on specifically H3K4
trimethylation levels (Figure 2.1A and 2.1C). We then made the H3K14 mutations in
a strain that had JHD2 deleted. Deletion of JHD2 resulted in the recovery of WT
H3K4 trimethylation levels in the H3K14R and H3K14Q mutant strains (Figure 2.1B
and 2.1D).
We further show that deletion of the histone acetyltransferase GCN5, which is
part of the SAGA complex, also resulted in a decrease in H3K4 trimethylation levels
dependent on Jhd2’s demethylase activity (Figure 2.1F and Figure 2.3A and 2.3B).
During our study, another group also showed that deletion of two genes, ADA2,
another member of the SAGA complex, and SAS3, a histone acetyltransferase found
in the NuA3 complex, also caused a decrease in H3K4 trimethylation levels in a Jhd2
dependent manner (288). However, they characterize the mechanism of how H3K14
acetylation affects Jhd2. We show that deletion of GCN5 results in increased levels of
Jhd2 interacting with chromatin (Figure 2.5C and 2.5D). We also show that deletion
of three histone deacetylases increase H3K14 acetylation and H3K4 trimethylation
while resulting in a reduction in the levels of Jhd2 interacting with chromatin (Figure
2.6A-C). To show that this is a direct mechanism, we did in vitro binding analysis and
showed that Jhd2 can interact with an unmodified H3 N-terminal tail, but this
interaction is reduced when H3K14 or H3K18 is acetylated (Figure 2.6D).
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We wanted to know if this mechanism of cross-talk between H3K4
trimethylation and H3K14 acetylation by histone demethylation was conserved. To
do this a complementation assay and yeast genetics were used. The human JARID1B
histone demethylase was expressed in yeast and found to be functional (Figure 2.8A).
Furthermore, we wanted to know if JARID1B’s activity could be modulated by the
H3K14 site. JARID1B was expressed in a yeast strain with a WTH3 background and
a yeast strain expressing a H3K14 mutation. Reduction of H3K4 trimethylation by
JARID1B was even further enhanced when H3K14 is mutated indicating that this
mechanism is conserved (Figure 2.8B). Furthermore, knock-down of Gcn5 in
Drosophila results in a decrease in H3K14 acetylation and H3K4 trimethylation,
similar to what is observed in S. cerevisiae (Figure 2.8C).
Finally, we wanted to understand what to know if this cross-talk mechanism
was involved in a biological function. Previous reports in S. pombe have shown that
Gcn5 is involved in transcription elongation, and deletion of GCN5 results in a 6-AU
sensitivity (Figure 2.9A) (296;309;310). Furthermore, if we delete JHD2 in a gcn5
background we were able to rescue the gcn5 6-AU sensitivity phenotype (Figure
2.9A). This indicates that proper H3K4 trimethylation levels may be important for
transcriptional elongation. Deletion of SET1 also has a 6-AU sensitivity phenotype,
but how it or H3K4 methylation is involved with transcriptional elongation has not
been examined. Further analysis will need to be performed to investigate H3K4
trimethylation’s role in this process, for example if H3K4 trimethylation is involved
in recruitment of elongation factors or if H3K4 methylation is necessary for the
proper removal or reincorporation of the nucleosomes before or after the elongating
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RNAPII, respectively. This study is the first to show that modulating H3K4
trimethylation levels effects elongation, and much more work will need to be done to
understand what role it plays in this process.

5.2.2

Rpd3 and H3K4 trimethylation
H3K4 trimethylation has a distinct pattern across the open reading frame of

actively transcribed genes (42). However, how this pattern is established or
maintained is not known. Through our previous study we show that histone
acetylation has a direct effect on H3K4 trimethylation levels and that deletion of three
histone deacetylases results in an increase in global H3K4 trimethylation levels
(Figure 2.6A and Figure 3.1A)). We wanted to know where this increase of H3K4
trimethylation was located across the open reading frame of actively transcribed
genes. Through ChIP analysis we show that there was a significant increase in H3K4
trimethylation at the 5’-ORF and 3’-ORF of the genes analyzed (Figure 3.2A and
3.2B). Interestingly, even though no global change in H3K36 trimethylation was
observed, ChIP analysis revealed that there was a significant increase in H3K36
trimethylation levels at the 3’-ORF of PYK1 and PMA1, suggesting that HDACs
could also play a role in maintaining proper H3K36 trimethylation levels as well
(Figure 3.1B and Figure 3.2C and 3.2D). Through this analysis we observed a
significant loss of histone H3 levels across both genes analyzed; however, no change
in the transcript levels of the two transcriptionally active genes was observed (Figure
3.4). Therefore, we wanted to know if the deletion of the three histone deacetylases
had any effect on the transcript levels of genes, and found that there was a either a
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loss of silencing or derepression in a subset of genes analyzed to varying degrees
(Figure 3.5). Further genome wide analysis would need to be performed to further
classify what genes are affected by deletion of multiple HDACs.
We wanted to further study what roles histone deacetylases play on the levels
of H3K4 trimethylation across the ORF of actively transcribed genes. To do this
without the decrease in histone H3 levels, individual deletions of the histone
deacetylases in the 3-HDAC strain were tested to see if they affected H3K4
trimethylation levels. We found that deletion of RPD3 caused a global increase in
H3K4 di- and trimethylation. ChIP analysis of the rpd3 strain showed that there was
a significant increase, most notably at the 3’-ORF of the actively transcribed genes
analyzed (Figure 3.6 and 3.7). However, how Rpd3 affects H3K4 trimethylation
levels is unknown.
Rpd3 as a member of the Rpd3S complex has previously been associated with
H3K36 trimethylation to play a role in repressing cryptic transcription
(98;307;320;321). One study has shown that H3K4 trimethylation was increased
when members of the Rpd3S complex were deleted, and this was hypothesized to be
as a result of cryptic transcription (98;308). Other studies have shown that there is an
increase in H3K4 di- and trimethylation at the GAL10-GAL1 locus with the
transcription of a ncRNA (331;332). Further analysis will need to be performed to test
if cryptic transcription or the transcription of a ncRNA is occurring at the genes
analyzed, PYK1 and PMA1, in a rpd3 strain. Furthermore, deletion of RPD3 did not
affect the localization of either Jhd2 or Set1 (Figure 3.8). Therefore, if Rpd3 affects
the activity of either of these proteins will need to be investigated.
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5.3

Future prospects

The knowledge gained by these studies brings further insight into how H3K4
methylation is modulated in the cell and can lead to both short term and long term
expansion of the knowledge of how histone H3K4 demethylases function and how
this function can be regulated. Based on the conservation of the H3K4 histone
demethylases, information gained through the study of yeast Jhd2 can be potentially
applied to how the human demethylases function. Of the four histone demethylases
three have been shown to play roles in diseases such as cancer and mental retardation
(201). JARID1B has been described as a potential target for cancer drugs due to its
expression in many types of cancers and limited expression in normal adult tissue
(209;210;244). Furthermore, knockdown of JARID1B has been shown to reduce
tumor growth and cell proliferation (138). From our study, mutation of H3K14 affects
how JARID1B functions in demethylation of H3K4 trimethylation in yeast. A
previous study had shown that the first PHD and third PHD finger of JARID1B
interacts with the H3 N-terminal tail (35;139). By further examining how JARID1B
interacts with the H3 N-terminal tail and characterizing if H3K14 acetylation inhibits
this interaction potentially through binding of one of JARID1B’s PHD fingers,
inhibitors of this protein can be designed to disrupt its interaction with the
nucleosome, potentially through an acetylation mimic.
Furthermore, our study begins to elucidate what role H3K4 demethylases may
play in transcriptional elongation and transcriptional turnover. Other histone
modifications and histone modifying enzymes have been shown to play a role in this
process, such as H3K36 methylation and histone deacetylases. These enzymes
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function to reset a more compact chromatin state as RNA polymerase II transcribes
through an open reading frame (98;307;308). The reason for this is to prevent
transcription of cryptic promoters (98;307;308). Our results suggest that Jhd2 may
play a role in negatively regulating transcriptional elongation and could potentially
play a role in removing H3K4 trimethylation after the RNAPII to cause a more
compact chromatin state. Another hypothesis is that Jhd2 plays a role to negatively
affect elongation through RNA polymerase II pausing. H3K4 trimethylation has been
shown to be involved in promoting transcriptional elongation through modulating the
RNAPII’s release from initiation to elongation (358). Furthermore, in Drosophila
ASH2, a member of the H3K4 methyltransferase complex, has been implicated in
playing a role in transcriptional pausing (359). However, if or under what conditions
Jhd2 or H3K4 demethylation plays a role in this process is unknown. The 6-AU
phenotype is only observed if Jhd2 is overexpressed or when GCN5 is deleted
indicating the cellular levels of Jhd2 or Jhd2 protein level at chromatin may be critical
in its role in transcriptional elongation (Figure 2.9B and 2.9C). Under standard
growth conditions, Jhd2 protein is observed at low levels; however, Jhd2 protein has
been shown to shown to be modulated through 23S proteasome degradation (67).
However, what conditions alter Jhd2 protein levels and if Jhd2 protein regulation is
involved in negatively regulating transcription elongation is not known. Therefore,
further understanding of Jhd2 protein regulation and if this regulation affects
transcriptional elongation will give further insight into the biological role Jhd2 plays
in the cell.
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Finally there are immediate short term experiments that can be performed to
further examine how the histone deacetylase Rpd3 is affecting the H3K4
trimethylation pattern, which was discussed in the section 3.5. Furthermore, we have
evidence that suggests that Jhd2 interacts with the nucleosome independent on the H3
n-terminal tail. Therefore, there are experiments that can be immediately performed
to further characterize how Jhd2 interacts with the nucleosome. Finally, we show that
iChIP is a versatile method that can be used to detect histone post-translational
modifications and chromatin associated proteins in both Saccharomyces cerevisiae
and Arabidopsis thaliana. The future of this method is to optimize the procedure for
mammalian cells and use iChIP to answer biologically relevant questions about the
role in H3K4 methylation in cholesterol biosynthesis in prostate cancer.

5.3.1

Determining how Jhd2 interacts with the nucleosome to demethylate H3K4
methylation
In our studies we show that H3K4 trimethylation is modulated by H3K14

acetylation via the histone demethylase Jhd2. We further show that we can modulate
the levels of Jhd2 protein interacting with chromatin by deletions of either a histone
acetyltransferase or multiple histone deacetylases. One study of Jhd2 revealed that it
can interact with chromatin independent of the H3 N-terminal tail (187). However,
we show through an in vitro analysis that Jhd2 can directly interact with an
unmodified H3 N-terminal tail (Figure 2.6D). This indicates that Jhd2 has two
different interaction sites with the nucleosome, its substrate the H3 N-terminal tail,
and another unknown site. Furthermore, what domains or regions of Jhd2 that
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mediates either of these interactions is unknown. Because Jhd2 is conserved,
identifying how Jhd2 can bind to the nucleosome and where its binding sites are on
the nucleosome may provide insight into new mechanisms of inhibiting the
demethylase activity of the JARID1 proteins.
Both PHD fingers and charge-charge interactions have been shown to
facilitate the interaction between histone modifiers to the nucleosome. PHD fingers
have been shown to mediate many protein-nucleosomal interactions. These domains
have been shown to interact with lysine residues specifically those that are methylated,
but also unmodified or even acetylated lysine residues (135-137). Furthermore,
previous studies in our lab have shown that a basic patch on histone H4 is necessary
for H3K79 methylation by Dot1 (314). Our lab has also shown that charge-charge
interactions are important for the interaction between members of the Set1 complex,
Set1 and Swd1 (147). Jhd2 has a single PHD finger upstream of the catalytic JmjC
domain, and we have also identified two acid patches directly upstream of the PHD
finger and an acid and basic patch downstream of the JmjC domain (Figure 5.1A).
Before determining if the PHD finger or the acid/basic patches are necessary
for Jhd2’s interaction with the nucleosome, we first wanted to test what regions of
Jhd2 are important for its demethylase activity. To test this Jhd2 and the individual
mutations were overexpressed from the constitutively active promoter (PYK1p).
Expression of JHD2 from this promoter had been previously shown to reduce global
H3K4 trimethylation levels. As previously reported from our lab, the PHD finger was
necessary to observe a loss in global H3K4 trimethylation levels (Figure 5.1B) (67).
Individual deletions of the first acid patch (AP1), the third acid patch (AP3), and the
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basic patch (BP) resulted in a loss of Jhd2’s ability to reduce global H3K4
trimethylation when overexpressed (Figure 5.1B). Deletion of the second acid patch
(AP2) did not affect Jhd2’s ability to reduce global H3K4 trimethylation levels. These
data indicate that the PHD finger as well as AP1, AP3, and BP are necessary for the
decrease in H3K4 trimethylation when Jhd2 is overexpressed making them ideal
candidates for the potential domains/motifs of Jhd2 that are directly interacting with
the nucleosome.
Jhd2’s PHD finger contains similar conserved residues to JARID1B’s Nterminal PHD finger (PHD1) (35). Recent publications have shown that PHD1 of
JARID1B interacts with an unmodified H3 N-terminal tail (35;139). Further analysis
showed that acidic residues directly upstream of JARID1B’s PHD1 were important
for its interaction (35). Our in vitro binding data suggests that Jhd2 also interacts with
the unmodified H3 N-terminal tail (Figure 2.6D). Therefore, we hypothesized that
Jhd2’s PHD finger and upstream acidic residues mediate Jhd2’s interaction of the H3
N-terminal tail. To test this hypothesis an in vitro binding assay was performed.
Because AP2, the acid patch directly upstream of the PHD finger did not affect
Jhd2’s ability to reduce H3K4 trimethylation levels but AP1 was necessary (Figure
5.1), the portion of Jhd2 from AP1 through the PHD finger was used for this in vitro
binding assay. Preliminary results indicate that Jhd2(AP1-PHD) does interact with the
H3 N-terminal tail. Interestingly, similar to full-length Jhd2, this interaction also
disrupted when H3K14 was acetylated (Figure 5.2). Further biological repeats would
need to be performed to determine that Jhd2(AP1-PHD) interacts with the H3 Nterminal tail in a H3K14 acetylated dependent manner.
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To further analyze if Jhd2 interacts with the nucleosome independent of the
H3 N-terminal tail, a ChIP analysis was performed targeting Jhd2 in a yeast strain
that had the H3 N-terminal tail deleted. First a Western blot analysis was performed
to determine Jhd2-3xFLAG protein expression in the H3 1-23 strain. An -FLAG
specific antibody indicated that Jhd2 protein expression was not altered in the H3 123 strain compared to the WT strain (Figure 5.3A). When ChIP analysis was
performed, Jhd2 was shown to interact with chromatin to the same extent in a WT
background compared to the H31-23 strain at the two genes analyzed (Figure 5.3B).
This is consistent with what was previously reported using a chromatin fractionation
assay showing that Jhd2 was able to be pulled down in the chromatin fraction when
the H3 N-terminal tail was deleted (187). To determine what domains or motifs are
important for the interaction between Jhd2 and the nucleosome independent of the H3
N-terminal tail, further analysis would need to be performed using truncations of Jhd2.
The mutational screen that identified H3K14 affecting H3K4 trimethylation
levels also identified mutations in H2A that caused a reduction in H3K4
trimethylation levels (283). To test if this reduction in H3K4 trimethylation is
dependent on Jhd2, H2A mutations were expressed in a jhd2 strain. When H2A E65
and L66 were mutated to an alanine, H3K4 trimethylation was lost; however, this was
found to be independent of Jhd2 (Figure 5.4A). Interestingly, H2A L66A also
resulted in a loss of H3K79 trimethylation levels (Figure 5.4A). Mutating H2A N69
and D73 to an alanine resulted in a decrease in H3K4 trimethylation and a slight
recovery was observed when JHD2 was deleted (Figure 5.4A). Interestingly,
structural analysis of the nucleosomal surface revealed that not only are H2A N69
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and H2A D73 solvent accessible they seem to form a surface with a residue in H2B,
(H2B H52) (Figure 5.4B and C). Further mutational analysis will need to be
performed to determine if this H2A-H2B surface is involved in Jhd2’s interaction
with the nucleosome.
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Figure 5.1 Jhd2’s PHD finger and acid and basic patches are required for
reduction of H3K4 trimethylation levels when overexpressed.
(A) Schematic of Jhd2 including domains and acid/basic patches. (B) FLAG-tagged
Jhd2 and mutants were overexpressed utilizing the PYK1 promoter in a WT BY4741
strain. Whole cell extracts were analyzed for levels of mono-, di-, ant trimethylated
H3K4. An anti-FLAG Western blot was used to analyze expression of Jhd2 and the
Jhd2 mutants. H3 was used as a loading control.
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Figure 5.2 Jhd2(AP1-PHD) interacts with the H3 N-terminal tail dependent on
H3K14 acetylation.
Purified GST-Jhd2(AP1-PHD) was incubated with either unmodified or H3K14
acetylated H3 N-terminal peptides (aa 1-20) that were C-terminally biotinylated.
Western blot analysis using either an α-GST antibody or streptavidin conjugated with
HRP was used to analyze the interaction between Jhd2 and the H3 N-terminal
peptides. A binding assay with glutathione agarose beads and peptide was used as a
negative control.
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Figure 5.3 Deletion of the H3 N-terminal tail does not affect the levels of Jhd2
interacting with chromatin.
ChIP analysis using an α-FLAG antibody was used to analyze Jhd2-3xFLAG levels
in a WT and 3-HDAC strain. Jhd2 protein levels were analyzed across the promoter,
5’-ORF, and 3’-ORF of PYK1 (A) and PMA1 (B). Input was used for normalization
and the levels of Jhd2-3xFLAG were set relative to an untagged control. Three
biological repeats were used with three technical repeats each. The error bars
represent the standard error of the mean.
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Figure 5.4 H2A mutations cause a decrease in H3K4 trimethylation levels
dependent on Jhd2 and form a surface on the nucleosome with a H2B residue.
(A) Whole cell extracts from the indicated strains were used to analyze H3K4,
H3K36, and H3K79 methylation levels compared to WT using H3K4 mono-, di-, and
trimethylation, H3K36 trimethylation, and H3K79 trimethylation specific antibodies.
Histone H3 was used as a loading control. (B) A zoomed in view of the nucleosome
is depicted showing residues H2A D73 and H2A N69 and adjacent residues,
including H2A R72 and H2B H52. (C) The residues of H2A that affect H3K4
trimethylation in a Jhd2 dependent manner form a surface with H2A D72 and H2B
H52. Structural modeling of H2A and H2B was done in PyMOL by Kelly Sullivan
from Joe Kappock’s lab at Purdue University.
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Table 5.1 ChIP analysis comparing Jhd2-3XFLAG binding in a H31-23 strain
to Jhd2-3xFLAG binding in a WT background normalized to an untagged
control (See Figure 5.3A and 5.3B)
Strain
Gene location
RQ
Fold change
P value
relative to WT comparing Jhd2
binding in WT
WT
PYK1 promoter 1
Jhd2-3xFLAG
PYK1 promoter 6.91
6.91 +/- 2.75
PYK1
promoter
10.99
10.99 +/- 3.70 0.426
H31-23 Jhd23xFLAG
WT
PYK1 5’
1
Jhd2-3xFLAG
PYK1 5’
12.66 12.66 +/- 2.35
PYK1
5’
11.77 11.77 +/- 1.63 0.801
H31-23 Jhd23xFLAG
WT
PYK1 3’
1
Jhd2-3xFLAG
PYK1 3’
13.63 13.63 +/- 2.15
PYK1 3’
9.25
9.25 +/- 1.04
0.188
H31-23 Jhd23xFLAG
WT
PMA1 promoter 1
Jhd2-3xFLAG
PMA1 promoter 9.66
9.66 +/- 1.09
PMA1 promoter 14.47 14.47 +/- 0.72 0.034
H31-23 Jhd23xFLAG
WT
PMA1 5’
1
Jhd2-3xFLAG
PMA1 5’
10.02 10.02 +/- 1.07
PMA1 5’
10.69 10.69 +/- 2.26 0.829
H31-23 Jhd23xFLAG
WT
PMA1 3’
1
Jhd2-3xFLAG
PMA1 3’
11.65 11.65 +/- 1.52
PMA1 3’
10.96 10.96 +/- 2.18 0.835
H31-23 Jhd23xFLAG
*Data represent three biological repeats with three technical repeats each.
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5.3.2

iChIP analysis in the human LNCaP cell line
We have developed a new ChIP procedure that we have named immediate

ChIP or iChIP. We show that iChIP shortens the time of a ChIP assay to a few hours
from cell lysis to data analysis (Figure 4.1, Figure 4.6, and Figure 4.7). iChIP also has
higher sensitivity as shown by the analysis of proteins that were previously difficult
to detect, Jhd2 and Rph1 (Figure 4.2). Furthermore, we also show the versatility of
this method by showing that iChIP could be used in both S. cerevisiae and A. thaliana.
However, this method had not been adapted for mammalian cells. Therefore, we
wanted to optimize iChIP for mammalian cells, specifically LNCaP cells, a prostate
cancer cell line. We were specifically interested in prostate cancer cell lines to further
analyze the connection between Set1 and cholesterol biosynthesis in a biologically
relevant system. We have previously shown in our lab that Set1 modulates the
synthesis of ergosterol, the yeast equivalent of cholesterol (184). In this study, we
show that cellular ergosterol levels are decreased in a set1 strain (184). We further
show that there was a reduction in the transcript levels for the genes involved in the
ergosterol biosynthetic pathway in when SET1 was deleted (184). Many of the genes
in the ergosterol pathway are conserved in the cholesterol biosynthetic pathway
(360;361). Interestingly, knock-down of WDR5, a member of the human H3K4
methyltransferase complex, resulted in a decrease in the expression of HMG-CoA
(362). This suggests that the role that Set1 and H3K4 methylation plays in ergosterol
production is conserved to humans.
HMG-CoA is the rate limiting step in both the ergosterol and cholesterol
biosynthetic pathways (360;361). It is also the target of Statin drugs, a FDA-approved
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drug that is prescribed to lower cholesterol levels (363;364). An interesting
hypothesis is that combined treatment with a Statin drug and an inhibitor for human
Set1 would further reduce cholesterol levels. Not only are modulating cholesterol
levels important for cardiovascular diseases, but there is a link between cholesterol
levels and cancer (363;364). Cancer cells show increased levels of HMG-CoA as
well as increased cholesterol levels (364-366). Increased cholesterol levels have been
shown to promote of cell proliferation and cell migration and there is a correlation in
high circulating cholesterol with aggressive prostate cancer (364;367;368).
Furthermore, the use of statins has been suggested to be an effective treatment for
prostate cancer (364;365). Therefore, with this strong correlation between cholesterol
and prostate cancer, we wanted to know if Set1 and H3K4 methylation plays a role in
promoting cholesterol biosynthesis in the prostate cancer cell line, LNCaP.
Before we test if knock-down of SET1A/B or members the histone
methyltransferase complex affects expression of HMG-CoA or cholesterol levels, we
need to optimize the iChIP protocol for mammalian cells. To optimize this procedure
iChIP was used to analyze histone H3 and H3K4 trimethylation levels at the first
exon of HMG-CoA in the LNCaP cell line.
5.3.2.1 Cell culture reagents and formaldehyde cross-linking
The epithelial prostate cancer cell line LNCaP was purchased from the
Americal Tissue Culture Collection (ATCC: Manassas, VA). The cells were
maintained at 37C with 5% carbon dioxide. The cells were maintained in RPMI1640 medium supplemented with 10% fetal bovine serum (FBS), 1% HEPES buffer,
1% sodium pyruvate, and 1% non-essential amino acids (NEAA). 20x107 cells were
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harvested using a 0.25% trypsin-EDTA solution. The cells were centrifuged at 150xg
for 7 minutes and the supernatant was removed. The cell pellet was resuspended in 37
mL of a 1% formaldehyde solution diluted in PBS and fixed for 8 minutes with gentle
rocking at room temperature. The cells were then centrifuged at 300xg for 7 minutes
and washed with 50 mL ice-cold PBS twice. The cells were pelleted and stored at
-80C. Cell maintenance and formaldehyde cross-linking was performed by Renee
Vickman from Dr. Tim Ratliff‘s lab at Purdue University.
5.3.2.2 Generating soluble chromatin for LNCaP cells
The cells were responded in 10 mL ice cold 1xPBS. They were resuspended
by pipetting up and down and then pelleted at 1200 rpm for 5 minutes at 4C. The
cells were then washed with 3 mL ice-cold Wash Buffer I (0.25% Triton X-100; 10
mM EDTA, pH 8; 0.5 mM EGTA, pH 7.5; 10 mM HEPES, pH 7.5) with protease
inhibitors (0.2 g leupeptin, aprotinin, and pepstatin A, 0.2 mM PMSF) and
centrifuged at 2100 rpm for 5 minutes at 4C. The pelleted cells were washed with 3
mL ice-cold Wash Buffer II (0.2 M NaCl; 1 mM EDTA, pH 8; 0.5 mM EGTA, pH
7.5; 10 mM HEPES, pH 7.5) with protease inhibitors and centrifuged at 2100 rpm for
5 minutes at 4C. The cells were then resuspended in 1 mL Lysis Buffer I (150 mM
NaCl; 25 mM Tris, pH 7.5; 5 mM EDTA; 1% Triton X-100; 0.1% SDS; 0.5% sodium
deoxycholate) with protease inhibitors. The resuspended cells were split into two 500
mL fractions. Each fraction were sonicated three times each (Misonix sonicator:
Power 6, 10 seconds, 6 times with 10 second rest) to shear the chromatin. After each
sonication the cells were placed directly on dry ice for 10 seconds. After sonication,
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the samples were centrifuged at 14000 rpm for 10 minutes at 4C. The supernatant for
each of the two samples were then combined and mixed.
5.3.2.3 LNCaP iChIP protocol
Before immunoprecipitation, two 225 µL of soluble lysate samples were
incubated with 5 µL magnetic beads (Dynabeads, Life Technologies 10004D) for 30
minutes with rotation at 4C to preclear the lysate. After the lysate samples were
precleared, the samples were combined and mixed. During this time 1 µL histone H3
antibody (Abcam; ab1791) and 1 µL H3K4 trimethylation specific antibody
(Millipore; 07-473) was individually incubated with 10 µL magnetic beads
(Dynabeads, Life Technologies 10004D) for 30 minutes with rotation at room
temperature in 200 µL 1xPBS(-K), pH 7.0 (39 mM NaH2PO4·H2O; 32.3 mM
Na2HPO4·7 H2O; 150 mM NaCl) to conjugate the antibody to the beads. 200 µL
1xPBS(-K) was also incubated with 10 µL magnetic beads as a no antibody control.
The antibody bound beads and no antibody control were then each rotated with 100
µL soluble lysate and 100 µL 1xPBS(-K). The beads were incubated with the soluble
lysate for 2 hours at 4C with rotation. The beads were then washed at room
temperature for 5 minutes each with sFA-140 wash buffer (50 mM HEPES-KOH, pH
7.5; 140 mM NaCl; 1 mM EDTA; 0.1% Triton X-100), sFA-500 wash buffer (50 mM
HEPES-KOH, pH 7.5; 500 mM NaCl; 1 mM EDTA; 0.1% Triton X-100), and finally
with 1xPBS(-K). 50 µL water was used to resuspend the beads.
5.3.2.4 Testing sonication efficiency
To prepare a DNA sample to test the sonication efficiency, 25 µL of soluble
chromatin was diluted with 370 µL TE, pH 8.0 (10 mM Tris; 1 mM EDTA) and
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reversed cross-linked overnight at 65C. After reverse cross-linking, the DNA was
ethanol precipitated and dried. The dried DNA was resuspended in 180 µL TE, pH
8.0. RNase (20 µg) was then added and incubated for 30 minutes at 37C. 20 µL
Proteinase K buffer (0.1M Tris-HCl, pH 7.8; 0.05 M EDTA; 5% SDS) was added
followed by the addition of 20 µg Proteinase K (Sigma P2308). This was then
incubated for 1 hour at 42C. The DNA was extracted with two
phenol/chloroform/IAA washes. The DNA was again ethanol precipitated, dried, and
resuspended in 50 µL water. 10 µL and 5 µL of this sample were run on a 1% agarose
gel. Though there was a smeared band at about 1000 bp, but the more prominent band
was between 100-200 base pairs (Figure 5.5A). However, this is a smaller fragment
than what was suggested, which is about 300-800 base pairs. Therefore, the
sonication of the mammalian chromatin will need to be further optimized to prevent
over-shearing. Furthermore, the chromatin may need to be treated with MNase to
ensure proper shearing.
5.3.2.5 LNCaP real-time PCR and statistical analysis
qRT-PCR was performed using the StepOnePlus Real-Time PCR System
(Life Technologies). To ensure equal amount of DNA loaded into the reaction
mixture, the samples were regularly vortexed to ensure suspension of the beads. 1 µL
of the on-bead mixture were used for each of the three technical repeats. The DNA
was amplified using TaqMan Master Mix (Life Technologies 4369510) and
PrimeTime probe sets (Integrated DNA Technologies), which are described in Table
5.2. The mean relative fold changes compared to the no antibody control of three
technical repeats are found in Table 5.3. qRT-PCR analysis indicated that histone H3
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and H3K4 trimethylation levels were observed over the no antibody control (Figure
5.5B and 5.5C). This procedure was repeated (n2) without the addition of protease
inhibitors. For the second experiment a signal was observed over the no antibody
control; however, the signal was reduced indicating that for the mammalian iChIP
protease inhibitors will need to be added to ensure the integrity of the sample (Figure
5.5B and 5.5C). Further analysis will need to be performed to compare the iChIP
protocol to the standard ChIP procedure. For a positive control, a highly active gene
that is known to have high levels of H3K4 trimethylation will need to be used. A
heterochromatic gene would be used as a negative control. Once the iChIP protocol is
optimized for histone post-translational modification, the iChIP protocol will then be
used to specifically target chromatin-associated proteins.
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Figure 5.5 Sonication of LNCaP chromatin results in a 100-200 base pair
fragments and Histone H3 and H3K4 trimethylation levels are observed above
background at HMG-CoA exon 1.
(A) 10 µL and 5 µL of isolated DNA from the LNCaP soluble lysate were run on a 1%
agarose gel for 20 minutes at 100V. (B and C) ChIP analysis of two biological
repeats was use to analyze Histone H3 (B) and H3K4 trimethylation (C) levels at
HMG1-CoA exon 1. The levels of histone H3 and H3K4 trimethylation were set
relative to no antibody control (No Ab).
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Table 5.2 Probe sets for iChIP analysis in LNCaP cells
Primer name
Sequence 5’-3’
HMG1 exon 1
/56FAM/ATTGTGTGT/ZEN/GGGACCGTAATGGCT/3IABkFQ/
AAATGCCCGGCAGCTTG
CTGCCAATGCTGCCATAAGT
Table 5.3 iChIP analysis of H3 and H3K4me3 in LNCaP cells
Gene
Biological repeat
Target
Fold Change relative to no
antibody control
HMG1 exon 1 1
Histone H3
13.29
HMG1 exon 1 2
Histone H3
8.04
HMG1 exon 1 1
H3K4me3
26.10
HMG1 exon 1 2
H3K4me3
8.76
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In the 2009 Cell Cycle feature “To be or NOT to be demethylase” I focused on
writing about the human histone H3K4 demethylases, and how these demethylases that
are homologues of Jhd2 are correlated with multiple diseases, such as cancer and mental
retardation

In the 2013 Proceedings of the National Academy of Sciences publication “H3K4
methyltransferase Set1 is involved in maintenance of ergosterol homeostasis and
resistance to Brefeldin A” my role was to demonstrate that H3k4 methylation and not just
the Set1 protein caused a reduction of transcript for the genes involved in the ergosterol
pathway and an increase in transcript for genes involved in ergosterol uptake. To do this I
looked at the transcript levels of two genes: HMG1, the rate limiting enzyme in
ergosterol biosynthesis, and DAN1, a protein that is important in the uptake of ergosterol
from the external environment when the cell cannot make ergosterol. I looked at two
different histone mutations compared to wild-type in the respective yeast strains. The first
mutation was the H3K4R mutation. This mutant cannot be methylated and therefore
represents the unmodified H3K4 state. The other mutation was H3B K123R. This
mutation prevents the monoubiquitination of H2B, which is necessary for H3K4 di- and
trimethylation and for wild-type levels of H3K4 monomethylation. Both of these histone
mutants gave a similar phenotype to a set1 strain. These experiments were essential for
the study to be accepted to PNAS, as they were requested by the reviewers and the editor.

226

227

228

229

230

231

232

233

234

235

236

237

238

